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Abstract 
Near-infrared (NIR) spectroscopy offers tremendous advantages for pharmaceutical 
manufacturing as a fast and non-destructive method of quantitative and qualitative 
analysis. Content uniformity (end-product analytics) and process analytics are two 
important applications of the method. 
Both modes of analysis, diffuse transmission (DT) and diffuse reflection (DR) are 
sensitive to changes in sample physical parameters. Scaling as well as baseline shifts due 
to tableting variations would be a potential cause of many outliers and prediction errors, 
and therefore these effects need to be more clearly understood. Moreover, there is 
currently no clear literature information about the sampling span in both modes 
(horizontal or radial in DT, and vertical or information depth in DR). This information is 
vital in content prediction using NIR in cases where inhomogeneities in the sample are 
detrimental (e.g. low-dose API in large samples). 
The press effect was investigated using placebo tablets of different thickness and 
porosity ranges, which showed an exponential relationship with the diffuse 
transmission (DT) signal. The drug content of 2.5% m/m folic acid tablets produced 
under different compaction conditions was predicted and found to be in statistical 
agreement with UV assay results after inclusion of physical outliers to the training sets. 
To determine the sampling span in DT, placebo tablets of 10 mm diameter were covered 
by different paper filters with incremental central block and the DT maximum at 8880 
cm-1 was used to assess the degree of block. 90% of the signal was detected from a 
diameter of up to 7 mm. 
For DR information depth assessment, three experiment approaches were pursued: I. 
0.5–10 mm incremental thickness placebo tablets with constant porosity, II. 
MCC/Phenylbutazone (PBZ) double layered (DL) tablets (PBZ layer 0-100% in 0.5 mm 
steps) and III. Comparison of placebo and 30% caffeine tablet cores with incremental 
film coating (film thickness of 0 – 0.35 mm). Incremental thickness and cluster analysis 
of DL tablets showed that DR information depth was < 0.5 mm, while the data fitting 
from incremental coating showed that signal drop reached 50% at 0.05 – 0.07 mm 
depending on the wavenumber and 90% signal drop (10% information content) can be 
seen between 0.2 – 0.25 mm without extrapolation. 
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1. Introduction 
Near-infrared spectroscopy (NIRS) is the measurement of the wavelength and intensity 
of absorption of near-infrared (NIR) light by a sample. The NIR spectral region spans the 
range from 700 to 2,500 nm (14,285 – 4,000 cm-1) with absorptions representing 
overtone and combinations from the fundamental molecular vibrations found in the 
mid-infrared (MIR) region. These overtones and combinations mainly are associated 
with C–H, N–H, O–H and S–H functional groups. NIRS uses chemometrics to analyze the 
functional groups present in a sample mixture. As a quality and process control 
technique NIRS analysis methods are applied to raw material, intermediates and 
finished products. NIRS historically was developed as a quantitative analysis technique, 
but during the past 10 years chemometrics methods have led to qualitative applications. 
As NIRS continues to grow in importance as a useful analytical technique, it offers 
unique potential as a rapid, non-destructive method of quantitative and qualitative 
evaluation. NIRS has been used extensively in the food and agricultural industries for 
many years to determine moisture, protein, and starch content in grains. The 
pharmaceutical industry has been cautiously slow to accept NIRS as a commonly used 
technique, probably because of the absence of primary absorption bands. In recent 
years, an increasing amount of academic research is being carried out on the theory 
behind NIR. The use of NIRS for pharmaceutical applications has grown owing, in part, 
to technological advances in instrumentation and software. 
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1.1 Historical overview 
In his famous work, “Experiments on the Refrangibility of the Invisible Rays of the Sun,” 
presented to the Royal Society (Hershel 1800), Sir William F. Herschel first 
demonstrated the existence of optical radiation beyond the limits of the visible 
spectrum. In a series of experiments probing the relationship between colour and heat, 
Herschel observed an increase in temperature from violet to red. In a serendipitous 
moment, however, he discovered that the hottest temperature was actually beyond the 
red limit of visible light. This invisible radiation, which he initially termed as “calorific 
rays,” is actually what has come to be known as short-wave near-infrared. 
The NIR spectral region was largely ignored as an analytical asset for nearly 150 years 
following Herschel’s discovery (Burns and Ciurczak 2001) until Karl Norris, an 
agricultural engineer working for the U.S. Department of Agriculture (USDA), saw its 
potential for rapid, quantitative analysis of complex biological samples. Norris’s work 
eventually initiated the development of an NIR industry that produced analyzers capable 
of rapidly determining the concentration of constituents in whole foodstuffs with very 
little sample preparation. From the mid-1960s until 1986 the rate of publications on NIR 
spectroscopy increased dramatically, with most articles concerned primarily with the 
analysis of food and agricultural products and in 1987 Phil Williams and Karl Norris 
edited a comprehensive text with nearly 1000 references on the subject of NIR 
technologies (Williams and Norris 2001). 
NIR technology has generally advanced by following technology developments in 
seemingly unrelated industries. The interest in the NIR region of the electromagnetic 
spectrum lagged behind the UV, VIS and MIR regions for most of the twentieth century. 
Unlike the sharp absorbance bands of the MIR fingerprint region utilized for qualitative 
analyses in synthetic organic chemistry, the absorbance bands in the NIR are weak, 
broad, overlapping,  and of great complexity to interpret. Moreover, early chemists had 
difficulty specifying baseline effects in the NIR region, and they viewed NIR spectroscopy 
as being less reliable for quantitative assays relative to UV/VIS spectrophotometry.  
As enabling technologies began to appear in the mid of the 20th century, Karl Norris’s 
early work was revolutionary in that it utilized grating/prism monochromators, new 
broad-band detectors and powerful digital computing capabilities (Norris and Williams 
1984). After that, the popularity of NIR spectroscopy accelerated during the 1970s and 
1980s with the development of low-cost personal computers. 
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After the 1990s, NIRS grew more with the introduction of InGaAs diode array detectors, 
tunable NIR lasers and fibre-optics and the method started to earn its reputation as a 
powerful analytical technology in its own right. It was not until then that the negative 
aspects of the technology were turned into positive features and NIRS was ultimately 
found to be useful because the relatively weak absorbance bands in the region allow for 
interrogation of sample matrices to greater depth than is possible in the IR and UV/VIS 
regions. 
The complex nature of NIR absorbance bands and baseline effects initially posed a 
dilemma. The study of chemometrics has yielded the ability to resolve NIR spectra for 
simultaneous multi-component analyses. The scope of data treatment display and 
interpretation was enhanced to include MLR, PLS, PCA, and cluster analysis and third-
party software suppliers started to offer a wide choice of chemometrics software freeing 
users from the constraints of instrument suppliers. 
Today, NIRS have gained wide acceptance from many industries, including 
pharmaceutical, and is being tested and used in many areas of production starting from 
identification of raw materials, process control and end product analysis. 
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1.2 Theoretical aspects 
An important point to be realized is that the NIRS has unique features among other 
regions of the electromagnetic spectrum. Therefore, treating the NIR region as an 
extension of IR or UV/VIS during method development or application will only lead to 
failure because of the unique aspect of the interaction between solid materials and NIR 
radiation at the molecular and particle scales set NIR spectroscopy apart from other 
methods. 
1.2.1 Molecular vibrations 
Atoms in a molecule are in a continuous movement even close to the absolute zero 
temperature. The physical scale of the vibrational movement of atoms in molecules is 
rather small. This movement is confined within this narrow range by a potential energy 
well, formed between the binding potential of the bonding electrons, and the repulsive 
(mainly electrostatic) force between the atomic nuclei a quantum distribution of energy 
levels is expected (Figure 1A) with a set of discrete allowed energy levels of equal 
intervals of energy between them and a non-zero potential energy within the well. 
However, real molecules show non-conformity to the potential energy well in with the 
simple harmonic model. In the simple harmonic model, the potential well is entirely 
symmetrical and the potential energy rises equally with displacement in both positive 
and negative directions from the equilibrium position. This is counter-intuitive because 
the forces responsible for the rise in potential energy are different in the two cases. In 
the bond-stretching case the dominant factor is the shifting of the molecular orbital 
away from its minimum energy configuration. In the bond-compression case, there is the 
additional factor of electrostatic repulsive energy as the positively charged atomic nuclei 
approach each other. Thus one would expect the potential energy curve to rise more 
steeply on the compaction cycle, and (due to the weakening of the bond with 
displacement) to flatten off at large displacements on the decompression cycle (Figure 
1B). 
There are two effects of the anharmonicity of the quantised energy levels described 
above, which have significance for NIRS. First, the gap between adjacent energy levels is 
no longer constant, as it was in the simple harmonic case. The energy levels converge as 
n increases. Secondly, weak absorptions can occur with Δn = ±2 (first overtone band), or 
±3 (second overtone band), etc. 
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Figure 1: Schematic representation of the harmonic (A) and anharmonic (B) models for 
the potential energy of a diatomic molecule.  
de = equilibrium distance (U = minimum) (Pasquini 2003) 
1.2.2 The origin of absorption bands in the NIR region 
The match of radiation energy with the energy difference between two vibrational levels 
causes a selective response of the molecular system to the incident radiation. It means 
that in a given wavelength range, some frequencies will be absorbed; others (that do not 
match any of the energy differences possible for that molecule) will not be absorbed 
while some will be partially absorbed. This complex figure of the intensity of absorption 
versus wavelength constitutes the absorption spectra of a substance or sample. For a 
vibration to be active, it is necessary that the electrical oscillating field of the 
electromagnetic wave can interact with the molecule. This can only occur if the 
displacement of the atoms in a vibrational mode can produce a change in the dipole 
moment of the molecule or in the local group of vibrating atoms.  
In polyatomic molecules, transitions to excited states involving two vibrational modes at 
once (combination bands) are also weakly allowed, and are also affected by the 
anharmonicity of the potential. The role of combination bands in the NIR can be 
significant. The only functional groups likely to impact the NIR spectrum directly as 
overtone absorptions are those containing C-H, N-H, O-H or similar functionalities. 
However, in combination with these hydride-bond overtone vibrations, contributions 
from other, lower-frequency fundamental bands such as C=O and C-C can be involved as 
overtone-combination bands. The effect may not be dramatic in the rather broad and 
overcrowded NIR absorption spectrum, but it can still be evident and useful in 
quantitative analysis. For combination bands to occur, it would be necessary that only 
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one of the combining vibrations be active (causing dipole change). This feature may 
cause some vibrations, which cannot be observed in the middle infrared, to be displayed 
by a NIR spectrum. 
The intensity of a given absorption band is associated with the magnitude of the dipole 
change during the displacement of atoms in a vibration and with its degree of 
anharmonicity. Both phenomena are present in great intensity associated with bonds 
involving the hydrogen atom and some other heavier element such as carbon, nitrogen 
and sulphur. The O-H, C-H, N-H and S-H bonds tend to present high anharmonicity and 
high bond energy with fundamental vibrational transitions in the region of 3000 – 4000 
nm. Intensities are in between 10, for combinations, up to 1000, for successive 
overtones, times lower than the absorption resulting from fundamental vibrations. The 
spectral occurrences in the NIR region are dominated by overtones and combination 
absorption bands. Coupling or resonance between different vibrations of the same 
functional group and Fermi resonance between a fundamental and an overtone when 
their difference in energy is very low also occur resulting in a greater separation 
between the position of the two bands and in the intensification of the overtone band. 
The complexity of the combination spectral region in the NIR spectrum of hydrocarbons 
is partly due the possibility of resonance between the combination bands and high order 
overtone for C-H bonds. The primary practical consequence of both types of resonance 
on a NIR spectrum is the possibility of the appearance of two instead of one band in the 
combination region (1600 – 2500 nm).  
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1.3 NIR diffuse transmission for solids 
One of the most important aspects of the interaction between NIR radiation and 
particulate solids is the unique combination of relatively weak absorbance intensity 
with high scattering efficiency. This combination allows the NIR radiation to probe the 
interior of many solid samples with little or no sample preparation. The spectroscopic 
analyses of solids in the NIR region are performed using two primary modes of sampling 
geometry: transmittance and diffuse reflectance (DR). The transmittance measurement 
through particulate solids is a distinctive capability of spectroscopy in the NIR relative to 
UV/VIS and IR.  
In general, sample transmittance, T, is estimated as the ratio of intensities for light 
transmitted through an empty path (e.g., cuvette), I0, and light transmitted through an 
equal distance of a particulate sample, Is. Transmittance data are most often reported in 
terms of Beer-Lambert absorbance: 
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where, for a single wavelength, γ: 
A = Beer-Lambert optical absorbance 
T = transmittance ratio 
a = absorption coefficient, cm-1 
b = pathlength (or sample thickness), cm 
c = concentration of absorbing species. 
 
In contrast to UV/VIS (transmission) absorption spectrophotometry, which is typically 
performed in dilute solution, the transmittance of NIR radiation through a sample 
matrix comprised of tightly packed solid particles is expected to deviate nonlinearly 
from the Beer-Lambert law of absorption. The source of these deviations becomes 
apparent when the derivation and simplifying assumptions of the Beer-Lambert law, or 
simply Beer’s law, are considered. The most notable deviations from Beer’s law for NIR 
transmittance through clear liquids are due to changes in absorption coefficients across 
wide ranges of concentration. Beer’s law assumes that the response between optical 
absorption, A, and concentration c, is expected to be linear. The transmittance through 
particulate solids is less accurately described by the Beer-Lambert law, however, 
because it also assumes that all radiation encountering an absorbing particle will either 
be transmitted or absorbed. There is, however, a finite probability that incident photons 
will be scattered or reflected either forward or backward relative to the direction of 
propagation of the incident beam, I
transmitted directly through particulate samples; rather
through the material with multiple opportunities for scattering and backward reflection 
(Figure 3). 
Figure 2: The optical interactions, of which the three fluxes are comprised of: (a) 
incident beam absorption, (b) specular reflectance, (c) transmittance, (d) forward 
scatter, (e) back scatter, (f) anisotropic scattering intensity fields
Because the intensity of scatt
transmittance through a solid sample will become less diffuse as the absorptivity 
decreases. These effects tend to increase the path a photon will travel before being 
emitted from the sample. Thus, the 
plane of compressed particulates of thickness b will be a normally distributed amount 
greater than b. Furthermore, as b increases, the transmitted radiation will become more 
diffuse until the diffuse thickne
maximum amount of incident radiation reflected back toward the source occurs. Hence, 
solid-state transmittance in the NIR region mi
transmittance spectroscopy.
DT NIRS is usually performed in the third overtone region, between 780
Although scatter coefficients increase in the NIR with increasing frequency, the 
scattering efficiency in the third
loss to backward reflection is reduced along due to the decreasing absorption coefficient 
(Dahm and Dahm 2001). 
0 (Figure 2). Thus, the incident photons are not 
, they take a tortuous path 
ered radiation decreases along with absorptivity, the 
effective pathlength for transmittance through a 
ss is achieved (Birth and Hecht 1987), at which point the 
ght more aptly be termed diffuse 
 
 overtone region is low because the amount of radiation 
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-1100 nm. 
The absorptivity, reflectance, and scattering characteristics for a particular sample are 
dependent on multiple material qualities, such as particle size and morphology, packing 
density, and index of refraction. Hence, the effective pathlength and the level of 
nonlinearity relative to Beer’s law are difficult to predict in practical situations.
Figure 3: Diagram showing the types of light interaction in the NIR region with 
particulate solids. In practice, only diffuse reflection and transmission are 
  
 
26 Introduction 
 
 
observed 
 
27 Introduction 
1.4 NIR diffuse reflection for solids and its 
theories 
1.4.1 Early theories 
NIR DR analysis is a defining quality of the method which permits quantitative analysis 
of material qualities for granular or particulate samples in fluidized beds, mixing vessels, 
or on moving belts.  
The sample reflectance, R, is most often estimated as the ratio of intensities for light 
reflected from a non-absorbing, diffusely reflecting surface (e.g., white ceramic or inner 
surface of an integrating sphere), I0, and light reflected from the sample, IS. Reflectance is 
most often reported in terms of absorbance units, log (1/R), regardless of the derivation 
of Beer’s law mentioned earlier. These apparent absorbance spectra collected in 
reflectance are also treated as being linearly correlated with the concentration 
according to Beer’s law with nonlinearities being either ignored over a narrow 
concentration range or are approximated by additional empirical model factors or 
nonlinear terms. 
The earliest attempts to describe DR treated it strictly as a surface phenomenon. 
Bouguer (1760) suggested it as mirror-type reflections from microcrystalline faces 
statistically distributed over all possible angles.  
Lambert cosine law (Lambert 1760) went a step further by describing a mathematical 
relationship between the intensity of an incident beam of light, angle of incidence and 
angle of observation. The problem was that an ideal diffuse reflector postulated by the 
theory has never been found, and this was the reason why the theory fails in practice. 
Seeliger (1888) was the first to consider DR as penetrating the surface of materials, 
where it is either absorbed or returned to the surface via reflection, refraction, or 
diffraction from the surfaces of the internal microstructure (summation of surface 
reflection and elastic scatter). 
Mie Theory (Mie 1908) was one of the major works describing elastic scattering 
phenomenon and its relationship with the frequency of radiation. The theory’s central 
assumption is that scattering is associated with isolated, spherical particles. According 
to this theory, scattering is not distributed isotropically (uniform optical properties in all 
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directions); rather, a complex pattern is produced; with forward scatter preferred over 
reverse scatter. 
 ( )
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where 
λ  = single wavelength under consideration 
Iθscat  = intensity of scattered radiation at distance R and angle π from the centre 
of the scattering particle 
i1, i2  = Complex functions of the angle of the scattered radiation, the spherical 
harmonics, or their derivatives with respect to the cosine of the angle of 
scattered radiation, the refractive index of both the sphere and 
surrounding medium, and the ratio of the particle circumference to 
wavelength 
 
Equation (0.2) shows that as the wavelength increases, the intensity of scattered 
radiation will increase, one of the factors contributing to the shape of the upward-
sloping baseline observed in the NIR absorbance of solids (downward sloping if 
reflectance is reported). 
However, particles in real solid systems are not isolated but in intimate contact with one 
another. Additionally, the theory did not consider multiple forward- or back-scattering 
events. Theissing (Theissing 1950) showed that as the number of times a photon is 
scattered increases the distribution of scattered radiation will deviate further from Mie’s 
theory, becoming more isotropic and with greater proportion of the radiation being 
scattered in the reverse direction.  
1.4.2 Later works and Kubelka-Monk’s theory 
Most other theories have evolved from energy transfer treatments, which describe the 
change in intensity of a beam of radiation of a given wavelength in a sample of a given 
density and pathlength due to total radiation loss from scattering and absorption that 
corresponds an attenuation coefficient (Truelove 1988) and (Craig and Incropera 1984). 
Schuster (1905) reported a simplified solution of the radiation transfer equation for the 
case of reflectance by assuming the total radiation flux is comprised of two components, 
one flux travelling in the forward direction and a second flux travelling in the reverse 
direction. 
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Kubelka and Munk (1931) made more assumptions in their derivation of a simplified 
solution to the radiation transfer equation. The final derivation is shown in equation 
(0.3) and shows that the measured DR (R∞) is dependent on the ratio of K and S 
(absorption and scattering coefficients respectively). 
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Kubelka and Munk’s solution is the most widely accepted DR explanation since it is a 
two-constant equation and therefore experimentally testable. Moreover, many other 
derivations by other workers like Smith (1931), Amy (1937) and Bruce (1926) have 
been shown to be derivable from Kubelka and Munk’s work. 
1.5 Instrumentation and analyzer technologies 
1.5.1 Light sources 
The tungsten-halogen source is almost universally used for NIRS. It has a broadband, 
pseudo-blackbody emission spectrum with no significant structure. It is inexpensive and 
remarkably long-lived if operated at appropriate filament temperature and lamp 
wattage. The peak spectral radiance of a tungsten lamp is located at approximately 
10,000 cm-1 (1000 nm) with a lifetime of around 10,000 hours. 
1.5.2 Photon detectors 
The most frequently employed detectors for the NIR spectral region are based on silicon, 
PbS and InGaAs photoconductive materials. The latter possess a very high photo-
detectivity and response speed. Together with high powered radiation sources (a 
tungsten coil or a halogen lamp, see above) these detectors can impart a very high signal-
to-noise ratio for NIR measurements. This fact partially compensates for the lower 
intensities of NIR absorption bands. 
1.5.3 Wavelength section methods 
1.5.3.1 Filter-based instruments 
Filter instruments often employ a set of 10–20 interference filters mounted on a high-
speed rotating filter wheel positioned between collection optics and a single detector. 
High-speed measurement is possible (approximately as fast as a diode array 
spectrometer) by spinning the filter wheel at a very high rate (10,000 rpm). Fast Fourier 
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transform (FFT) of the detected signal can be used to isolate the spectral intensity data 
from instrumental noise effects, which, along with the simple, efficient design, make 
filter instruments very robust devices for single-material measurement. Filter 
instruments have been significantly deployed as in-line moisture gauges, though some 
have been successfully calibrated for multi-constituent content predictions. However, 
they provide limited spectral information and are more expensive compared with low-
cost diode array systems. (Scott 1995) 
1.5.3.2 LED-based instruments 
To reduce the price and size of the instruments, Light Emitting Diodes (LED) technology 
is used in some applications. These devices can produce NIR radiation with a band width 
of about 30 - 50 nm, centred in any wavelength of the spectral region. The instruments 
can employ a set of LEDs as sources of narrow bands of near infrared radiation28-30 or use 
them to produce a polychromatic, highly stable source whose radiation is dispersed by 
using common monochromator devices such as those based on gratings or filter optics. 
However, LEDs operating at wavelengths higher than 1100 nm are still expensive. 
(Wilson, Barnes et al. 1995) 
1.5.3.3 AOTF instruments 
Acousto-Optical Tunable Filter (AOTFs) technology allows constructing instruments 
with no moving parts, capable of reaching very high scan speeds over a broad range of 
the NIR spectral region. Any number of wavelengths necessary to perform a given 
analytical determination can be easily implemented with scan speeds of up to 2000 
wavelengths per second, which is only limited by the detector response time. 
An AOTF is a device made of a birefringent crystal of TeO2, cut in a special angle and a 
piezoelectric material (usually LiNiO4) is attached to one end of the crystal which, under 
excitation from an external RF signal, producing an acoustic wave which propagates 
through the crystal and produces a periodic variation of the refractive index of the 
crystal in a frequency determined by the RF signal, in the range of 50 to 120 MHz. The 
interaction of the electromagnetic wave and the acoustic wave causes the crystal to 
refract selectively a narrow wavelength band. The birefringence of the TeO2 crystal leads 
to the production of two monochromatic beams and both or only one diffracted beam 
can be used by NIR instruments (Figure 4). 
This non-moving parts concept of the AOTF-based NIR spectrophotometers impart to 
them some unbeatable qualifying characteristics for use in the field or on the factory 
floor, aiming at in-line monitoring. The wavelength precision is about ±0.05 nm and the 
resolution is dependent on the wavelength, with typical values in the range 5 to 15 nm 
for the wavelength in the range 1000 to 2500 nm. 
Figure 4: Schematic representation of AOTF 
1.5.3.4 Dispersive optics-based instruments
Diffraction gratings dispersive instruments were among the earliest technologies 
employed in NIR (Figure 5). These instruments have the advantage of a relatively low 
cost when compared with other scanning instruments employing modern technologies. 
The main disadvantages, however, is the slow scan 
which deteriorates with time due to mechanically driven mechanism fatigue, which 
limits the use of dispersive instruments in production environments.
Figure 5: Diffraction grating NIRS. The inc
mirror and guided on to the diffraction grating, where it is spatially split into its 
different spectral components. A second concave mirror focuses the various spectral 
components of the light onto different co
light's spectrum in a single acquisition.
Nevertheless, recent evolution in sensor production technology gave dispersive optics a 
longer life by constructing linear arrays of PbS and InGaAs sensors containing u
independent elements. This allowed scanning an entire spectrum in a few milliseconds 
and eliminated the moving parts.
(Tran 1992) 
(Davidson, Spring et al. 2006)
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1.5.3.5 Fourier transform (FT) instruments 
FT-NIR spectrometers are most advantageous when high-resolution capabilities are 
important or if the spectrometer needs to have many options for sample interaction. The 
spectral resolution of an FT-NIR analyzer is constant across the spectral range detected 
and is adjusted by varying the length of the interferogram. In a Michelson 
interferometer, this corresponds to the range of displacement for the moving mirror and 
will require longer scan times for equivalent performance in terms of signal-to-noise 
ratio (SNR). 
The FT spectrometers have a combination of three theoretical advantages, which make 
the technology attractive: 
All frequencies (wavelengths) are detected simultaneously (Fellgett’s advantage) 
Wavelength accuracy is constantly maintained by an internal laser line (Connes 
advantage) 
The interferometer has much higher optical throughput than other (dispersive) 
technologies (Jacquinot’s advantage) 
In contrast to the analyses of gases or liquids, the resolution needs for most applications 
of NIR for the analysis of pharmaceutical solids could be met with relatively low 
resolution (8–64 cm-1 or 6–12 nm). This is due to the extensive coupling of molecular 
bond vibrations in pharmaceutical solids, which results in rather wide absorbance 
bands, which offers the advantage of a higher SNR. The spectral range of modern FT-NIR 
spectrometers is mainly limited by the sensitivity of the detector material, rather than 
the mechanical stability of the optical platform.  
The polarizer interferometer (Ciurczak 2005) relies on a two-piece birefringent crystal 
wedge polarizer and birefringent compensator to modulate optical energy in the pattern 
of a Fourier interferogram. Figure 6 shows that randomly polarized radiation passes 
through a linear polarizer and a birefringent crystal, which separates the light into two 
orthogonally polarized parallel rays with a (wavelength specific) phase shift, thereby 
slightly rotating the plane of polarization. The phase-shifted rays are transmitted 
through the two-piece wedge polarizer, which then rotates the plane of polarization in 
the opposite direction, reducing the phase shift. The angle of polarization rotation is 
dependent on the effective pathlength through the wedge polarizer, and wavelength. At 
the initial position, the thickness of the wedge polarizer is set so that the polarization 
rotation angle (at all wavelengths) perfectly offsets the compensator, resetting the 
polarization state to that of the first polarizer. In this state, the maximum light energy at 
all wavelengths will pass through the second polarizer (DC intensity). As the thickness of 
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the wedge polarizer is varied, the polarization angle incident on the second polarizer 
will vary in a sinusoidal pattern between 0 and 100% transmittance; the frequency of 
the sinusoidal pattern will vary according to optical frequency. Therefore, the sum of the 
components incident on the detector will produce an optical interferogram. The optical 
efficiency of the device is limited by absorption in the beam path, especially as the 
thickness of the wedge polarizer reaches a maximum (which will limit maximum 
resolution). 
 
Figure 6: Overall schematic of the polarization interferometer. A sample is placed after 
the last lens and before the detector. A second lens then is needed to compensate for 
signal divergence through the sample. (Ciurczak 2005) 
Early polarisation instrument models suffered from some wavelength stability 
problems, recent upgrades of the technology have yielded a very robust instrument with 
more than adequate resolution capability (Cogdill and James K. Drennen 2006), (Buchi). 
Because there is only a single optical path through the instrument (compared with the 
dual path of Michelson, Sagnac, or Mach-Zender interferometers), the polarization 
interferometer is less affected by small misalignments in the beam path, the sort of 
which might arise during at-line or in situ operation. Furthermore, the simple design is 
more cost-effective and can be produced with a smaller footprint.  
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1.6 Application-based instrument selection 
criteria 
Modern NIR instrumentation for the analysis of pharmaceutical solids is best classified 
according to the demands of the application, as follows (FDA 2004): 
At-line and off-line: Measurement where the sample is removed, isolated from, 
and analyzed in close proximity to (at-line) or away from (off-line) the process 
stream. 
Applications include raw material identification, investigation of in-process (sampling) 
and finished materials, and data collection for method development. Many at-line NIR 
analyzers have automated sample conveyors and/or fibre-coupled probes. As they may 
be used for a wide variety of tasks, at-line analyzers generally offer the widest spectral 
range (often covering the entire NIR region), the highest spectral resolution, and 
internal means for background correction and performance qualification. These 
analyzers can be both interferometric, usually FT-NIR, or dispersive, typically utilizing a 
grating monochromator. 
On-line: Measurement where the sample is diverted from the manufacturing 
process and may be returned to the process stream. 
Process analyzers are often located in hazardous or controlled environments and their 
performance must be stable and robust to environmental variation. In addition, frequent 
instrument standardization and maintenance may be hindered by access or scheduling 
restrictions. Furthermore, frequent re-standardization or calibration updates can 
become a regulatory problem. The other critical factor affecting technology selection 
(and method development) is robustness (Zeaiter, Roger et al. 2004). 
An at-line type of spectrometer can be adapted for on-line use by employing an 
automated sample handling mechanism if analysis speed was not critical. However, 
speed will often be a critical factor for on-line analyses of in-process materials or 
finished products. Thus, spectral range, resolution, sensitivity, or SNR may be sacrificed 
to increase the measurement speed. FT-NIR instruments have been developed for on-
line applications by significantly reducing the length of measured interferograms. 
Grating monochromators can also be deployed effectively for some on-line applications. 
Acousto-optic tunable filter (AOTF) and holographic grating diode arrays have also some 
advantages in this field. 
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In-line: Measurement where the sample is not removed from the process stream. 
The main difference from on-line instruments is the way the sensor interacts with the 
process. In-line measurements are typically performed by non-invasive or noncontact 
sensing directly through an optical window while the process is running.  
Because the material being analyzed by in-line sensors is typically in motion, very high-
speed spectrometers, especially diode array devices, are preferred. Slower-scanning 
instruments will often work for dynamic processes, provided that scan time is much less 
than the overall process time. In common with on-line applications, robust design of the 
sampling system is also a critical aspect of in-line sensor design. The spectrometer 
window should be resistant to material-wearing effects (e.g., sapphire) and might have 
an automated cleaning mechanism.  In-line instruments may often be small and like to 
resemble a sensor much more than an analyzer. The use of RF wireless communication 
and battery-powered source illumination allow process spectrometers to be attached to 
moving equipment (e.g. blenders).  
Diode array instruments are usually the most ideal for in-line use. Because in-line 
applications often involve long-term measurement of a single type of material, filter-
type instruments (discrete photometers) are another option. Fast Fourier transform 
(FFT) of the detector signal can be used to isolate the spectral intensity data from 
instrumental noise effects, which, along with the simple, efficient design, make filter 
instruments very robust devices for single-material measurement.  
Recently, NIR “micro-spectrometers” have been developed, which has the potential to 
greatly increase the pervasiveness of NIR process monitoring by producing extremely 
small, relatively inexpensive devices, based on microscopic tunable Fabry-Perot 
interferometers that are built into a single microchip. (Axsun) 
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2. Chemometrics 
The term chemometrics was first used in 1971 to describe the growing use of 
mathematical models, statistical principles, and other logic-based methods in the field of 
chemistry and, in particular, the field of analytical chemistry. Chemometrics is an 
interdisciplinary field that involves multivariate statistics, mathematical modelling, 
computer science, and analytical chemistry. 
Rapid technological advances, especially in the area of computerized instruments for 
analytical chemistry, have enabled and necessitated phenomenal growth in the field of 
chemometrics over the past 30 years.  
Multivariate analysis 
Because our environment is inherently multivariate, it is only logical to treat multiple 
measurements simultaneously in any data analysis procedure. By properly considering 
the distribution of multiple variables simultaneously, more information is obtained than 
could be obtained by considering each variable individually.  
The additional information comes to us in the form of correlation which is overlooked if 
one variable at a time was examined. The advantages of chemometrics are often the 
consequence of using multivariate methods. Multivariate methods offer many 
advantages compared with univariate methods. Noise reduction is possible by 
eliminating redundant variables and partially selective measurements can be obtained 
free of the effects of interfering signals. Also, easier identification of false-identity or 
low-grade samples because the calibration is dependent on multiple factors which are 
more likely to point in the wrong direction in such cases (Bro 2003). 
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2.1 Spectral pre-processing (pretreatments) 
The successful application of multivariate calibration methods is hindered by the 
presence of uninformative variance in the NIR spectra. Baseline effects may occur from 
small changes in sample properties (packing density, surface texture, temperature and 
humidity, inhomogeneities, etc.). In addition, uninformative variance may be introduced 
into a data set by changes in the operational parameters of the NIR spectrometer. 
One approach to minimise these effects, is by applying mathematical pre-treatments to 
spectra. There are many types of such pre-treatments options, some of which are 
commonly indicated for certain conditions (like derivatives to exclude baseline shifts), 
while in many cases their use is strictly sample- and application-dependent.  
2.1.1 Mean Centring and Variance Scaling 
The application of mean centring and variance scaling is auto-scaling. Mean centring is 
applied by subtracting the mean spectrum of the data set from every spectrum in the 
data set, equation (0.4). 
 ,
, ,
1
J
i jmc
i j i j
j
R
R R
J
=
 
= −  
 
∑  (0.4) 
where 
R = Spectrum j in an array of J spectra 
i = wavelength data point 
 
In a multivariate sense, this pre-processing method translates the collection of data to 
the origin of the multivariate space where analysis will be performed. The practical 
consequence of mean-centring data is often a more simple and interpretable regression 
model. In effect, mean centring removes the need for an intercept from the regression 
model. Consequently, since fewer terms in the regression model may need to be 
estimated, estimated analyte concentrations may be more precise following mean 
centring of the data. 
Variance scaling is applied to the jth wavelength of every spectrum by division of the 
standard deviation of the jth wavelength over all spectra in the calibration set. Thus, by 
variance scaling, the impact each variable has in determining the parameters of the 
calibration model is equalized. 
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Equation (0.5) shows that variance scaling is performed by dividing mean centred 
spectra by variance at each wavelength over all wavelengths. Variance scaling is best 
employed when the variance of a particular wavelength has no correlation to the useful 
information content of that particular wavelength. Variance-scaled data gives equal 
weight to all wavelengths, regardless of whether they represent a vibrational overtone, 
scattering, or just baseline noise. Consequently, variance scaling is seldom beneficial for 
NIR calibration. However, in instances where the analytically useful signal is very weak 
compared to other absorbances, variable scaling can be essential. 
2.1.2 Smoothing 
With smoothing, it is possible to improve the signal-to-noise ratio of a signal recorded, 
for example, as a function of time or more commonly, wavelength.  
Caution must be used when smoothing data. Strong smoothing gives better signal-to-
noise ratios than weak smoothing, but strong smoothing may adversely reduce the 
resolution of the signal and hence affects methods involving spectra with sharp peaks or 
shoulders. 
The simplest method of smoothing is to calculate a running average for a narrow 
window of points. The smoothed spectrum is generated by using the average value from 
the window. This causes problems at the endpoints of the curve, and numerous authors 
have described different methods for treating them. 
The most commonly used type of smoothing is polynomial smoothing, also called 
Savitzky-Golay smoothing (Savitzky and Golay 1964). Polynomial smoothing works by 
fitting of a smooth polynomial function to the data in a sliding window of width w, where 
w is usually an odd number. Smoothed points are generated by evaluating the 
polynomial function at its midpoint. The window is moved to the right by dropping the 
oldest point from the window and adding the newest point to the window until the 
entire curve has been smoothed. The degree of smoothing is controlled by varying the 
width of the window, w, and by changing the degree of the fitted polynomial function. 
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2.1.3 First and second derivatives 
Taking the derivative of a continuous function can be used to remove baseline offsets, 
because the derivative of a constant is zero. In practice, the derivative of a digitized 
curve can be closely approximated by numerical methods to effectively remove baseline 
offsets. (Brown, Vega-Montoto et al. 2000) 
The derivative transformation is linear, and curves produced by taking the derivative 
retain the quantitative aspects of the original signal. The most commonly used method is 
based on polynomial smoothing. As in polynomial smoothing, a sliding window is used; 
however, the coefficients for the smoothing operation produce the derivative of the 
polynomial function fitted to the data. As in polynomial smoothing, the frequency-
response function of these types of filters is not ideal, and it is possible to introduce 
distortions and artefacts if the technique is misused. Zero crossing points can be used to 
identify the location of peaks in the original spectra. 
2.1.4 Normalisation 
Here, each spectrum is normalized to constant area, thus removing the effect of the 
fluctuating signal. The simplest normalization technique is to simply set the sum of 
squares for each spectrum to 1, i.e., each spectrum has unit length. This procedure is 
similar to variance scaling, except the method is applied to rows in the data matrix 
rather than columns. Many other normalization schemes can be employed, depending 
on the needs dictated by the application. Normalisations by height, local band area or 
largest peak are other methods commonly used in spectroscopy. 
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2.1.5 Multiplicative scatter correction (MSC) and standard 
normal variate (SNV) 
MSC is used a method to correct differences in baseline offsets and path length due to 
differences in particle-size distributions in near-infrared reflectance spectra of 
powdered samples. (Isaksson and Naes 1988) 
In NIR reflectance measurements, there are two components of reflected light that reach 
the detector: specular reflectance (light reflected without being absorbed or interacting 
with the sample) and diffuse reflectance (light that is reflected by the sample after 
penetrating the sample particles, where some of the light is absorbed by the chemical 
components present in the particles). Powdered samples with very small uniform 
particles tend to pack very efficiently compared to samples with large, irregularly 
shaped particles. Samples with small, efficiently packed particles give a greater intensity 
of specular reflectance, and after transformation as log(1/reflectance), the higher levels 
of specular reflectance appear as increased baseline offsets; thus samples with smaller 
particle-size distributions tend to have larger baseline offsets. Beam penetration is 
shallow in samples with small, efficiently packed particles; thus these kinds of samples 
tend to have shorter effective path lengths compared to samples with larger irregularly 
shaped particles. MSC attempts to compensate these two measurement artefacts by 
making a simple linear regression of each spectrum against a reference spectrum. The 
mean spectrum of a set of training spectra or calibration spectra is usually used as the 
reference. The least-squares coefficients are first estimated and then used to calculate 
the MSC-corrected spectrum. 
MSC has been shown to work well in several empirical studies, which showed an 
improvement in the performance of multivariate calibrations and a reduction in the 
number of factors in PCA. (Geladi, MacDougall et al. 1985) 
However, in SNV transformation, the mean of each spectrum is subtracted and the 
length is normalized to 1, and it produces results similar to MSC in many cases, which 
sometimes makes it difficult to choose between the two methods. In practice, it is best to 
try both methods and select the pre-processing method that gives superior performance. 
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2.2 Multiple-linear regression (MLR) 
MLR generalizes the simple linear regression model by allowing for many terms in a 
mean function rather than just one intercept and one slope. 
Considering a response Y to a variable X1 and the simple linear regression mean function 
with a slope of β1 and an intercept of β0: 
 ( )1 1 0 1 1E |  Y X x xβ β= = +  (0.6) 
By adding a second variable X2, with which to predict the response, a mean function that 
depends on both the value of X1 and the value of X2 is needed: 
 ( )1 1 2 2 0 1 1 2 2E | ,  Y X x X x x xβ β β= = = + +  (0.7) 
The main idea in adding X2 is to explain the part of Y that has not already been explained 
by X1 (Weisberg 2005) .  The equation can be expanded to: 
 ( ) 0 1 1 p pE |    Y X x xβ β β= + + … +  (0.8) 
With NIR spectroscopy, the correlation of absorbances (or transmissions) of adjacent 
wavelengths leads to collinearity. Also, there are usually fewer calibration samples 
available than there are recorded wavelengths in NIR spectra. Consequently, MLR often 
leads to unstable estimates of the response E. Also, the MLR model will fit the calibration 
set well, but if the regression vector is unstable, small random errors in future samples 
will be magnified. This may result in large prediction error in future samples. 
However, MLR should not be summarily rejected. For applications with a small number 
of wavelengths (i.e., data from filter-wheel spectrometers), MLR is a potentially good 
method. In some cases, application of MLR following judicious selection of a wavelength 
may outperform other calibration methods. (Boysworth and Booksh 2001) 
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2.3 Principle component analysis (PCA) and 
regression (PCR) 
The term principal component analysis (PCA) refers to a method of data analysis for 
building linear multivariate models of complex data sets (Thielemans and Massart 
1985). The linear multivariate PCA models are developed using orthogonal basis vectors 
(eigenvectors, also called loadings), which are usually called principal components. 
One of the significant goals of PCA is to eliminate the principal components associated 
with noise, thereby reducing the dimensionality of complex problems and minimizing 
the effects of measurement error. 
PCA is a statistical method that tries to explain the covariance structure of data by 
means of a small number of components. These components are linear combinations of 
the original variables, and often allow for an interpretation and a better understanding 
of the different sources of variation. Because PCA is concerned with data reduction, it is 
widely used for the analysis of high-dimensional data, which are frequently encountered 
in chemometrics. PCA is then often the first step of the data analysis, followed by 
classification, cluster analysis, or other multivariate techniques. It is thus important to 
find those principal components that contain most of the information (Hubert and 
Engelen 2004). 
In the classical approach, the first principal component corresponds to the direction in 
which the projected observations have the largest variance. The second component is 
then orthogonal to the first and again maximizes the variance of the data points 
projected on it. Continuing in this way produces all the principal components, which 
correspond to the eigenvectors of the empirical covariance matrix. 
This method would also be very sensitive to anomalous observations. Consequently, the 
first components are often attracted toward outlying points and thus may not capture 
the variation of the regular observations. Therefore, data reduction based on classical 
PCA (CPCA) becomes unreliable if outliers are present in the data. 
2.3.1 Finding the factors
There are algorithms that can calculate the factors for a data matrix. The two most 
common are the NIPALS (nonlinear iterative partial least squares) algorithm, and SVD 
(singular value decomposition). In both, only t
PCs) where N is large enough to enable the determination of how many factors should 
be included in the basis space (secondary PCs). 
Figure 7: The PCA model. Spectral data matrix (A) is decomposed into eigenvectors (V) 
and their eigenvalues (T), plus additional non
or noise). Modified from 
SVD is a way of decomposing a data matrix into factors in a more general sense. Most 
SVD algorithms allow for proper
problems of digital round-off error. The eigenvectors are organized into a matrix (V) 
which has as many rows as there are wavelengths in the original spectra (
length, or magnitude, of each eigenvector is normalized to unity. Thus, the vector cross 
product of each eigenvector multiplied with itself should be equal to 1. Also, all of the 
eigenvectors are mutually orthonormal. This means that the vector cross product of any 
eigenvector times any other eigenvector must equal 0. Each eigenvector in Vc has a 
corresponding eigenvalue 
vector. (Kramer 1998) 
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2.3.2 Factor selection 
This is critical because retaining more factors than needed would only add more noise to 
predictions. On the other hand, if less than enough factors are kept, potentially 
meaningful information would be discarded that could be necessary for a successful 
calibration. There are a number of tools to help in the decision making process: 
Indicator functions (for data sets for which no reference values, or y-data, are 
available), which provide less reliable selection. 
PRESS for validation data 
One of the best ways to determine how many factors to use in a PCR calibration is 
to generate a calibration for every possible rank (number of factors retained) and 
use each calibration to predict the concentrations for a set of independently 
measured, independent validation samples. The predicted residual error sum-of-
squares, or PRESS, is calculated for each calibration according, and the calibration 
that provides the best results is chosen. The number of factors used in that 
calibration is the optimal rank for that system. 
Cross-validation 
In some cases, a sufficient set of independent validation samples with which to calculate 
PRESS is not available. In such instances, the original training set can be used to simulate 
a validation set. This approach is called cross-validation. The most common form of 
cross-validation is performed as follows: 
Calculate a calibration matrix using all of the training set samples except for one. 
Use the calibration to predict the concentrations of the components in the sample 
that was left out of the training set. 
Calculate the sum-squared of errors between the expected and predicted 
concentrations for the sample that was left out. 
Return the excluded sample to the training set, and leave out a different sample. 
Calculate a new calibration for this new subset of the original training set. 
Return to Step 2, above. Add the new PRESS value calculated in step 3, to the 
PRESS values calculated so far. Continue this process until PRESS values for all 
combinations of "leave one out" have been computed and summed. 
Steps 1 - 6 are repeated for calibrations generated with every possible rank (number of 
factors). The PRESS is examined for each of the calibrations to choose the one that gives 
the best results. The number of factors used in that calibration is the rank of the system. 
This procedure is known as "leave one out" cross-validation. This is not the only cross-
validation method, but rather the most popular. (Kramer 1998) 
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2.3.3 Spectral reconstruction and model calculation 
By discarding the noise eigenvectors, it is possible to remove a portion of the noise from 
the data. The spectra which are generated after noise removal are the reconstructed 
spectra. When principal component regression, there is not really a separate, explicit 
data regeneration step, but by operating with the new coordinate system however, the 
spectra are automatically reconstructed with fewer noise using the factors that explain 
the spectral variation related to the change in the property under study rather than 
other influencing factors. 
2.3.4 Predicting unknowns 
To predict the concentrations in an unknown sample from its measured spectrum 
(Aunknwon), the calibration matrix (Fcal) calculated with the pre-selected factors is used to 
give: 
Cunknown = Fcal Aunknwon 
The prediction accuracy can be evaluated in light of the calibration model qualities 
obtained from validation (or cross-validation), as well as the closeness of the spectrum 
to the calibration data set (residual information – discussed in the following chapter). 
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2.4 Partial least squares (PLS) regression 
(PLSR) 
PLS is a variation of PCR that takes its concept one step further by using a different 
strategy to find a coordinate system that can have advantages over the coordinate 
system used for PCR. This strategy involves finding factors for both the spectral and the 
referencing data. 
The reasoning behind this approach is twofold: First, to utilize the noise removal 
capabilities of PCA and remove some of the noise from the reference data. Second, and 
because the noise in the spectral data will, in general, deflect each eigenvector slightly 
out of the plane containing the theoretical, noise-free data in some randomly different 
direction than the deflection of the corresponding spectral eigenvector (since noise in 
the reference and spectral data are independent of each other). PLS will rotate the 
vectors back toward each other until they are aligned, and provide better noise removal 
by bringing the vectors closer to the ideal planes containing the noise-free spectral and 
concentration data. 
2.4.1 PLS principles 
In addition to the set of new coordinate axes (basis space) for the spectral data (the x-
block), we also find a set of new coordinate axes (basis space) for the referencing data 
(the y-block). These referencing data are expressed as projections onto the 
concentration factors (basis vectors) in a way similar to expressing the spectral data as 
projections onto the spectral factors (basis vectors). 
Each pair of factors is rotated towards each other on a factor-by-factor basis to 
maximize the fit of the linear regression between the projections of the spectra onto the 
spectral factor with the projections of the reference data onto the concentration factor. 
The calibration (regression) coefficients are then calculated using linear regression 
between the projections of the spectra on each individual spectral factor with the 
projections of the reference data on each corresponding referencing factor of the same 
order. 
The prediction step for PLS is also slightly different than for PCR where it is also 
performed on a rank-by-rank basis using pairs of spectral and referencing factors. 
Taking predicting concentration as an example, for each component, the projection of 
the unknown spectrum onto the first spectral factor is scaled by a response coefficient to 
become a corresponding projection on the first concentration factor. This yields the 
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contribution to the total concentration for that component that is captured by the first 
pair of spectral and concentration factors. The process is then repeated for the second 
pair of factors, adding its concentration contribution to the contribution from the first 
pair of factors, and continued until all of the factors in the basis space have been used. 
2.4.2 Factor rotation in PLS 
PLS will search for a single vector, W, that represents the best compromise between the 
spectral factor and the reference factor, which is not necessarily the factor that lies 
exactly half-way between them. It is, instead, the factor that maximizes the linear 
relationship between the projections (scores) of the spectral points onto the factor and 
the projections (scores) of the corresponding reference points onto this same factor and 
maximizes the covariance between the two. 
2.5 Cluster analysis 
The term ‘‘cluster’’ has the meaning of ‘‘concentrated’’ group. Cluster analysis tries to 
identify concentrated groups (i.e., clusters) of objects, while no information about any 
group membership is available, and usually not even the number of clusters is known. In 
other words, cluster analysis tries to find groups containing similar objects (Ripley 
1996).  The task of identifying concentrated groups of objects presumes that such a 
group structure is inherent in the data. This does not, however, lead to the assumption 
that an object belongs to only one group. Thus, clustering methods that perform a 
partitioning of the objects into separated groups will not always give the desired 
solution. For this reason many clustering algorithms have been proposed in the 
literature that do not only perform differently, but that even work on different 
principles. 
2.5.1 Principal component analysis (PCA) 
The first few principal components or factors represent a relevant part of the total data 
variance. Thus, when plotting pairs of principal component scores or factors, the data 
structure can be visually inspected in two dimensions in order to identify groups of 
objects. This approach works fine as long as objects of different groups are sufficiently 
different in the variable space, and the multidimensional space can be well represented 
by a projection (low intrinsic dimensionality), which is often the case. 
Like PCR, PCA transforms a data matrix X(n×m), containing data for n objects with m 
variables, into a matrix of lower dimension T(n×a). In the matrix T, each object is 
characterized by a relative small number (a) of PCA scores (PCs, latent variables). 
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Score ti of the ith object xi is a linear combination of the vector components (variables) of 
vector xi and the vector components (loadings) of a PCA loading vector p. The score 
vector tk of PCA component k contains the scores for all n objects; T is the score matrix 
for n objects and a components; P is the corresponding loading matrix. 
PCA is usually the first choice to visualize multivariate data by scatter plots and 
transform highly correlating variables into a smaller set of uncorrelated variables. 
Outliers may heavily influence the result of PCA and diagnostic plots help to find outliers 
(leverage points and orthogonal outliers) falling outside the hyper-ellipsoid which 
defines the PCA model. 
In cases where PCA fails because of a complicated data structure, nonlinear methods like 
Kohonen mapping, Sammon’s NLM, and cluster analysis with a dendogram can be useful 
alternatives, which are beyond the scope of this research. 
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3. Calibration model development 
Univariate calibration is specific to situations where the instrument response depends 
only on the target analyte concentration. With multivariate calibration, however, model 
parameters can be estimated where responses depend on the target analyte in addition 
to other chemical or physical variables and, hence, multivariate calibration corrects for 
these interfering effects. 
With multivariate calibration, wavelengths no longer have to be selective for only the 
analyte, but can now respond to other chemical species in the samples. Additionally, a 
set of calibration standards must be selected that are representative of the samples 
containing any interfering species. It would be possible to build a calibration model that 
compensates for the interfering species. However, due to spectroscopic noise and 
spectral collinearity (spectral overlap or selectivity), concentration estimates can be 
seriously degraded. Thus, selection of specific wavelengths to be included in the model is 
critical to the performance of the model. 
3.1 Data sets and representative sampling 
Calibration samples must include representation for every responding chemical species 
in a system under study. Spectral shifts and changes in instrument readings for mixtures 
due to interactions between components, changes in pH, temperature, ionic strength, 
and index of refraction are well known. The use of mixtures instead of pure standards 
during calibration enables multivariate calibration methods to form approximate linear 
models for such interactions over narrow assay working ranges, thereby providing more 
precise results. 
The calibration samples must cover a sufficiently broad range of composition that a 
suitable change in measured response is instrumentally detectable. For simple systems, 
it is usually possible to prepare mixtures according to the principles of experimental 
design, where concentrations for all ingredients are varied over a suitable range. 
Because it is more desirable to make interpolations rather than extrapolations when 
making predictions from a calibration model, the range of concentrations in the 
calibration standards should exceed the expected working range of the assay. 
Calibration sample compositions should give a fairly uniform coverage across the range 
of interest. However, if the range is too large, deviations from linearity could begin to 
appear. The recommended minimum number of calibration samples is 30 to 50, 
although this depends on the complexity of the problem (ASTM 1999). 
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It is very important that validation sets do not contain aliquots of samples used for 
calibration. The validation sample set must form a truly independent set of samples. 
Another equally important point is that the composition of validation samples should be 
designed to lie at points in between calibration points, so as to exercise the interpolating 
ability of the calibration model.  
Different validation data sets should be prepared to investigate every source of expected 
variation in the instrument response, operational environment changes, as well as 
expected sample variability. 
Proper setup of calibration sets yields calibrations that are superior in terms of both 
precision and accuracy. The complexity of calibration development has not allowed, yet, 
completely automated mathematically modelling in any current software. In any case, 
the most critical step in calibration is the proper collection of samples to represent the 
population for routine analysis. 
3.2 Method development and evaluation 
It is the best mathematical model that when applied to photometric data obtained from 
a sample of unknown concentration will compute a reliable, accurate, and reproducible 
value of percent composition for the component(s) of interest. The ideal mathematical 
model will be “blind” to endogenous instrument variation, temperature effects, 
background interferences, and the like, and at the same time be most sensitive to 
changes in the concentration of the component(s) of interest. the commonly used 
calibration techniques include the rigor of experimental design, calibration modelling, 
and validation testing. 
3.2.1 Wavelength selection 
When performing multivariate analysis on such mixtures, the analyst musts elect 
wavelengths where the molar absorptivities for the components are most different. Only 
with perfectly error-free data will any wavelength set permit the generation of a 
calibration equation that fits the data perfectly. 
With complex matrices, it is impossible to know if an ideal set of wavelengths has been 
selected for a calibration equation. Often when new instrumental effects are indicated 
and when new calibration sets are selected, new wavelengths are chosen for the same 
application. 
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Different wavelengths will, of course, give rise to different values for the calibration 
coefficients, reflecting the different values of the extinction coefficients at different 
wavelengths.  
In simple calibrations, the differences between the spectra would be considerable and 
can be ascertained visually and the wavelengths to use for the discriminations selected 
manually. If the spectra are very similar, or if there are so many different materials 
involved that visual inspection becomes confusing, then such an a priori selection would 
not be possible. In the absence of a prior knowledge of which wavelengths are suitable 
for performing the desired discriminations, a method of selecting the optimum set of 
wavelengths is needed that maximizes the distances between groups that are close 
together in the multidimensional space, in other words, a criterion that emphasizes the 
differences between those materials that have similar spectra but different reference 
values. A solution to this problem would to compute all the intergroup distances and 
select the variables that maximize the distance between the closest pair of groups.  
One method of wavelength selection that has been devised for implementation with the 
current algorithms in use in NIR is to calculate the distances D, between all pairs of 
groups i and j, and the sum of the inverse squared distance, in other words, (1/Dij) is 
formed. The groups that are closest together will contribute most heavily to this sum; 
thus selecting those wavelengths that cause this sum to be smallest results in the 
selection of the wavelengths that best separate the closest groups, in other words, best 
distinguish the most similar spectra. This approach has an advantage over the simpler 
one in that this technique will optimize among all groups that are comparably closely 
spaced rather than concentrating on only the single closest pair (Mark 2001).  
3.2.2 Model evaluation and optimisation 
Many parameters can be used to assess the performance of NIR calibration models. 
Although automatic optimisation routines exist in literature and practice, manual 
intervention is needed because, depending on the application, each calibration will be 
evaluated differently. 
3.2.2.1 Coefficient of Multiple Determination (r2 or R2)  
Also termed total explained variation, this statistic allows us to determine the amount of 
variation in the data that is adequately modelled by the calibration equation as a total 
fraction of 1. Thus R2 = 1.00 indicates the calibration equation models 100% of the 
variation within the data, while an R2 = 0.50 indicates that 50% of the variation in the 
difference between the actual values for the data points and the predicted or estimated 
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values for these points are explained by the calibration equation (mathematical model), 
and 50% is not explained. R2 values approaching 1.00 are attempted when developing 
calibration. 
3.2.2.2 Student's t value for regression or residuals (t, √F) 
This statistic is used to determine of the correlation between X and Y data. It can be used 
to determine whether there is a true correlation between an NIR value and the primary 
chemical analysis for that sample. It is used to test the hypothesis that the correlation 
really exists and has not happened only by chance. A large t value indicates a real 
(statistically significant) correlation between X and Y. 
When used for residuals, the test allows evaluating criteria for assessing the variation 
between an NIR value and its primary chemical value, and t values greater than 2.5 are 
considered significant and such predictions may possibly be outliers. Most often, high t-
test values here indicate poor laboratory results or a problem with sample presentation 
and positioning. 
3.2.2.3 Standard error of estimate (SEE), or standard error of calibration (SEC) 
This statistic, equation (0.9), is the standard deviation for the residuals due to 
differences between actual (primary wet laboratory analytical values) and the NIR 
predicted values for samples within the calibration set. It is an indication of the total 
residual error due to the particular regression equation to which it applies. The SEC will 
generally decrease with higher number of wavelengths (independent variable terms) 
used within an equation, indicating that increasing the number of terms will allow more 
variation within the data to be explained, or “fitted”. 
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where 
N = total number of samples used in the calibration 
yi = a singular y value for the ith sample 
ŷi = estimated y  value given a regression line 
 
The SEC statistic is a useful estimate of the theoretical “best” accuracy obtainable for a 
specified set of wavelengths used to develop a calibration equation. 
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3.2.2.4 Standard Error of Prediction (SEP) 
The SEP is also termed the standard error of performance, is the standard deviation for 
the residuals due to differences between actual (primary wet chemical analytical values) 
and the NIR predicted values for samples outside of the calibration set. The SEP is 
calculated from equation (0.9) using validation instead of calibration samples. It allows 
for comparison between NIR-observed predicted values and wet laboratory values. 
The SEP is generally greater than the SEC but could be smaller in some cases due to 
chance alone. When calculating the SEP, it is critical that the constituent distribution be 
uniform and the wet chemistry be very accurate for the validation sample set. If these 
criteria are not met for validation sample sets, the calculated SEP may not have validity 
as an accurate indicator of overall calibration performance. 
3.2.2.5 Standard Error of Cross-Validation (SECV) 
The calculation of SECV is a method for determining the “best” number of independent 
variables to use i n building a calibration equation. The SECV method is based on an 
iterative (repetitive) algorithm that selects samples from a sample set population to 
develop the calibration equation and then predicts on the remaining unselected 
samples. Some procedures for calculating SECV may calibrate using two-thirds of the 
samples while predicting on the remaining one-third of the samples. The SECV is an 
estimate of the SEP and is calculated as SEP or SECV as the square root of the mean 
square of the residuals for N - 1 degrees of freedom, where the residual equals the actual 
minus the predicted value. 
3.2.2.6 Bias-Corrected Standard Error 
Bias-corrected standard error measurements allow more accurate evaluation of error in 
cases where model bias has been evaluated. The bias value (b0) is calculated as the mean 
difference between two columns of data, most commonly actual minus NIR predicted 
values. 
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where 
N = total number of samples used in the calibration 
yi = a singular y value for the ith sample 
ŷi = estimated y  value given a regression line 
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3.2.2.7 PRESS (Prediction Sum of Squares) 
This statistic calculates the error sum square (between predicted and reference values) 
as a function of the number of factors (eigenvectors, principal components or principal 
factors). The optimum number of PC is always given by the smallest number of PC where 
the PRESS function for the calibration and validation sets is approximately equal and 
minimal. 
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where 
N = total number of samples used in the calibration 
yi = a singular y value for the ith sample 
ŷi = estimated y  value given a regression line 
 
3.2.2.8 Other performance indicators 
3.2.2.8.1 SEC / SEP RATIO 
This describes the relation between the standard errors of the calibration and validation 
sets. An SEC much higher than SEP indicates over-fitting of the model to the calibration 
samples. 
3.2.2.8.2 BIAS 
This is the average deviation between the calibration and validation predictions, 
calculated from equation (0.12) below. 
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where 
N = total number of samples used in the calibration 
yi = a singular y value for the ith sample 
ŷi = estimated y  value given a regression line 
 
3.2.2.8.3 REGRESSION COEFFICIENT, INTERCEPT AND SLOPE 
Absolute regression coefficient near 1.0 shows that two properties are linearly 
dependent. Slope should be as close as possible to 1.0 and intercept to 0. 
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3.2.2.8.4 DURBIN-WATSON STATISTIC 
This statistic can be used to assess the lack of inter-correlation between data points in 
the regression. Since the correlation coefficient R only describes the tendency of the line, 
not the trueness of fit to a linear model. If there is no inter-correlation of the residuals 
described by the Durbin–Watson statistic, then a linear model is appropriate and may be 
used.  A value closest to 2 indicates good linear correlation referenced and predicted 
values. 
3.2.2.8.5 LEVERAGE 
The concept of leverage in statistics is comparable to the physical model of a lever. The 
hinge for the calibration line lies the centre of the x-values. Calibration samples close to 
the mean of the x-values tend to exert little force on the slope of the calibration curve. 
Calibration samples farthest from the mean of the x-values can put forth a greater force 
on the slope of the calibration curve, so that their residuals are made as small as 
possible.  Leverage plots can be used to find optimal factors or to detect outliers. 
3.3 Method validation 
Validation of a multivariate calibration model is a critical step that must take place prior 
to widespread adoption and use of the calibration model for routine assays or in 
production environments.  Many official monograms, standards, papers and published 
guidelines exist, directed both to NIR use in general, or specific for pharmaceutical 
release purposes. Of these, the most notable guidelines are through: 
USP (USP 30 NF25 2007) 
1119 – Near-infrared spectrophotometry 
1225 – Validation of compendia procedures 
EP and BP (BP 2007, EP 5.5) 
Ph. Eur. method 2.2.40 – Near-infrared spectrophotometry 
SC III F. Validation of analytical procedures 
EMEA 
“Note for guidance on the use of near infrared spectroscopy by the 
pharmaceutical industry and the data requirements for new submissions and 
variations” , 2003 
ICH guidelines 
Q2(R1) “Validation of analytical procedures: text and methodology” 
PASG 
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Guidelines for the development and validation of near infrared (NIR) 
spectroscopic methods, 2001 
Assuming that an appropriate quality assurance program is in place, three criteria must 
be met: validation of the software; validation of the hardware; and validation of the NIR 
spectroscopic method (or any analytical method). Currently, reputable NIR software and 
hardware manufacturers provide considerable regular automated suitability tests using 
approved standards in order to validate NIR software and hardware. 
The purpose of method (or model) validation is to determine the reproducibility of a 
multivariate calibration, its bias against a known method or accepted values, and its 
long-term ruggedness (robustness). Regardless of the numerous sources providing 
general direction to the method developer, validation is an extremely complex 
regulatory issue that is not easily defined. 
The term validation, in the regulatory context of a NIR method, refers to the 
establishment of appropriate data and documentation to certify that the method 
performs as intended. 
Provided that instrument and software validation have been established, as well as 
following cGMP and cGLP guidelines, NIR method validation can be achieved by 
observing the points outlined below. 
3.3.1 Specificity 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components that may be expected to be present. A major problem with utilizing NIR to 
accurately determine concentrations of actives in solid dosage forms is that the analysis 
is performed without removing the analyte from its matrix. 
The very property that makes NIR so attractive, allowing analysis of intact dosage forms 
and intermediate products without dissolution/extraction of the active agent, is also the 
issue that could potentially limit its application to pharmaceutical analysis, if we are 
restricted to current validation regulations. 
Because NIR spectra represent all materials present in the formulation, including the 
active, specificity is a major validation hurdle that must be overcome if NIR is to be used 
as a release testing technique. 
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One mechanism that is proposed to address this problem is to first identify the product 
being tested before quantifying the analyte of interest, using several lots of product with 
varying analyte values.  
3.3.2 Linearity 
The linearity of a NIR spectroscopic method is determined from the multiple correlation 
coefficients (R) of the NIR predicted values of either the calibration or validation set 
with respect to reference values. It may be argued that this is an insufficient proof of 
linearity since the analyst is comparing information from two separate instrumental 
methods, and thus simple linearity correlation of NIR data through regression versus 
some primary method is largely inappropriate without other supporting statistics. 
A potentially more appropriate statistical tool, that being the Durbin–Watson statistic 
(d) (Draper and Smith 1998), can be used to assess the lack of inter-correlation between 
data points in the regression. The Durbin–Watson statistic is more of a test for 
nonlinearity, calculated from residuals obtained from fitting a straight line. The statistic 
evaluates for sequential dependence in which error is correlated with those before and 
after the sequence. 
If successive residuals are positively serially correlated, that is, positively correlated in 
their sequence, d will be near zero. If successive residuals are negatively correlated, d 
will be near 4, so that 4 - d will be near zero. The distribution of d is symmetric about 2. 
3.3.3 Range 
The ICH guidelines recommend a minimum range of 80 to 120% of the test 
concentrations for assay of a drug substance or a finished product and 70 to 130% of the 
test concentration for content uniformity. 
This brings about the need for out-of-specification samples to extend the very narrow 
concentration ranges from production samples to this range. This might seem trivial, but 
in reality, is not so simple. The first problem is that it would mostly be impossible to 
provide out-of-specification product in the production environment. 
Manufacturing these out-of-specification samples in a pilot plant or laboratory will lead 
to further problems. Despite the use of identical raw materials (relative to the 
production samples), the ‘‘process signature’’ is often so significantly different from 
laboratory to production to pilot scale that significant calibration errors will arise. For 
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example, the dwell time, compaction force, and feed rate variations that exist between 
the different scales of manufacturing can cause significant variations in sample 
properties and hence NIR spectra, even when formulations are identical. Thus, 
expansion of the range of concentration values through the use of laboratory or pilot 
plant samples is, in most cases, impractical. It is possible that the range problem is the 
single most significant issue prohibiting a uniform approach in wide implementation of 
quantitative NIR techniques in the industry. 
3.3.4 Ruggedness/Robustness 
The robustness of any method may be measured by inflicting small, deliberate variations 
in the method and ascertaining whether any changes in the predictions gleaned are 
significant, e.g. turning the tablet over from one side to the other. Method developers 
must consider tests to evaluate algorithm stability during the development and 
validation processes. 
For solid dosage forms in particular, this issue is of prime importance, and if the 
variation in physical parameters as a result of small process variability is not sufficient 
to flag the sample as an outlier, it is still unknown whether or not this variation would 
contribute to significant prediction errors. This issue is one the topics investigated in 
this research. 
The evaluation of robustness should be considered during the development phase and 
depends on the type of procedure under study. It should show the reliability of an 
analysis with respect to deliberate variations in method parameters. One consequence 
of the evaluation of robustness should be that a series of system suitability parameters 
(e.g., resolution test) is established to ensure that the validity of the analytical procedure 
is maintained whenever used. (ICH 2005) 
3.3.5 Accuracy 
The accuracy of an analytical procedure expresses the closeness of agreement between 
the value which is accepted either as a conventional true value or an accepted reference 
value and the value found (trueness).  There are several methods of establishing 
accuracy (ICH 2005): 
Application of the analytical procedure to synthetic mixtures of the drug product 
components to which known quantities of the drug substance to be analysed 
have been added. 
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Compare the results obtained from a second, well characterized procedure, the 
accuracy of which is stated and/or defined. 
Accuracy may be inferred once precision, linearity and specificity have been 
established.  
3.3.6 Precision 
Precision of any analytical procedure describes how close the agreement is, between a 
series of measurements obtained from multiple sampling of the same homogenous 
sample under the prescribed conditions. The precision of an analytical procedure is 
usually expressed as the variance, standard deviation or coefficient of variation of a 
series of measurements and can be described in terms of:  
Repeatability 
This is precision under the same operating conditions over a short interval of time. 
Repeatability is also termed intra-assay precision and should be assessed using:  
Minimum of 9 determinations covering the specified range for the procedure (e.g. 
3 concentrations/3 replicates each); or  
Minimum of 6 determinations at 100% of the test concentration.  
Intermediate precision 
This expresses within-laboratories variations and should establish the effects of 
random events on the precision of the analytical procedure. Typical variations to 
be studied include days, analysts, equipment, etc. It is not considered necessary 
to study these effects individually. 
Reproducibility 
This describes the precision between laboratories (collaborative studies, usually 
applied to standardization of methodology).  
Since this discussion is specific to intact dosage forms, repeatability takes on a slightly 
different colour than for HPLC methods. While sample preparation is usually 
significantly reduced for NIR methods in comparison to traditional wet chemical 
methods, thus reducing method error from dissolution, extraction, and the like, the 
diffuse reflectance and diffuse transmittance methods common to NIR practice are 
susceptible to other factors that can ultimately reduce precision. The ‘‘repack error’’ 
once described for ground grain samples that were repacked into the traditional NIR 
sample cup may more aptly be described as a ‘‘positioning error’’ for today’s non-
destructive analyses of intact dosage forms. Appropriate sample handling and various 
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mathematical routines allow minimization of the spectral variability and imprecision 
arising from this type of error. 
3.3.7 Detection and quantification limits 
The detection limit of an individual analytical procedure is the lowest amount of analyte 
in a sample which can be detected but not necessarily quantified as an exact value, while 
the quantification limit is the lowest amount of analyte in a sample which can be 
quantitatively determined with suitable precision and accuracy. The quantification limit 
is a parameter of quantitative assays for low levels of compounds in sample matrices, 
and is used particularly for the determination of impurities and/or degradation 
products. 
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4. NIRS and process analytics 
In 2004, the US FDA announced their guidance document on process analytical 
technology (PAT) and triggered a rapidly growing movement within the pharmaceutical 
industry. In the FDA definition, PAT consists of “Systems for the analysis and control of 
manufacturing processes based on timely measurements, during processing of critical 
quality parameters and performance attributes of raw materials and in-process materials 
and processes to assure acceptable end product quality at the completion of the process” 
(Hussain 2002). 
From this definition, the PAT toolbox consists of four main elements: 
Multivariate data acquisition and analysis tools 
Modern process analysers or process analytical chemistry tools 
Process and endpoint monitoring and control tools 
continuous improvement and knowledge management tools 
Since then, PAT has been an important subject of research and industry, suppliers, 
government, and academia are still wrestling with a huge number of method 
development and implementation issues. Despite this tremendous effort, PAT is in an 
early stage of development in the pharmaceutical manufacturing industry. 
Although PAT has been applied extensively in other industries (e.g., chemical and food 
processing), the nature of pharmaceutical manufacturing presents new challenges in 
terms of regulation, risk, and complexity. In addition, PAT applications will place new 
demands on the existing industrial infrastructure and a significant amount of practical, 
application-specific research is required to support the deployment, operation, and 
maintenance of associated analytical methods. 
Critical issues that must be considered during PAT method development include 
(Cogdill, Anderson et al. 2004): 
risk analysis of the process 
feasibility studies 
experimental design 
sensors and technology selection 
model development and transfer 
process sampling 
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information management 
The integration of these concepts and issues into the development effort will produce a 
more effective method and a better grasp of the technology. This understanding 
corresponds to fundamental knowledge about the basis for method operation and 
critical factors affecting method performance. The result of integrated development is a 
validated method that provides information about the process.  
Near infrared (NIR) spectroscopy is an important process analyser and is perhaps the 
most dominant technology within this group of process analysers. Because NIR spectra 
are capable of providing a very detailed physical and chemical picture of the process at 
many positions in the manufacturing line, this makes NIR such a versatile and powerful 
instrument for PAT applications.  
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5. Sample properties affecting spectra 
As has been discussed in previous sections, NIR spectra are the convolution of chemical 
and physical interactions between the sample and NIR radiation. 
Although the value of the chemical information in NIR spectra is obvious, the physical 
factors, which affect NIR spectra may also yield useful information related to the quality 
(state) of the sample material. In other cases, the presence of strong variations in 
concomitant physical parameters may overwhelm the analytical signal of interest.  
5.1 Particle Size 
The particle size distribution (PSD) and mean particle size are critical quality control 
factors for pharmaceutical solids (e.g. raw material quality or process control). Drug and 
excipient PSD variability can affect dosage form performance by altering dissolution rate 
or bioavailability, or it can affect drug product quality in manufacturing by altering the 
flow properties of the materials. 
Since the angle of optical diffraction for a single-particle event is inversely proportional 
to particle size, the actual angle of diffraction will depend not only on particle size and 
wavelength of incident light but also on particle morphology and refractive index, as 
described by Mie and Fraunhofer theories of optical scattering (Ingle and Crouch 1988). 
Thus, as particle size varies, the relative level of forward and backward scattering events 
will vary as well, causing a change in apparent optical absorption. Larger particles, for 
example, will have a greater proportion of forward scatter, which reduces the 
probability that a diffusely scattered photon from an incident beam will be returned to 
the surface of a sample in DR (Figure 8). 
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Figure 8: NIR DR spectra of (from below up) 40, 100, and 200µ aspirin powder samples 
Particle size variation will also affect particle packing characteristics, leading to more 
complex spectral effects. Hence, there has been great interest in using NIR spectroscopy 
for rapidly determining MMPS or PSD of pharmaceutical solids and granules. Ciurczak 
(1986) published some of the first pharmaceutical work relating the particle size of 
pharmaceutical raw materials to variation in NIR spectra, demonstrating a linear 
relationship between the absorbance at any wavelength and the reciprocal of particle 
size as measured using low-angle laser light scattering. 
Numerous references on the use of NIR for particle size analysis followed. Examples 
include the application of NIR for real-time median particle size determination during 
granulation (Rantanen and Yliruusi 1998) and MPS of API in a binary mixture (Frake, 
Luscombe et al. 1998). Laser diffraction or sieve analysis was used for reference testing 
in all cases. 
 
65 Sample properties affecting spectra 
5.2 Crushing strength-related physical 
properties 
Crushing strength (hardness) has been observed to have a measurable effect on NIR 
spectra. Tablet crushing strength is a common product release parameter and is 
important for process control, because varying crushing strength might affect product 
friability, disintegration, dissolution, and ultimately, bioavailability. The crushing 
strength and apparent density (or porosity, solid fraction) are common parameters for 
process control during roller compaction. 
Drennen published the first examples of using NIR spectroscopy and chemometrics for 
non-destructive tablet crushing strength in 1991. Subsequent publications by Ciurczak 
and Drennen  (1992)  and Drennen and Lodder (1993) further explored the application 
using both quantitative and qualitative methods. It was observed in all of these 
experiments that changes in dosage form crushing strength are indicated by a sloping 
baseline shift of the apparent absorption spectrum measured in reflectance. 
As the tablet (or compact) crushing strength increases, the apparent absorption baseline 
increases. Although the root cause of the spectral effect is not conclusively established, 
some references do posit hypotheses. It is suggested however, that as tablet crushing 
strength increases (and the total surface area of inter-particle contact increases), less 
fraction of the radiation is backscattered due to the air–particle interface, reducing the 
magnitude of reverse flux. At the same time, a greater fraction of the radiation 
propagates through points of inter-particle intimate contact, increasing the magnitude of 
forward flux. As fewer scattered photons reach the reflectance detector via reverse flux, 
the apparent absorbance increases (measured reflectance decreases). This hypothesis is 
supported by the observed relationship between the tablet crushing strength and NIR 
transmittance, whereby increasing crushing strength reduces the apparent tablet 
absorbance. 
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Figure 9: Effect of increasing crushing strength on NIR Transmittance (downward 
arrows) and reflectance spectra (upward arrows). Arrows indicate direction of 
increasing crushing strength. (Cogdill and James K. Drennen 2006) 
As is for the effect of particle size, the rate of baseline increase is more pronounced near 
strong absorption bands. Although baseline shifting is the most pronounced spectral 
change observed with varying tablet crushing strength, other spectral changes (e.g., 
peak shifting) have been observed. 
It has been shown that the crushing strength can be predicted with reasonable accuracy 
by simply fitting linear or nonlinear functions to the NIR baseline (Guo, Skinner et al. 
1999) and then correlating crushing strength to selected coefficients of the baseline fit. 
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5.3 NIR sampling span 
The need for effective sampling is common to all analytical techniques. With NIR 
spectroscopy, a great deal of attention is usually given in the selection of calibration 
samples highly representative of end product units over different batches. However, 
another aspect of sampling is as equally important and sometimes overlooked. NIR 
radiation in classical diffuse reflection mode is reflected from a central area of the 
surface and is only assumed rather than proven representative of the whole tablet.  
The scale of mass to be assayed ‘scale of scrutiny’ (Donoso, Kildsig et al. 2003), 
(Berntsson, Danielsson et al. 1998) by any method depends on both the magnitude of 
the unit dose in question and the application. For example, monitoring blend uniformity 
requires minimal effective sampling mass, while the reverse is true for individual dosage 
forms. Moreover, the effective sampling mass has a complex and nonlinear effect on NIR 
transmittance and reflectance spectra. (Bull 1990) 
5.3.1 Diffuse reflectance 
There is little experimental evidence of how deep the radiation penetrates the surface in 
diffuse reflection. This penetration is sample-dependant and the difference between 
loose and compacted powders is significant. 
Few researchers have tried to DR estimate information depth for powder mixtures. 
Olinger and Griffiths (2001) used absorbance values for mixtures with known 
absorptivities and particle size values and reported an upper boundary of 1 mm at 1653 
nm. It was also reported that if scattering effect was to be considered, this range would 
unlikely be more than 300 µm. Others have reported different values but without 
supporting experimental or theoretical evidence: 5 mm (MacDonald and Prebble 1993), 
1-2 cm (Ciurczak 1991), 1-4 mm (Olinger and Griffiths 1992), 0.5 mm (Stephen Victor 
Hammond 1997).  
The evidence is even smaller for compacted solids. Iyer (Iyer, Morris et al. 2002) have 
tried to estimate the sampled mass in DR using single and double-layered tablets and 
second derivative spectra. He concluded that the effective sampling depth was between 
1.9 and 2.7 mm depending on the wavelength. Another study by Andersson  (Andersson, 
Josefson et al. 1999) showed different values and suggested an information depth of 0.1 
- 0.2 mm using incremental coating and tablets with 2 different components. The 
authors however maintained that these figures are only rough estimates because the 
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results were obtained using extrapolation and may only be valid for specific materials 
and instruments. 
Because of such varying views on DR information depth, the exact value is still not clear 
to operators of the method. Additionally, since the majority of pharmaceutical tablets 
range in thickness between 1 – 4 mm, determining this depth is crucial to the selection 
of appropriate measurement modes for different coated, uncoated and multi-layered 
tablets and can provide better understanding of the performance differences between 
DR and DT modes. 
5.3.2 Diffuse transmission 
Diffuse transmission mode penetrates the whole thickness of the tablet and would 
theoretically be more representative of the whole tablet (Berntsson, Burger et al. 1999) 
especially for low-dose units where aggregation has a higher effect. It is not clear, 
however, what path the radiation follows inside the tablet and hence the percentage 
actually being scanned. Moreover, transmission is more sensitive to path-length and 
density variability. Iyer et al. (2002) did a series of experiments to address this issue. 
They calculated a wavelength-dependent information depth for reflection ranging 
between 1.9 to 2.7 mm using second derivative spectra from tablets of increasing 
thickness. They also showed a limiting tablet thickness of 3.5 – 4.8 mm for transmission. 
Another set of experiments showed an effective transmission diameter of 7 mm and 
concluded that the mass sampled for both modes was comparable and around 200 mg. 
However, the radiation intensity inside this diameter is fading towards the periphery in 
all directions making the mass over-estimated in this case, especially for reflection. Also, 
the fact that sampled mass is largely dependent on physical properties of the sample, 
mainly crushing strength and packing, makes this issue an open question. 
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6. Pharmaceutical Tableting 
The oral route is the most common way of administering drugs, and among the oral 
dosage forms tablets of various different types are the most common. The EP defines 
tablets as ‘solid preparations each containing a single dose of one or more active 
ingredients and obtained by compressing uniform volumes of particles’ (EP 2006). 
Tablets are prepared by forcing particles into close proximity to each other by powder 
compaction, which enables the particles to cohere into a porous, solid specimen of 
specified geometry. This compaction takes place in a die by the action of two punches, 
the lower and the upper, by which the compressive force is applied.  
Powder compaction is the reduction in volume of a powder by the application of a force. 
Because of the increased proximity of particle surfaces accomplished during 
compaction, bonds are formed between particles which provides coherency to the 
powder, i.e. a compact is formed. 
 
Figure 10: Stages of tablet manufacture (encyclopaedia of ph tech, p 3654) 
Irrespective of the press type used, a complete tablet manufacturing cycle occurs in the 
following steps (Figure 10): (i) the die is filled and adjusted (scraped), (ii) the tablet is 
compacted, and (iii) the tablet ejected from the die. 
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6.1 Single-punch press (eccentric press) 
Eccentric tablet presses are single station tablet presses that use an eccentric shaft con-
nected to a rotating wheel to control the displacement of the upper punch into the die. In 
an eccentric press, the displacement profile of the upper punch is sinusoidal and the 
displacement rate is controlled by adjusting the rotation rate of the eccentric wheel 
(Figure 11). The lower punch remains stationary during the compaction and acts only to 
enable uniform die filling prior to tablet formation and tablet ejection after tablet 
formation. Eccentric presses utilize single-sided compaction to make tablets, where as 
rotary presses use double-sided compaction. Also, eccentric press compaction cycles do 
not have a dwell time, where rotary presses typically use a punch head flat which 
enables a dwell time as the punch passes under the compaction roller. Finally, the 
degree of machine deflection is different for these different presses. (Augsburger and 
Hoag 2008) 
 
Figure 11: Displacement profile of an eccentric press compared to a rotary press 
(Augsburger and Hoag 2008) 
 
71 Pharmaceutical Tableting 
6.2 Rotary press 
The rotary press was developed to increase the output rate of tablet production. A 
rotary press operates with a number of dies and sets of punches. The dies are mounted 
in a circle in the die table and both the die table and the punches rotate together during 
operation of the machine, so that one die is always associated with one pair of punches. 
The vertical movement of the punches is controlled by tracks that pass over cams and 
rolls used to control the volume of powder fed into the die and the pressure applied 
during compaction. The powder is held in a hopper whose lower opening is located just 
above the die table. The powder flows by gravity on to the die table and is fed into the 
die by a feed frame. The reproducibility of the die feeding can be improved by a rotating 
device, referred to as a force-feeding device. During powder compaction both punches 
operate by vertical movement. After tablet ejection, the tablet is knocked away as the die 
passes the feed frame. 
 
Figure 12: Rotary press production cycle a) top view, b) unfolded view (Sinka and 
Motazedian 2009) 
The location of the compaction roll on the punch head determines the phase of 
compaction. The loading phase begins when the upper punch first makes contact with 
the compaction roller, and lasts until the compaction roller reaches the edge of the flat 
portion of the punch head. At this point the dwell phase begins and continues until the 
compaction roller rolls off the top of the torus (Augsburger and Hoag 2008). During the 
dwell phase the strain is constant, with unloading beginning at roll-off and continues 
until the punch stress drops to zero; this point is called lift-off. Once the punch stress is 
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zero the relaxation phase begins and continues until the tablet is ejected from the die. 
The stress created during compaction is a consequence of a reduction in tableting 
material volume. 
6.3 Compaction mechanics 
The compaction process can be described by a series of sequential phases: 
Particle rearrangement 
Elastic, viscoelastic, and plastic deformation of particles 
Fragmentation of particles 
Formation of inter-particulate bonds 
As the powder volume is reduced, the particles become rearranged into a closer packing 
structure. At a certain point, the packing characteristics of the particles and inter-
particulate friction between particles will prevent any further particle rearrangement. 
At this point, the further reduction in compact volume results in the elastic, viscoelastic, 
and plastic deformation of the particles. (Wu, Ruddy et al. 2005) 
Elastic deformation is reversible, whereas the plastic deformation is irreversible. In 
addition, particle fragmentation or breakage results in smaller particles, which further 
decreases in compact volume. As the volume is further reduced, the smaller particles 
formed by fragmentation can undergo deformation. As a consequence of these 
processes, particle surfaces are brought into close proximity to each other which can 
lead to the formation of inter-particulate bonds. These bonds may later break which 
facilitates further compaction. 
All materials posses varying degrees of elastic, viscoelastic, plastic, and brittle 
characteristics, and the type of volume reduction mechanism that will predominate for a 
specific material is dependent on factors such as temperature and compaction rate. 
Three types of bond mechanisms can occur during tableting: mechanical interlocking 
between irregularly shaped particles, inter-particulate attraction forces (Van der Waal 
forces, hydrogen and electrostatic forces) and melting solid bridges. 
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6.4 Tablet production by direct compaction 
The aim of direct compaction, as opposed to tableting via granulation, is to minimize the 
number of operations involved in the pre-treatment of the powder mixture before 
tableting. Tablet production by direct compaction involves only two operations in 
sequence, powder mixing and tableting. The advantage with direct compaction is 
primarily a reduced production cost. However, in a direct compactable formulation, 
specially designed fillers and dry binders are normally required, which usually are more 
expensive than the traditional ones. They may also require a larger number of quality 
tests before processing. As heat and water are not involved, product stability can be 
improved. Finally, drug dissolution is generally faster from a tablet prepared by direct 
compaction owing to fast tablet disintegration into primary drug particles (depending 
on formulation). (Göran Alderborn 1995) 
The disadvantages of direct compaction are mainly technological. In order to handle a 
powder of acceptable flowability and bulk density, relatively large particles must be 
used which, firstly, may be difficult to mix to a high homogeneity; and secondly are 
prone to segregate. Moreover, a powder consisting mainly of drug will be difficult to 
form into tablets if the drug itself has poor compactibility. Finally, an even colouring of 
tablets can be difficult to achieve with a colourant in dry particulate form. 
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6.5 Tableting excipients 
In addition to the active ingredient(s), a series of excipients are normally included in a 
tablet; their role is to ensure that the tableting operation can run satisfactorily and to 
ensure that tablets of specified quality are prepared. Depending on the intended main 
function, excipients to be used in tablets are subcategorized into different groups. 
However, one excipient can affect the properties of a powder or the tablet in a series of 
ways, and many substances used in tablet formulations can thus be described as mul-
tifunctional. The functions of the most common types of excipients used in tablets are 
given in Table 1 (Aulton 2002). 
Table 1: Common tableting excipients 
Excipient category Examples 
Filler Lactose 
 Sucrose 
 Glucose 
 Mannitol 
 Sorbitol 
 Calcium phosphate 
 Calcium carbonate 
 Cellulose 
Disintegrate Starch 
 Cellulose 
 Cross-linked polyvinyl pyrrolidone 
 Sodium starch glycolate 
 Sodium carboxymethyl cellulose 
Solution binder Gelatine 
 Polyvinyl pyrrolidone 
 Cellulose derivatives 
 (e.g. hydroxypropylmethyl cellulose) 
 Polyethylene glycol 
 Sucrose 
 Starch 
Dry binder Cellulose 
 Methyl cellulose 
 Polyvinyl pyrrolidone 
 Polyethylene glycol 
Glidant Silica 
 Magnesium stearate 
 Talc 
Lubricant Magnesium stearate 
 Stearic acid 
 Polyethylene glycol 
 Sodium lauryl sulphate 
 Sodium stearyl fumarate 
 Liquid paraffin 
Antiadherent Magnesium stearate 
 Talc 
 Starch 
 Cellulose 
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6.6 Determinants of the compaction process 
As discussed previously, the bulk volume reduction during compaction ( compression) is 
a complex process involving several events. Thus, the success and efficiency of compact 
formation can be influenced by numerous factors. These factors could be 
product/formulation related, process/equipment related and/or environment related. 
Some of the most important factors affecting the compressibility/compactibility of 
pharmaceutical materials are: 
6.6.1 Crystallinity/Polymorphism 
Polymorphism, pseudo-polymorphism, and the crystal ordering/disordering of pharma-
ceutical materials are known to affect their densification behaviour and the final 
compact attributes. Typically, crystalline materials undergo brittle fragmentation 
whereas amorphous materials undergo plastic deformation (Singhal and Curatolo 
2004). 
6.6.2 Porosity and Bulk Density 
The relative density and hence porosity vary largely among pharmaceutical materials. 
Moreover, the porosity of these materials may change significantly during processing. 
Since the process of compaction is aimed at reducing the porosity of a powder or 
granule, the initial porosity largely determines the extent to which the porosity can be 
reduced in a given tablet press. Also, increases in the original intra-granular porosity 
increased the compressibility at a given applied pressure (Eriksson and Alderborn 
1995). 
6.6.3 Particle size and shape 
The particle size, size distribution, and shape are among the important determinants of 
the deformation behaviour of pharmaceutical powders and granules. Increasing the 
irregularity and roughness of granules changed the compaction behaviour from plastic 
deformation towards a more complex process including fragmentation and attrition of 
the granules. Compressibility is generally better in larger particle size systems due to a 
greater degree of densification. This is attributed to increased frictional and cohesive 
forces associated with the smaller size range; which tends to restrict particle flow and 
thus reduce densification (Fichtner, Rasmuson et al. 2005). 
 
76 Pharmaceutical Tableting 
6.6.4 Compaction Force 
Compaction force is the major driving force in the powder densification process. The 
rate and extent of the applied force on the powder bed not only affects the way particles 
physically deform but also determines the integrity of the compact formed (crushing 
strength/tensile strength). There is a positive correlation between compaction force and 
compactibility of the material up to a threshold pressure beyond which either the 
crushing force of compact remains unchanged, decreases or results in manufacturing 
problems like capping and lamination (Wu, Ruddy et al. 2005). 
6.6.5 Lubricants and Glidants 
Lubricants are usually added to formulations to reduce die-wall friction, although they 
may also help improve flow properties (those having a glidant characteristic), as well as 
function as anti-adherents. The amount of lubricant added and the extent or duration of 
mixing a lubricant have been shown to affect several formulation properties including 
powder flow, deformation behaviour, crushing strength, and dissolution rate. It has been 
traditionally observed that increasing the concentration of lubricant in a formulation 
results in tablets with decreased crushing strength. This effect is attributed to a decrease 
in the degree of cohesiveness between the particles as well as decreased frictional 
effects at the punch faces and die-wall (Moody, Rubinstein et al. 1981). 
Glidants are typically incorporated in solid dosage formulations to improve the flow 
properties of granules or powders. There are several mechanisms by with a glidant can 
increase the flowability of formulations, including 
• Decreasing surface roughness of the particles by forming a uniform coating 
around them; thus, reducing the frictional drag between the particles. 
• Acting as physical barriers between particles which reduces attractive forces 
between particles. 
• Removing absorbed moisture from the surface of the particles, making them 
drier and more flowable. 
 
6.6.6 Moisture 
Moisture is known to affect a wide range of properties, such as powder flow, 
compactibility, and stability (physical chemical and microbiological). The interaction 
between moisture and a solid is complex and can occur in a variety of ways. For 
example, water can be stoichiometrically incorporated into a solid's crystal structure in 
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the form of a hydrate (pseudo-hydrate). In addition, moisture can have nonspecific 
interactions with a solid by adsorbing on the surface or being absorbed into the material 
and acting as a plasticizer, and these interactions are more common in amorphous or 
semi crystalline materials. 
Absorbed moisture increases the deformability of the material by facilitating a 
temporary transition of the amorphous material from a glassy to a rubbery state 
(particularly for long chain polymeric materials), occurring during the compaction 
phase, resulting in the formation of solid bridges (due to evaporation of moisture during 
processing) with a subsequent increased inter-particulate bonding area, which increases 
the deformability of the particles (Sun 2008). 
6.6.7 Tableting speed 
The deformation behaviour of many pharmaceutical materials is time-dependent and 
the nature of this time dependency is often related to the mechanism of compaction for a 
given material. It is thought that time dependency or speed sensitivity arises from the 
viscoelastic or viscoplastic characteristics of a material. In contrast, studies have shown 
that brittle materials are much less speed dependent that ductile materials because 
yielding and fragmentation are not as dependent on the rate of compaction. It is also 
believed that the particle size and size distribution of the powder or granules have an 
important role in the speed sensitivity due to the fact that this property affects the pre-
dominant mechanism of deformation. 
The speed sensitivity of pharmaceutical materials can have serious implications on the 
final tablet attributes. The effect of punch velocity can be pronounced when a material is 
transferred from a single station laboratory press to a rotary press or scaled up to a very 
high speed industrial press. Several studies have found that materials that have a high 
degree of elastic recovery or deform via plastic deformation tend to show a decrease in 
tablet strength with increase in tableting speed, and problems like capping and 
lamination are more likely to occur when such materials are scaled up to a high-speed 
press (Akande, Rubinstein et al. 1997). 
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6.7 Compaction simulators 
A compaction simulator is a tool for the characterization, scale-up, and troubleshooting 
of powder compaction performance. In the simplest of terms, a compaction simulator is 
a highly instrumented single station compaction machine fitted with an upper punch, 
lower punch, and die that is capable of mimicking a modelled compaction event. These 
machines are either hydraulically or mechanically powered to deliver a range of 
compaction forces using highly controlled punch displacement profiles. Compaction 
simulators use sophisticated instrumentation to monitor, at minimum, the displacement 
and force profiles associated with the compaction event. Therefore, the data generated 
while using a compaction simulator offers a significant advantage over traditional 
pharmaceutical unit operations for studying and understanding powder compaction 
behaviour. 
6.7.1 Hydraulic Compaction Simulators 
The hydraulic system is electronically controlled, with either compaction force cycles or 
movement of the punches being freely adjustable. The primary aim is to mimic the 
densification process of a rotary machine and the mechanical factors influencing it. 
The force-time profile of a rotary tableting machine can be theoretically deduced and 
calculated using machine geometries (Oates  and Mitchell 1989). But this is only possible 
to a certain extent, because of the amount of factors influencing the measured force 
outside the simulation, e.g. the tableted material, the geometries of the machine, the 
machine wear time, tableting speed, and tableting tools (Pudipeddi , Venkatesh  et al. 
1993). Similarly, the displacement-time profile of a tableting machine, especially a 
rotary tableting machine, is very difficult to calculate. Thus either an approximated 
displacement-time profile can be used for programming the compaction simulator or 
approximation of real punch movement is only possible using recorded data from real 
tableting machines 
However, hydraulic compaction simulators are still used in research for basic material 
characterization. They show the advantage of controlling speed exactly and of using low 
and high punch travel speeds, between 10 and 300 mm s-1. 
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6.7.2 Mechanical Compaction Simulators 
These employ a single pair of punches moving linearly forth and back on a lower and an 
upper punch track. For tableting, the punches pass along exchangeable compaction 
wheels which are equivalent in dimensions to those of rotary tableting machines used in 
practice (Natoli, Levin et al. 2009). 
Tableting speed can be varied and different tableting machines are simulated by using 
similar dwell times. In addition, pre-compaction wheels can also be mounted to simulate 
pre-compaction. Therefore, mechanical compaction simulators allow process simulation 
of rotary tableting machines to a greater extent than when using hydraulic compaction 
simulators when used for formulation development and scale-up (e.g. Presster™, section 
12.2.1 - page 159). 
6.7.2.1 Dwell time 
Because different presses employ different number of stations and pitch circle 
diameters, matching tablet press speed (rpm) has no real scientific value. The solution 
would be to express tableting speed in terms of dwell time or contact time. 
Functionally, the effective dwell time (EDT) can be defined as the time it taken by the 
force–time curve to traverse the 90% of the peak height (with effective contact time 
(ECT) being the time between points at 10% of the peak height). 
Mechanical Definitions of dwell and contact times disregard material properties and 
concentrate on press and punch geometry. They would be preferred for dwell time 
calculations because they serve as an objective material-independent measure of 
compaction speed: 
1. Contact time can be defined as the time the punch is in contact with the 
compaction wheel; and 
2. Dwell time, equation (0.13), is defined as the time the flat portion of punch head is 
in contact with the compaction wheel (time at maximum punch displacement, or 
time when the punch does not move in vertical direction). 
 ( ) 3,600,000 mesc L NSDT
PCD TPHpi
⋅ ⋅
=
⋅ ⋅
 (0.13) 
where 
DT = dwell time in (msec) 
L = length of the flat portion of the punch head (mm) 
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NS = number of stations 
PCD = pitch circle diameter of the turret (mm) 
TPH = tableting speed (tablets per hour) 
 
6.8 Powder deformation during compaction 
The material property that predominantly affects the tableting of powders is the 
deformation behaviour of powder under stress. The deformation characteristics may be 
elastic, plastic, brittle fracture or a combination of these deformation mechanisms. 
Various parameters that characterize the deformation characteristics of powders 
include Young's modulus, Poisson's ratio, yield stress, and fracture toughness. 
Elastic deformation is time independent, reversible deformation of a particle, and can 
create residual stresses within the compact during the decompression phase of the 
compaction cycle. The force applied on a compact or powder divided by the surface area 
of a compact causes a change in dimensions. The linear portion of the stress-strain plot 
and the proportionality constant between stress and strain is given by the Young's 
modulus (DWIDEDI, OATES et al. 1992). 
For elastic deformation:  
 d Eσ ε=  (0.14) 
Where E is the Young's modulus of elasticity of material, ε is the deformation strain 
and σd is the deformation stress (Rowe and Roberts 1996). 
Plastic deformation is the permanent deformation of a particle that is controlled by the 
applied stress. The amount of plastic deformation depends on the overall time of 
compaction, contact time or rate of application of compaction force and the time during 
which the material is subjected to maximum force (dwell time). Plastic deformation 
facilitates the formation of permanent particle–particle contact regions during 
compaction, and is given by: 
 d yσ σ=  (0.15) 
Where σy is the yield stress of material, which is the stress beyond which material is not 
elastic. When the yield stress is exceeded, the material may either flow or break upon 
compaction (Cartensen 1993). 
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And for brittle fracture: 
 icd
AK
d
σ =  (0.16) 
Where Kic is the critical stress intensity factor of material that provides an indication of 
the stress required to produce propagation of crack, d is the particle size diameter 
and A is a constant depending on geometry and stress application. Kic describes the state 
of stress around an unstable crack, and is a measure of the resistance of material to 
cracking via tensile stresses normal to the crack walls (Roberts, Rowe et al. 1993). 
6.9 Analysis of the tableting process 
Instrumented tableting variables, namely force, time, displacement, and temperature, 
can be combined differently and can be analyzed afterward. From the functional 
relations, conclusions can be drawn about the compaction and compaction behaviour of 
the materials. 
6.9.1 Changes in bed density or porosity during compaction 
During tableting, the bed density or porosity of the powder changes as the compaction 
force is applied. This reduction in volume or density of the compact upon application of 
force can be calculated using the Heckel equation (Heckel 1061), and is given by the 
mean yield pressure, PY: 
 ( )Ln 1/1 D KP A− = +  (0.17) 
Where D is the relative density of the compact in die at the pressure P. K and A are 
regression coefficients of the linear portion of the curve, and the reciprocal of K is the 
mean yield pressure, PY. 
The Heckel equation is applicable to systems that deform plastically, but deviations from 
linearity at low applied stress tend to suggest alternative compaction mechanisms such 
as brittle fracture. The Heckel equation has been used to distinguish three types of 
volume reduction mechanisms based on the effect of stress on initial powder bed 
density. 
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Figure 13: Heckel plot (Ruegger, Royce et al. 2007) 
 
These materials were categorized by compressing different particle size fractions of 
various powders. In type A materials, the variation in initial bed densities results in 
different final bed densities under applied stress. Particle size fractions had different 
initial packing fractions and the plots remained parallel as the compaction pressure was 
increased. In these densification takes place by plastic flow preceded by particle 
rearrangement. In type B materials, irrespective of the initial bed density, a single linear 
relationship occurs above certain pressures. Below this pressure plots are slightly 
curved at initial stages of compaction. Powder densification happens by fragmentation 
of particles. The initial structure of the powder column is completely destroyed by 
fragmentation and hence differences in initial packing have no effect on further 
densification. In type C materials, the plots have an initial steep linear portion after 
which they become coincidental with only trivial volume reduction. Powder 
densification occurs by plastic flow but no initial particle rearrangement is observed. 
(Paronen and Iikka 1996) 
6.9.2 Tablet indices 
Strain index, P/E, is obtained from dynamic indentation hardness, P, and the reduced 
Young's Modulus, E . E  is given by: 
 ( )1 211
EE
υ
′ =
−
 (0.18) 
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Where E1 is the elastic modulus of the compact and υ1 its Poisson's ratio. Strain index is 
indicative of the relative strain or change in size during elastic recovery after plastic 
deformation, and is indirectly related to the proximity of surfaces that remain in contact 
after decompression. The values of P/E range from 0–0.04. A high P/E  implies 
potential structural failures such as capping or lamination (Shah and Davar 1995). 
Brittle Fracture Index (BFI) is the ratio of the tensile strength of the tablets with, (σT), 
and without a hole, (αTo), at their centre. This ratio may indicate the ability or inability of 
compact to relieve stress at a crack tip within the compact by plastic deformation. 
 
/ 1BFI
2
T Toσ σ −
=  (0.19) 
BFI is a measure of brittleness, which is the principal cause of capping and lamination. A 
BFI of <0.2 indicates better compacting properties, whereas values >0.2 indicate 
tendencies to cap and laminate (Shah and Davar 1995). 
6.9.3 Force displacement curves 
By adding a displacement transducer to the instrumented press, the upper punch force 
is measured against punch-tip displacement. The resulting curve shows a progressively 
increasing slope, reaching maximum force as the punch achieves maximum penetration. 
The characteristic shape of the force-displacement curves, recognizable in terms of its 
slope and elastic recovery, can be correlated to the ability of material to undergo plastic 
deformation and form strong compacts.  
The gross work done in compaction and the proportion of the total applied energy 
absorbed by the material are indicated by the area under the curve and are considered a 
measure of the tablet strength, although this value includes the work done to overcome 
die wall friction. Several limitations to the use of this approach include concerns with 
accurate measurement of punch displacement, errors introduced because of 
multiplication of a large number (punch pressure) with a small number (punch 
displacement at maximum pressure), die wall friction, deformation of machine parts 
under pressure, and separation of net work from gross work (Watt 1988). 
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Figure 14: A theoretical force-displacement compaction profile. 
Triangle ACD describes the mechanical energy (energy of compaction); triangle BCD is the theoretical energy (energy 
of compaction, excluding initial packing phase, AB); curve BCD is the total energy (energy involved during 
compaction, excluding initial packing and interparticulate friction); curve BCB is the frictional energy (friction arising 
due to particle-particle and particle-die wall friction, i.e., difference between theoretical energy and total energy); 
curve CDE is the elastic energy (energy released as a result of elastic deformation during compaction unloading); and 
curve BCE is the net energy (energy required to yield a particle under force). (Patel, Kaushal et al. 2007) 
6.9.4 Elastic recovery during multiple compaction 
Work done in each compaction cycle is calculated by integration of each 
force/displacement curve. When this work becomes constant, this force-displacement 
value is assumed as the work done to produce the elastic deformation during 
compaction and is an indicator of the elasticity of material. Elastic recovery (ER) is 
defined as percentage of axial expansion of the compact after ejection, relative to its 
height at maximum pressure: 
 ER 100c
c
h h
h
 
−
= ⋅ 
 
 (0.20) 
Where hc and h are the heights under compaction and after ejection, respectively. The 
plastic deformation takes place during initial compaction and, after a certain number of 
compaction cycles, elastic deformation is predominant. The fewer the number of 
compaction cycles required for arriving at constant work, the more readily is plastic 
deformation completed, exhibiting increased plasticity (Watt 1988). 
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6.9.5 Deformation hardness 
Deformation hardness of a tablet can be correlated with the compressive stresses during 
compaction (Leuenberger and Rohera 1986), assuming that increasing the relative 
density of the compact allows more particles to come into contact and increases the 
deformation hardness, P: 
 
y Sc 
maxP P (l e )pi−= −  (0.21) 
Pmax denotes the theoretical maximum deformation (Brinell) hardness when the number 
of non-bonding points is reduced to zero and the applied compressive stress, Sc, is 
highest or infinite. A low Pmax value shows a relatively poor compactibility, for even with 
high compaction stress this limiting value cannot be exceeded. The parameter γ specifies 
the rate at which the compact hardness P builds-up with an increase in applied 
compaction stress and provides information about compressibility. A high value of γ will 
imply P=Pmax and a sharp decrease in compact porosity may be attained with low 
compaction forces. A plastically deforming material will have a high value of γ and a low 
value of Pmax, whereas the reverse is the case for brittle materials. 
6.9.6 Compaction force versus tablet strength 
The effect of compaction force on tablet strength is obtained by operating the tablet 
press at any given speed for an extended range of compaction forces. The crushing 
strength and friability of the resulting tablets are evaluated to obtain the range of 
compaction parameters in which the formulation performs best. Tablet compaction 
profiles and crushing-strength data provide useful information for limiting compaction 
forces during tableting and can provide additional information about lamination or 
capping. The slope of a compaction-force versus crushing-strength profile provides 
qualitative information about the ability of material to produce strong tablets. A very 
high slope value may suggest potential problems in production processes as a small 
change in the compaction force could cause significant increases in the tablet crushing 
strength, which could result in capping or variability in disintegration and dissolution of 
resultant tablets. 
Crushing strength or breaking force F measures the force, which when applied across a 
specific plane of a compact produces fracture in tablets. It is a function of compact 
geometry and does not take into account the mode of fracture or the dimensions of the 
tablet (Davies and Newton 1996). Crushing strength can be affected by the presence of 
lubricant, its concentration, and state of subdivision and location of particles; pre- 
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compaction processing, including wet or dry processes; time and scale of mixing; storage 
condition; compaction force; variations in time of consolidation, dwell and contact; die 
residence and ejection; amount of bound or free moisture and initial porosity of the 
powder bed. (Shotton and Lewis 1964) 
Crushing strength is only a limited index of the compaction properties of starting 
materials. Most materials will either deform elastically or plastically, or fracture under 
the influence of applied stress. Therefore, measuring the final force required to produce 
fracture does not truly reflect the conditions during compaction. The strain rate and 
thus the time during which materials are subjected to compressive stress is another 
important variable for consideration. 
6.9.7 Tensile strength 
The radial tensile strength, which measures the tablet failure as a result of the 
application of tensile stress only, is given by the relationship: 
 
2
x
F
DT
σ
pi
=  (0.22) 
Where σx is the tensile strength, F is the force required to break the tablet, D is the 
diameter of the tablet, and T is the tablet thickness. Various factors, such as test 
conditions, deformation properties of the material, homogeneity of the compact, 
adhesion conditions between the compact and its support, and tablet shape, may 
influence the tensile strength measurement (David and Augsberger 1974). 
In the axial tensile strength test, the tablet cleaves in a plane along its axis. It is 
measured by straining the face of the tablet, mounted between a pair of adapters, and 
determining the maximum force required to cause failure due to tensile stresses 
(Leuenberger and Rohera 1986). The axial tensile strength, σz, is given by: 
 2
4
z
F
D
σ
pi
=  (0.23) 
Where F is the force required to break the tablet and D is the diameter of the tablet. A 
comparison of radial and axial tensile strengths is indicative of the bonding strength in 
two directions and may provide information about the laminating and capping 
tendencies of the material (Alderborn and Nystrom 1984).  
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7. Research aims 
This research aims to evaluate various factors affecting NIRS applications, in particular 
quantitative methods. 
The first study aims to assess the effects of tablet press variability, in terms of 
compaction force, on content predictions for low-dose tablets. Calibration model 
performance, as well as the effects on spectra, are investigated. 
The second study examines the horizontal sampling span for pharmaceutical tablets in 
DT mode. 
The third study is a series of experiments aiming to investigate and estimate the 
information depth for DR mode in pharmaceutical tablets. 
The three studies would provide better evidence and understanding on the use and 
applicability of both DR and DT modes for pharmaceutical tablets, and the critical 
aspects affecting their performance and selection criteria. 
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8. Press effect on NIR predictions of low-
dose tablets and DT sampling span 
The work on this section is summarised in the original scientific publication from the 
author (below), with detailed experimental methods and results in Appendices I & II. 
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8.1 Assessment of diffuse transmission mode 
in near-infrared quantification - part I: The 
press effect on low-dose pharmaceutical 
tablets (original paper) 
Journal of Pharmaceutical Sciences. Volume 98, Issue 12, 2009, Pages 4877-4886 
8.1.1 Keywords 
process analytical technology • diffuse transmission • porosity • optical pathway • 
compaction simulation • press effect 
8.1.2 Abstract 
Quantitative applications for pharmaceutical solid dosage forms using near-infrared 
(NIR) spectroscopy are central to process analytical technology (PAT) manufacturing 
designs. A series of studies were conducted to evaluate the use of NIR transmission 
mode under various pharmaceutical settings. The spectral variability in relation to tablet 
physical parameters were investigated using placebo tablets with different thickness 
and porosity steps and both variables showed an exponential relationship with the 
detected transmittance signal drop. The drug content of 2.5% m/m folic acid tablets 
produced under extremely different compaction conditions was predicted and found to 
agree with UV assay results after inclusion of extreme physical outliers to the training 
sets. NIR transmission was also shown to traverse a wide section of the tablet by 
comparing relative blocking intensities from different regions of the tablet surface and 
>90% of the signal was detected through a central area of 7 mm diameters of the tablet 
surface. NIR Quantification of both film thickness and active ingredient for film-coated 
tablets are examined in part II of this study. © 2009 Wiley-Liss, Inc. and the American 
Pharmacists Association J Pharm Sci 98:4877-4886, 2009 
8.1.3 Introduction 
8.1.3.1 NIR Spectroscopy and PAT 
Near-infrared (NIR) spectroscopy is the measurement of absorbed radiation in the 
spectral region of 780-2500 nm (12,800-4000 cm-1). The absorption bands arise from 
overtones and combinations of fundamental mid-IR stretching and bending modes. It 
offers unique advantages of being fast, non-destructive, with no sample preparation 
requirements and strong identification and quantification abilities. Therefore, NIR 
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spectroscopy possesses great potentials for in-process control and end-product 
analytics. 
The recent developments in the applications of near-infrared spectroscopy (NIRS) for 
pharmaceutical manufacturing have been the strongest manifestation of the push for 
successful implementations of process analytical technology (PAT) applications, and 
were facilitated by the explosive growth in both the types and sophistication of NIR 
equipment and software. If successful, PAT manufacturing can deliver quality products 
that require minimal or no end-product testing (real-time release), owing to the fact that 
they will be produced through critically controlled processes designed to produce in-
spec products (Davies 2004). 
Although NIR spectroscopy has now been long-investigated for a vast range of 
applications, from fuels to food and feed industries, its use in the pharmaceutical field 
has picked up momentum only recently. One issue for NIR in this tightly regulated 
industry is the fact that use of this technique involves careful ‘risk-assessment’, mainly 
because predictions are the result of statistical correlations with established assays 
rather than being a primary assay. This logically leads to the need for establishing 
concrete methodology for NIR quantification which is specific for solid dosage forms and 
thus minimising (rather than completely eliminating) physical properties effects that 
dominate the spectra down to an acceptable threshold of error (Blanco, Eustaquio et al. 
2000). 
8.1.3.2 Quantification Using NIR Spectroscopy 
The work by Sherken (1968) contained the earliest published NIR determination of 
actives in tablets after extraction. The analysis of intact dosage forms, however, was 
reported as early as 1987 through the works of Lodder et al (1987). In common with 
other spectroscopic methods, NIR quantification relies on regression over variations in 
one or more spectral regions, which follow the change of one component's concentration 
in the sample relative to the rest. However, unlike UV assays where very dilute 
concentrations of samples are needed to avoid nonlinearity and deviations from Beer-
Lambert law, NIR applications perform best with a 50:50 ratio of components 
(measured-entity relative to other entities), and difficulties start to materialise at either 
end of the scale. Low-dose (specifically low-concentration) tablets would have a higher 
relative standard error of estimation and smaller fluctuations in tableting parameters 
could have a bigger influence on NIR predictions in such conditions. Low-dose tablets 
are unavoidable with potent drugs and smaller tablets are usually utilised to minimise 
manufacturing problems. But there is a limit to how small a tablet can be manufactured 
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and yet easily handled by patients, which brings about the need for an evidence base 
supporting the use of NIR quantification under such conditions. 
8.1.3.3 NIR Transmission in the Solid State 
The combination of relatively weak absorbance and high scattering efficiency is an 
important characteristic of the interaction between NIR radiation and particulate solids. 
This combination allows the radiation to propagate through the voids inside tightly 
packed solid particles. However, transmittance is expected to deviate nonlinearly for 
Beer-Lambert law of absorption for very dilute and clear solutions, because it does not 
take into account the probability that incident photons will be scattered or reflected 
backward or forward relative to the incident beam direction. This produces changes in 
absorption coefficients across a wide range of concentrations as light takes a tortuous 
path through voids with continuous scattering and back-reflection. This makes the 
transmittance more and more diffuse as it travels through the sample before being 
detected (Birth and Hecht 1987). 
It has still proved difficult to describe the nonlinearity from Beer-Lambert because the 
absorptivity/reflectance/scattering characteristics of a certain solid compact would be 
dependent on particle size and morphology, packing density, index of refraction and 
many other sample qualities. Nevertheless, many still consider Absorbance = log 
(1/Transmittance) as a simple, but working, approximation (Cogdill and Drennen 2006). 
Micro-cavities inside tablets (porosity) cause light scattering due to rapid spatial 
changes in refractive index. Consequently, this scattering is very dependent on the 
manufacturing process, (compaction force, compacted mass, grain size, etc.). 
Abrahamsson et al. (2005) suggested that the scattering in a tablet is about 3-4 orders of 
magnitude larger than the absorption resulting in very long optical path lengths, so that 
a typical 3.5-mm thick tablet can have a mean optical transmission path length of 20-30 
cm. This implies that some photons can find optical pathways of few millimetres while 
others span a meter before being detected. However, the high reproducibility of NIR 
spectra of the same sample in transmission indicates that this phenomenon is occurring 
in a consistent manner, but with great dependence on sample density (solid fraction or 
porosity) and thickness. 
In his work on normalising weight variations of predicted samples, Baxter (1994) 
concluded that the variation in NIR reflection spectra is a picture of active per unit area 
and does not allow the detection of tablet weight, highlighting the need for correcting 
assay results from reference assay methods and again the NIR prediction results for 
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tablet weight. A reduction in residual values from 2.17% to 1.56% was reported by 
Baxter when he used this method. 
Pretreatments, tighter wavelengths and various chemometric techniques have been 
used to minimise baseline effects for both reflection and transmission modes. The main 
problem in correcting density and thickness effects in transmission mode is the 
presence of nonlinear spectral scaling. This can also explain the difficulty in predicting 
tablets made with slightly different manufacturing conditions (e.g. different batches) 
from calibration samples (Blanco, Romero et al. 2004). 
Numerous studies in literature examined the use of NIRS to predict tablet density and 
hardness. Many of the published papers describe baseline shifts in reflection mode in 
correlation with sample densities (Cogdill, Herkert et al. 2007), (Kirsch and Drennen 
1999). Research from Ciurczak and Drennen (2001) on predicting tablet hardness using 
NIR suggested that the increased absorption in harder tablets is probably due to a 
reduction of light scattering on the smoother surface of these harder tablets, allowing 
more light to penetrate. The effect of hardness on spectra was so pronounced that the 
publisher indicated that level of error in NIR hardness prediction is in the 
neighbourhood of traditional destructive crushing-strength tests of 0.5 kP. On the other 
hand, there are no clear mathematical models that relate transmittance to apparent 
sample density and thickness because of the absence of a complete theory defining NIR 
transmittance. 
8.1.3.4 Effective Mass Sampled during NIR Analysis 
The need for effective sampling is common to all analytical techniques. With NIR 
spectroscopy, a great deal of attention is usually given in the selection of calibration 
samples highly representative of end product units over different batches. However, 
another aspect of sampling is sometimes overlooked. NIR radiation in classical diffuse 
reflection mode is reflected from a central area of the surface and is only assumed rather 
than proven representative of the whole tablet. 
The scale of mass to be assayed ‘scale of scrutiny’ (Donoso, Kildsig et al. 2003), 
(Berntsson, Danielsson et al. 1998) by any method depends on both the magnitude of 
the unit dose in question and the application. For example, monitoring blend uniformity 
requires minimal effective sampling mass, while the reverse is true for individual dosage 
forms. Moreover, the effective sampling mass has a complex and nonlinear effect on NIR 
transmittance and reflectance spectra (Bull 1990). 
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There is little experimental evidence of how deep the radiation penetrates the surface in 
diffuse reflection. This penetration is sample-dependent and the difference between 
loose and compacted powders is significant. One paper assessed reflectance in NIR 
imaging and estimated a 50% signal drop over 27-180 µm depending on the wavelength 
(Clarke, Hammond et al. 2002). Other papers considered NIR reflection to have a 
penetration depth of less than 1 mm (Li, Bashai-Woldu et al. 2007). Olinger and Griffiths 
(1992),(2001) estimated an information depth around 1 mm using diffuse reflection and 
a mixture of powders. Considering that this penetration is occurring in a dissipating 
manner, this mode is logically even less useful for coated or multi-layered tablets. 
Diffuse transmission mode on the other hand penetrates the whole thickness of the 
tablet and would theoretically be more representative of the whole tablet, (Berntsson, 
Burger et al. 1999) especially for low-dose units where aggregation has a higher effect. It 
is not clear, however, what path the radiation follows inside the tablet and hence the 
percentage actually being scanned. Moreover, transmission is more sensitive to path-
length and density variability. Iyer et al. (2002) did a series of experiments at Duquesne 
University to address this issue. They calculated a wavelength-dependent information 
depth for reflection ranging between 1.9 and 2.7 mm using second derivative spectra 
from tablets of increasing thickness. They also showed a limiting tablet thickness of 3.5-
4.8 mm for transmission. Another set of experiments showed an effective transmission 
diameter of 7 mm and concluded that the mass sampled for both modes was comparable 
and around 200 mg. However, the radiation intensity inside this diameter is fading 
towards the periphery in all directions making the mass over-estimated in this case, 
especially for reflection. Also, the fact that sampled mass is largely dependent on 
physical properties of the sample, mainly hardness and packing, makes this issue an 
open question. 
8.1.3.5 Study Aims 
The aims of this study were to assess the effects of compaction variability introduced to 
the tableting process on the performance of content prediction using NIR diffuse 
transmission mode, as well as examining the effects of variation in tablet thickness 
and/or porosity on the spectra; and finally, to elucidate the proportional contribution of 
various areas of a tablet to the final NIR spectrum in diffuse transmission mode. 
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8.1.4 Experimental 
8.1.4.1 Materials 
Folic acid USP, Sigma-Aldrich, USA; Micro-crystalline cellulose (MCC) Sanaq 102G, 
Pharmatrans Sanaq AG, Basel, Switzerland; AcDiSol Croscarmellose Sodium, NF, Ph. Eur., 
FMC Biopolymer, Brussels, Belgium; Magnesium Stearate, Novartis Pharma AG, Basel, 
Switzerland. 
8.1.4.2 Folic acid tablets 
A directly-compactable tablet formulation was used to make 2 sets of 220 folic acid 
tablets in 11 batches per set (table 1) with an API range of 0-10 mg (0-5% m/m in 0.5% 
steps and 20 tablets per step). Optimizing particle size and mixing times was of prime 
importance to obtain a consistent API content within each batch. Powders were sieved 
with 90 µm mesh to minimise segregation potential and then mixed in a Turbula mixer 
for 12 minutes in a mix-sieve-mix manner. 
TABLE 1: Folic acid tablet formulation 
Substance Percentage (m/m) Function
Folic acid USP 0-5 % active
MCC 102 93.75-88.75 % filler
Ac-Di-Sol 6 % disintegrant
Mg Stearate 0.25 % lubricant
 
The tablets were produced by means of a tablet press compaction simulator (Presster™ - 
Metropolitan Computing Corporation) which is capable of constructing linear models of 
an industrial-scale rotary press by replicating its dwell time, compaction and pre-
compaction forces, and ejection angle. Dwell time was adjusted by changing compaction 
speed while compaction force was a function of punch gap adjustments – hence the need 
for calibrating gap size against compaction force, tablet hardness and thickness. All 
press functions were instrumented and controlled by a computer terminal. 
The first set of tablets was used to obtain NIR calibration models for low-dose folic acid 
tablets and test the model with an external 2.5% m/m batch (same formulation as the 
calibration set, but not involved in the calibration) while the second set was used to 
examine the press effect on predictions. Table 2 details the press settings and tablet 
specifications for the both sets. 
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Table 2: Tableting parameters 
First Set Average (SD) 
Tablet mass 200.46 (0.31) mg 
Diameter (flat face) 10.00 (0.01) mm 
Thickness 2.39 (0.01) mm 
Resistance to crushing 95.33 (1.51) N 
Porosity 30.79 (0.26) % 
Speed 10800 TPH 
Dwell time 118.30 msec 
Gap size 1.80 mm 
Upper compaction force 3.90 kN 
Pre-compaction None 
Second set – extra parameters 
Porosity range 18-40% 
Gap size range 1.14-1.8 mm 
Compaction force range 10-3 kN 
 
8.1.4.3 NIR measurements 
All NIR measurements were performed on NIRFlex-N500 Fourier transform NIR 
spectrometer with solids transmittance measurement cell from Büchi (Switzerland) in 
diffuse transmission mode, using 64 scans and 16 cm-1 resolution in the 11520 - 6000 
cm-1 range. NIRCal 5.2 chemometrics software was used for calibration model 
development and predictions. All models used PLS (partial least squares) regression. 
Validation was through an independent validation set (1/3 of spectra) rather than cross 
validation. 
8.1.4.4 UV referencing 
Folic acid is soluble in slightly alkaline solutions. Sodium hydroxide solution (0.1 M) was 
used to dissolve each ground tablet and the filtered solution was measured in a 1 cm cell 
at 235 nm and a UV calibration line with r2 ≥ 0.999 was obtained in that medium. 
2.5 Effect of porosity and thickness on spectra 
Porosity in 6 tablets (formulation in table 1 with 0% fold acid) was fixed while varying 
thickness by adjusting tablet mass and compaction force. In the same manner, thickness 
was varied while keeping porosity constant in 3 more tablets (Table 3). 
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Table 3: Tablet porosity and thickness, varying one variable at a time 
Tablet Mass [mg] Thickness [mm] Porosity [%]
P1 200 2.66 38.00
P2 240 2.54 22.08
P3 280 2.61 11.53
T1 100 1.00 20.4
T2 200 1.99 20.0
T3 300 3.00 20.4
T4 400 4.06 21.6
T5 500 5.09 21.8
T6 600 6.10 21.7
 
8.1.4.5 Radiation convergence 
Figure 15 illustrates how paper with LaserJet ink print (100% coverage) scales down 
the spectrum of a placebo tablet by at least 88%, compared to the same tablet covered 
with a blank paper.  
 
Figure 15: Transmission spectra of a 0% tablet (A) covered with white paper, (B) same 
tablet covered with LaserJet ink printed on paper 
This can be exploited to examine the effect of blocking different areas of the surface of a 
single tablet using printed rings with varying internal diameters Figure 16. Each ring 
was sized such that fitting the paper inside any position on the tablet plate aligns the 
centres. These rings would block the tablet periphery, leaving a hole (white paper area) 
in the centre ranging between 9 to 1 mm in diameter. These paper filters were applied to 
the 0% batch with varying porosity and thickness. Each tablet/filter combination was 
scanned 3 times and the average of transmittance maximum at 8880 cm-1 was used. 
 
Figure 16: 10-mm printed rings used to produce a block effect. The number indicates the 
internal diameter in mm. The block from each filter to that from F0 was used to calculate 
block percentage. 
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8.1.5 Results and discussion 
8.1.5.1 The first calibration 
Visual inspection of the pre-treated 0%, 2.5% and 5% spectra (normalisation by closure 
- ncl) showed wavelength regions related best with the folic acid property (Figure 17). It 
also showed the low signal of folic acid compared to the filler, which adds a further 
complication to the low-dose API problem. 
 
Figure 17: Transmission spectra of 0%, 2.5% and %5 m/m folic acid tablets before and 
after pre-treatments 
Although ncl or SNV (standard normal variate) pre-treatments produced good order and 
grouping amongst the spectra (Figure 17, zoomed pane), the spectral noise from tablet-
to-tablet variations in physical properties overwhelmed the element of folic acid in the 
spectra. The batches showed little difference in transmittance apart from a small shift in 
the transmission maximum at 8880 cm-1 and spectral scaling. At that point, to what 
extent the effect of small variations in tablet properties on spectral scale and hence 
predictions was unknown. Five PLS models were developed with different parameters 
and comparable performance (Table 4). Each model can be evaluated in accordance with 
the EMEA / ICH guidelines for new method development by inspecting its respective 
parameters. 
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Table 4: Calibration models’ parameters 
NIRF1 NIRF2 NIRF3 NIRF4 NIRF5 NIRVAR
Wavelengths 
Calibration Set
6000-
11520
7400-
11520
8500-
11520 
6000-
11520
7400-
11520
6000-
10600
Data 
Pretreatment 
Sequence
MSC full  MSC full  SNV 
1st
derivative 
BCAP,
SNV
1st
derivative 
BCAP, SNV
MSC full,
normalisati
on by closure
PCs 7 7 6 3 3 12
V-Set BIAS 0.020901 -0.02879 0.017055 -0.000960 -0.001550 0.015475
C-Set SEE
(SEC)
0.249761 0.323872 0.259507 0.286846 0.286303 0.312529
V-Set SEE 
(SEP)
0.258087 0.317960 0.254297 0.292198 0.290546 0.311205
Consistency 96.77390 101.8590 102.049 98.16820 98.53960 100.4260
Regression linearity
C-Set 
Coefficient
0.997209 0.995125 0.996986 0.996318 0.996332 0.995599
V-Set 
Coefficient
0.995108 0.994061 0.995263 0.993946 0.994011 0.992966
C-Set 
Intercept
0.027482 0.049445 0.029669 0.036633 0.036495 0.042896
V-Set 
Intercept
0.039841 -0.01142 0.056711 0.037676 0.041552 0.019216
C-Set Slope 0.994425 0.990275 0.993981 0.99265 0.992678 0.991217
V-Set Slope 0.987660 1.008510 0.985014 0.992555 0.991889 0.992981
Accuracy (n=20)
Mean 4.6663 4.5753 4.7229 4.7786 4.7784 4.7793
SD 0.2221 0.2527 0.2331 0.1845 0.1850 0.1849
texp 3.5304 3.8238 2.0392 1.3580 1.3702 1.3713
tcritical 1.7291 1.7291 1.7291 1.7291 1.7291 1.7282
P (texp < 
tcritical)
0.0011 0.0006 0.0278 0.0952 0.0933 0.0920
Repeatability (1 tablet x 10, same operator)
SD 0.0381 0.0365 0.0448 0.0311 0.0306 0.0308
RSD 0.8165% 0.7978% 0.9486% 0.6508% 0.6404% 0.6446%
 
Figure 18 shows the difference between folic acid predictions and UV assay results for 
all five models using a 2.5% set external to the model. Models 4 and 5 had the best 
agreement. The same conclusion can be reached by inspecting model protocol produced 
in NIRCal (a compromise between best consistency, best correlation and least SEP).  
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Figure 18: Absolute difference [mg folic a.] of NIR predictions from reference method for 
an external batch 
8.1.5.2 The press effect 
Figure 19A shows untreated transmission spectra for MCC placebo tablets made with 
varying porosity, thickness and hardness by applying increasing compaction force. 
There is a stark scaling effect, almost exponential, relating to apparent sample density 
(and hence tablet porosity and hardness) and thickness. This exaggeration in variability 
was used to demonstrate how difficult it is to completely remove the density and 
thickness element from spectra using pre-treatments (Figure 19B). A partial solution 
was to use multiple narrow wavelength regions where the spectra were grouped. 
 
Figure 19: (A) Untreated spectra for placebo tablets made with varying compaction 
force. Thinner tablets with lower porosity have an upward scaled spectrum. (B) 
Pretreatment examples for same spectra, from left to right: normalization, 1st derivative 
and multiplicative scatter correction. 
 
100 Press effect on NIR predictions of low-dose tablets and DT sampling span 
NIR predictions of the variable compaction force tablets are shown in Figure 20. Twenty 
2.5% folic acid tablets made with varying porosities showed deviations from the 
reference method in varying degrees which are more pronounced on the high-porosity 
side (due to the exponential spectral relationship with  thickness and density, see below). 
This highlights the need for careful model development for high density tablets.  
 
Figure 20: NIR predictions for 2.5% m/m folic acid tablets made with varying 
compaction force. All models perform well in a porosity range (31%) similar to that of 
calibration tablets. Calibration set with different porosities was added to model VAR 
which is more robust to porosity change. 
Pharmaceutical tablets are made within a range of acceptable physical properties in line 
with friability requirements and desired dissolution/disintegration qualities. Although 
tablets are made within a narrow range of hardness (resistance to crushing – EP 25) to 
obtain consistent properties and therapeutic effects, the limits are set by manufactures 
according to the formulation requirements, which can be broad. This means that a 
harder tablet that still complies with analytical limits would have a scaled spectrum and 
can either show up as an outlier when predicted with NIR or be over-/under-predicted. 
VAR is a sixth calibration model constructed from folic acid tablets with an extremely 
varying porosity range across all API concentrations for the calibration/validation set. 
This model (Table 4) had similar performance to the previous models but was much 
more robust in terms of tolerance to porosity variance (Figure 20). 
However, the inclusion of samples with such extreme hardness variability makes the 
model very robust for hardness but would also render it more susceptible to other 
outlier effect, such as positioning, surface texture, particle size, raw material grades, etc. 
when tighter wavelengths and more principle components are used. A better 
compromise is the inclusion of maximum and minimum hardness samples from 
production batches to minimise the potential of future prediction errors and high 
spectral residuals. 
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8.1.5.3 Uniscalar effect of  porosity and thickness 
A change in any of tablet mass, density (hence porosity and hardness) or thickness 
would affect the other two. To assess the effect of one variable at a time, mass had to be 
adjusted in order to fix porosity with different tablet thickness values or vice versa 
(Table 3). Transmittance at 8880 cm-1 showed an exponential relationship with porosity 
(Figure 21A) and thickness (Figure 21B).  The effects from these two variables were 
additive when tablets were pressed with varying compaction force and the resulting 
spectral scale was inversely related to both thickness and porosity (Figure 19A). These 
results offer a better understanding of the spectral relationship with tablet hardness 
presented in literature. (Cogdill, Herkert et al. 2007), (Kirsch and Drennen 1999), 
(Ciurczak and Drennen 2001) This also illustrates why tablets with thickness of less 
than 4 mm can have a significant spectral scaling when produced with a thickness SD as 
low as 0.1 mm, which can add to prediction errors and outlier potential (Figure 19B and 
Figure 21). 
 
Figure 21: Transmittance at 8800 cm-1 of untreated placebo tablet spectra. (A) variable 
porosity and fixed thickness (B) variable thickness and fixed porosity 
8.1.5.4 Transmittance through the tablet 
To obtain an estimation of what percentage of the tablet volume is scanned in NIR 
transmission spectroscopy, untreated transmittance values at 8880 cm-1 were compared 
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as the same tablet was covered with laser-jet printed rings of different inner diameters 
(Figure 16). Tablets of varying porosities were used to examine different settings. Figure 
22 shows that increasing the block area over a tablet towards its centre reduced the 
signal at the detector (transmittance at 8880 cm-1) in a sigmoidal pattern, which was 
similar across different porosities. This suggests that porosity has little or no role in the 
distribution of NIR radiation coming out of the tablet surface. 
 
Figure 22: Reduction of detected signal with different paper filters. Different porosities 
show similar shape but different scale. 
In Figure 23, average transmittance values from 10 tablets after block from all filters 
were expressed in relative terms to the intensity of a tablet covered by a white paper 
with no ink. This was also compared to the ratio of white area of each filter to the whole 
tablet surface area (drop in the signal if distribution was assumed to be equal across the 
tablet surface, Figure 23 - dark line). 
 
Figure 23: Reduction of detected signal with different paper filters relative to blank 
paper (grey) compared to ideal reduction if distribution was assumed equal across all 
regions of the tablet (black). Central regions carry more signal than peripheral. 
If the tablet was visualised to be composed of 1 mm rings of decreasing internal 
diameters, the intensities from each ring can be estimated from the experimental data 
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above and compared to the theoretical intensity that the ring should transmit according 
to its area. This is also shown in Figure 23 and Figure 24 and modelled in Figure 25. 
 
Figure 24: Actual distribution of transmittance through 1mm ring sections of a tablet 
from periphery to centre (grey) compared to ideal distribution if distribution was 
assumed equal across all regions of the tablet (black). Central rings carry more than 
their relative surface area. 
A gradual reduction of the signal was followed by a sharp drop beyond a diameter of 7 
mm across the tablet centre. However, the peripheral 3 mm also contributed by a small 
amount to the signal (<10%). Similar results were described by Iyer et al. 21 This also 
means that for a 10 mm tablet, the central 5 mm of a tablet carry 77% of the signal (area 
25% of the whole surface) and the peripheral 5 mm of the tablet carry 23% of the signal 
(area 75% of the whole surface). This modelled distribution, coupled with the fact that 
radiation traverses the whole thickness, provides evidence that NIR transmission mode 
holds information representative of a big percentage of the tablet space. In addition, the 
fact that spectral representation of the tablet fades towards the periphery makes 
estimation of the sampled mass for both diffuse reflection and transmission modes 
overestimated and very much dependant on the tablet physical properties. 
 
Figure 25: Final model representing NIR transmission through a 10-mm pharmaceutical 
tablet with a flat surface. Darker areas indicate higher signal contribution.  There is a 
gradual fade from the centre with >90% of the signal carried through the central 7mm. 
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8.1.6 Conclusions 
The time- and cost-saving benefits of NIR spectroscopy in quantifying solid dosage 
forms are too big to be ignored. Transmission mode is highly representative of 
pharmaceutical tablets but much more liable for interference from physical variations. 
This brings about the need for careful calibration model planning at the outset, with the 
inclusion of intended physical outliers in various possibilities in the calibration and 
validation sets, while employing representative sampling techniques and possibly 
partial factorial design for complex systems. On the other hand, the element of tableting 
parameters in spectra is a valuable resource in understanding the process, which is the 
rationale behind PAT manufacturing. 
The technique was shown to perform well compared to the UV assay even under very 
challenging parameters (minimal spectral variation related to active principal and 
maximum density and thickness interference) but only after proper sampling design. 
The arrangement and actual length of NIR optical pathways through a tablet have a 
major impact on spectra and, if not accounted for, predictions. Sources of variability 
such as pore size, shape, arrangement and total percentage inside a compacted tablet 
are important determinants of detected NIR absorption and intensity as well as the 
robustness of calibration models and can have potential answers for many issues related 
to prediction outliers. 
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8.2 Supplementary discussion to the published 
paper 
8.2.1 Sample preparation 
Folic acid is a water-insoluble and light sensitive drug and hence a good example where 
NIR spectroscopic analytics present clear advantages over wet-chemistry assays. 
Moreover, it is administered in very low doses (typically 5 mg), which would present 
more challenge to NIR methods. 
Direct-compaction was chosen as a method of tableting for this experiment and tablets 
were compressed directly from mixtures of the drug and excipients without any 
preliminary treatment (granulation, pelletisation, etc.). 
The mixture to be compacted must have adequate flow properties and cohere under 
pressure.  Since most active compounds have less of such properties, they are mixed 
with other materials are directly compactable and serve as tablet diluents. This means 
that direct-compaction properties usually derive from the diluent, and potent drugs (like 
folic acid) which are presented in low doses can be mixed with generous amounts of 
diluent and still have a low table mass. 
With direct-compaction, the original individual particles are still present and influence 
the compact properties and add to batch-to-batch variation problems. Further 
disadvantages of direct-compaction are segregation of mixture components which can 
further compromise tablet properties, adversely affect content uniformity and, in the 
case of NIR content analysis, present question marks on the validity of prediction.  
The most frequently used direct-compaction diluent is microcrystalline cellulose which 
has a low bulk density and is highly compactable to form strong compacts that 
disintegrate readily in water. An important feature of direct compaction diluents is their 
capacity or dilution potential which is the amount by which they can incorporate 
substances which are not directly compactable and yet still produce acceptable tablets 
(Lund 1994). 
An essential influence on the compaction process has likewise the crystal form and the 
grain size. A grain size between 0.5 and 1mm is regarded as optimal in direct-
compaction. The requirement for the success of direct-compaction tableting is, that the 
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substances are dry, i.e. just showing a low residual moisture, which is the case in the 
prepared powder mixture (section 12.4.1.1). 
Ideal directly compactable diluents should be physically and chemically inert and free 
flowing to ensure homogenous and rapid flow of powder for uniform die filling. High 
compactibility is also required and the mass must remain in the compact form once the 
compaction force is removed. Few excipients can be compacted directly without elastic 
recovery. Such fillers should also remain unchanged chemically and physically during 
the compaction process. 
Diluents should have a particle size equivalent to the active ingredient present in the 
formulation which is consistent from batch to batch and produce uniform blending with 
and minimum segregation. This is why all mixture components were sieved with 90 µ 
sieve before mixing, without much sacrifice in tablet hardness (section 12.4.1.6). 
Lubricants have a more adverse effect on the filler properties, and the softening effects 
as well as the hydrophobic effect of alkaline stearates can be controlled by optimising 
the length of blending time to as little as 2-5 min, as well as have lubricant concentration 
below 0.5%. 
The Presster (section 12.2.1) was chosen because it presents a perfect tool to produce 
tablets of varying thickness, as well as its ability to simulate industrial-scale presses 
(dwell time). However, another aspect of tablet presses which is of prime importance to 
NIR methods is tablet mass and die filling variability, in relation to tablet press speed. 
This would mass variability would reflect on tablet thickness and porosity and hence 
might affect predictions. However, this variability is also dependant on the powder mix 
flow properties as well as feeding speed and container scale, and therefore is not a 
trivial factor to be simulated by lab-scale tools. 
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8.2.2 Calibration models
The use of NIR Flex N500 for analysis allowed spectral acquisition of tablets 
wavelength accuracy, good spectral resolution (16 cm
reproducibility. The regular SST provided high reliability of the readings throughout the 
experiment. 
The calibration range chosen (0
guidelines of 70-130% of the SD of the target batch (around 1.75
have the potential for higher SEP. Slightly narrower range might achieve better 
predictions than in this experiment.
Another point is predicting total tablet API content (mg) versus predicting API 
concentration (mg mg-1). NIRS like other spectroscopic techniques probe sample 
portions through their optical pathway, and hence optimally predict concentration 
(Figure 26). 
Figure 26: Spectroscopic assays, test tubes A and B are identical to the method because 
they have the same concentration, although B has more total drug content.
Although in DT, it is still not exactly known how much of the tab
(also discussed in experiment II), but in all cases not all the tablet volume would be 
scanned. This means that NIR methods predicting total content are being able to do so 
because tablet mass variation is within a narrow range, and
prediction. Hence predicting percentage and converting to total content using precise 
tablet mass would be more accurate.
The UV method standard calibration curve was constructed from mixtures rather than 
folic acid stocks because the tablet contents would not be chromatically separated, like 
in HPLC, and all the components will be present in the sample solution. Although this 
was filtered before UV analysis and the components are not that soluble, but MCC is 
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slightly soluble in weak alkaline solutions and be might present in the cuvette during 
analysis. A calibration line made from such mixtures would perform in the same 
accuracy when a tablet is dissolved and assayed. The calibration fit had a zero intercept 
because the 0% tablets were inside the calibration and should not be assayed less than 0 
(apart from –SD). 
Because folic acid had very high UV absorption (light sensitive), 10.00 mg of the crushed 
tablet rather than the whole tablet was dissolved for assay sampling in order to remove 
the need for dilutions, the same applies to choosing 235 nm which is not the absorption 
peak, but rather 20 nm before it and lower in absorbance. 
This might be argued as adding error to the method, but dilutions would be more 
problematic, especially the need for huge amounts of NaOH stocks (which need dilution) 
and the fact that the drug is light sensitive. 
Every analytic method has its SD (or SE), and this is different than the SD of the UV 
apparatus itself. The SE of the whole method stems from errors in each step in the 
method, and in this experiment could be: sampling errors and scale SE, inhomogeneities 
not sampled (minimized by crushing and grinding), NaOH stock preparation, dissolution 
(complete or not), filtration (efficiency), cuvette cleanliness, and UV accuracy 
(wavelength and absorbance). To estimate the UV SEE, a more accurate analytic method 
needs to be available for comparison, and since that was not the case, SD can be used as 
a measure of SEE, in this case it was 0.1133 mg. This means that the NIR method will 
never have an SEP less than this figure, and in best cases will be 2 times that SEP. 
With regards to the calibration model set, excluding the 0 and 5% API batches from the 
validation was needed, otherwise the calibration performance would be understated, 
because these spectra are at the periphery of the property space and their predictions 
would be in most cases extrapolated and hence fall as outliers or potential outliers. The 
limits of any calibration model should not be the target for validation, but rather the 
centre. 
Outliers are spectra which, when applied to the constructed PCR or PLS calibration, 
cannot be fitted with the majority of the calibration model data. They can be identified 
by having residuals or scores outside the normally distributed SDs of the calibration 
model residuals and scores. There are many possible causes for outliers, but can 
generally classified into: 
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a. Abnormal sample (true outlier), e.g. wrong constituents or physical properties of 
the tablet 
b. Abnormal spectral acquisition, e.g. tablets out of position in the sampling plate or 
instrument problems. This can sometimes be excluded by re-scanning the 
sample. 
c. Abnormal referencing, e.g. errors in UV or HPLC dilutions, sampling, 
measurements, etc. This is difficult to detect due to the destructive nature of the 
referencing methods. 
d. Poor calibration model, e.g. models with numerous outliers should be re-
evaluated. 
In Figure 68, an outlier can be visually detected in the “predicted vs. original”, as well as 
the leverage plots. In many cases, it would be safe to exclude outliers from the model, 
especially if they are very infrequent. In other cases however, they might be an 
important indicator of the model’s performance, especially in terms of robustness. 
Although this amount of validation spectra are good enough to generate data that can 
fully validate the method, an external prediction batch that was not involved in the 
model development is needed, especially when model robustness is in question. In such 
cases, external batches taken at different points of time over the process life time would 
be the best approach. 
In NIRCal, there are two aspects unique to the software, namely Q-value and the model 
wizard. Both were researched and patented (Bossart and Grabinski 2002) and 
ultimately included in NIRCal in attempt to simplify calibration model optimization and 
evaluation. The Q-value (Figure 27) is a pool of weighted model indicators that sum up 
to a value between 0 and 1. Models above Q-value of 0.75 are claimed to be useful and 
those above 0.95 excellent. 
This Q-value is also used to find near optimum model optimization by changing the 
model variables (pretreatments, wavelength regions, number of PCs, and even sample 
sets) until the best Q-value is found. 
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Figure 27: NIRCal’s Q-value overview (Bossart and Grabinski 2002) 
During this experiment, both tools proved to be as good as (in some cases better than) 
manual optimization and evaluation of models. The only aspect where manual 
intervention is needed was wavelength selection. 
An SEP of 0.2731 mg (5.452% of prediction batch content) is 2.4 times the SD of the 
reference method and can be considered adequate. It must be noted however, the SEP is 
normally distributed and it means that 95% of the samples will be ±2×SD and 68% 
within 1×±SD (Figure 28). 
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Figure 28: Normal distribution of standard error 
The t-test results show that there is significant difference between the three models and 
the UV reference method. This shows typically how NIR models can be over-fitted to the 
training set, and fail with external prediction (see section 12.4.3, page 192 for better 
models). However this result should also be viewed in light of the low (20) sample size. 
Moreover, ICH guidelines permit for accuracy to be inferred once other parameters have 
been validated (page 58). 
8.2.3 Press effect 
It is known that density affects NIR spectra in both DT and DR modes. In tablets, 
however, there is a complex relationship between compaction force, tablet thickness 
and porosity (apparent density), which is further affected by fluctuations in tablet mass 
(Figure 29). 
Therefore, it is essential to investigate these effects on spectra, both in combination and 
singularly. The normal variability range might not show a clear effect on NIR spectra, 
apart from contributing to the SEP of prediction. However, when this variability was 
extended, the dependency of the spectra in DT mode to the compaction force was very 
clear (Figure 75). 
The spectral scale was non-linearly proportional to compaction force, and as the powder 
particles were more compacted and voids became smaller and less numerous (less 
porous), the air/solid interface total area became also smaller and therefore scatter was 
reduced. This meant that photons had a greater chance of escaping to the other side and 
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The effect of compaction force variability on predictions is clearly illustrated in Figure 
80 when all models show gradual drift in prediction from the referenced content, except 
in the porosity region they were trained for. 
It was possible, however, to develop a model that was robust to this variability by 
adding spectra of variable compaction force across all calibration concentrations (Figure 
81). Only then was the content predicted across the whole porosity range, of course with 
higher SEP and using much bigger number of PCs. 
Finally, the spectral scale relation to tablet thickness and porosity, each singularly is 
illustrated in Figure 82 and Figure 83. The scaling in both cases was exponential and 
running in the same direction of the compaction force change. 
8.2.4 Tablet sampling span in diffuse transmission 
The effect of placing a black paper over a tablet on DT spectra had to be tested first, and 
Figure 15 shows the scaled-down spectrum of an MCC tablet and blank paper. It also 
shows the effect of laser ink 100% coverage on paper over the tablet. The spectrum was 
scaled-down even further but in both cases preserved the same MCC spectral features. 
This meant that scaling, represented by transmittance at a single wavenumber can be 
taken to represent the degree of block, hence the maximum at 8880 cm-1 was chosen.  
With the application of paper filters F0 – F10 (from Figure 16) on the tablet, the DT 
spectra were scaled-down gradually with each increase in the block inner diameter 
(Figure 69). F1 and F2 block was small and difficult to judge whether due to positioning 
noise effect (most peripheral blocks) or real signal block. From F3 onwards, the block 
was strongly evident. 
In Figure 22, all porosity ranges tested showed similar sigmoidal block pattern, an 
indication that porosity change (in that range), was not affecting the signal distribution 
to a big degree. The plots do, however, have different scales, and it is due to due increase 
in radiation scatter at lower sample densities (higher porosity) – see press effect, 
chapter 8. 
The decrease in absolute transmittance at 8880 cm-1 was taken as a measure of the 
drop, and converted to proportional drop in comparison to F0 spectrum (section 11.2.4). 
Because F10 (100% coverage) would never scale-down the signal to 0%, the 
corresponding theoretical (ideal) distribution was also scaled-up to match this partial 
block. 
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The theoretical block describes how the block pattern should be if the DT radiation was 
assumed uniform across tablet surface, and used for comparison to appreciate the area 
of the block. 
The central areas were found to carry represent more of the signal than their 
proportional area (as expected). However, the representation of the tablet was 
continued up to 7 mm in diameter (90.6% of signal). However, although much less, the 
outer area is still represented in the spectrum, but eventually, tablets with bigger 
diameters have even smaller area sampled by the NIR radiation. Such big tablets in most 
cases have higher drug loadings (main reason behind increased tablet size) and would 
have less problems of drug segregation. 
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9. Tablet sampling span in diffuse 
reflection 
The work on this section is summarised in the original scientific publication from the 
author (below), with more detailed experimental methods and results sections in 
Appendix III. 
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9.1 Assessment of diffuse transmission and 
reflection modes in near-infrared 
quantification – part II: diffuse reflection 
information depth (original paper) 
 
J Pharm Sci. 2011 Mar;100(3):1130-41. 
9.1.1 Keywords 
process analytical technology • diffuse reflection • sampled depth • information depth • 
content uniformity • coated tablets • double-layer tablets 
9.1.2 Abstract 
Near-infrared (NIR) spectroscopy offers tremendous advantages for pharmaceutical 
manufacturing as a fast and non-destructive method of quantitative and qualitative 
analysis. Content uniformity (end product analytics) and process analytics are two 
important applications of the method. In part I of the study, diffuse transmission (DT) 
and the effect of tableting press and horizontal sampling span were discussed. 
Experimental evidence showed that 90% of the signal was detectable from a diameter of 
up to 7 mm. 
On the other hand, DR information depth (vertical sampling span) assessment is of equal 
importance in content prediction applications and to understand the effect of 
inhomogeneities in the sample. Three experiments were conducted: I. 0.5 – 10 mm 
incremental thickness MCC tablets with constant porosity, II. MCC/Phenylbutazone 
(PBZ) double layered (DL) tablets (PBZ layer 0-100% in 0.5 mm steps) and III. 
Comparison of placebo and 30% caffeine tablet cores with incremental film coating (film 
thickness of 0 – 0.35 mm). Incremental thickness and cluster analysis of DL tablets 
showed that DR information depth was < 0.5 mm, while the data fitting from 
incremental coating showed that signal drop reached 50% at 0.05 – 0.07 mm depending 
on the wavenumber and 90% signal drop (10% information content) can be seen 
between 0.2 – 0.25 mm without extrapolation. 
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9.1.3 Introduction 
Near infrared (NIR) spectroscopic methods have been widely used in pharmaceutical 
analysis for both qualitative and quantitative purposes, providing results of comparable 
quality in a more simple and expeditious manner. Therefore, they constitute effective 
alternatives to chromatographic techniques in many cases, encouraged by additional 
factors such as the ease of sample preparation and the reproducibility of measurements, 
which have often dictated their use in quality control analyses of both raw materials and 
finished products. The differential sensitivity and selectivity of spectroscopic techniques 
have so far dictated their specific uses. For example, UV-Vis spectroscopy has typically 
been used for quantitative analysis by virtue of its high sensitivity, while infrared (IR) 
spectrometry has been employed mainly for the identification of chemical compounds 
on account of its high selectivity.  
9.1.3.1 Theoretical aspects of diffuse reflection 
In NIR spectroscopy (NIRS), X-H (X is C, N or O) functional groups are almost exclusively 
involved in NIR spectroscopy (NIRS) because the overtones and combinations of their 
fundamental frequencies in the mid-IR and produce absorption bands of useful intensity 
in the NIR. The absorptivities of these overtone and combination bands are so much 
weaker than in mid-IR spectroscopy, and it is due to this fact that spectra of condensed 
phase, physically thick samples can be measured without sample dilution (non-
destructive analysis) and hence no sample preparation. The other advantage of low 
absorptivity is that measurements involving scattering effects are possible (diffuse 
transmission and refection). (Simpson 2005)  
Reflectance (R%) can be interpreted from equation (0.24), where IR is the intensity of 
the diffusely reflected light and I0 is the intensity of the incident light. Absorbance can be 
approximated as log of reciprocal reflectance, equation (0.25). 
 
0
% 100RIR
I
= ×  (0.24) 
 
1logA
R
=  (0.25) 
Diffuse reflectance (DR) differs from specular reflectance in that light penetrates the 
material up to some distance, where it is partially scattered on the surface of particles, 
as well as being partially absorbed. Therefore, considerable attempts have been made to 
describe it mathematically, the earliest being Lambert cosine law (Lambert 1760) in 
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which he proposed a correlation between the remitted radiation and the angle of 
observation for matte surfaces. Kortüm (1969) suggested that this law can be derived 
from the second law of thermodynamics but valid only for ideal diffuse reflectors and 
hence deviation from this law will occur in practice. 
Mie (1908) developed a more accepted theory that described the angular distribution of 
intensity and polarization of scattered radiation for a single scattering by one particle. 
This makes it applicable only to chemical systems in which particles are well separated. 
In practice, samples are expected to have multiple scattering taking place which led 
Theissing (1950) to take this theory a step further by including multiple scattering, but 
still particles in NIR/DR analyses are so densely packed that phase relations and 
interferences between scattered beams which have not been accounted for do exist. 
Thus for samples of this type no general quantitative solution to the problem of multiple 
scattering has been found. (Griffiths and Olinger 2002) 
Most other theories have evolved from energy transfer treatments, which describe the 
change in intensity of a beam of radiation of a given wavelength in a sample of a given 
density and pathlength due to total radiation loss from scattering and absorption that 
corresponds an attenuation coefficient, (Truelove 1988) and (Craig and Incropera 
1984). Schuster (1905) made an attempt to find simpler solutions to the radiation 
transfer equations by using different vectors for the light being incident or being 
remitted by the sample. 
Kubelka and Munk (1931) made more assumptions in their derivation of a simplified 
solution to the radiation transfer equation. The final derivation is shown in equation 
(0.26) and shows that the measured DR (R∞) is dependent on the ratio of K and S 
(absorption and scattering coefficients respectively). Kubelka and Munk’s solution is the 
most widely accepted DR explanation since it is a two-constant equation and therefore 
experimentally testable. Moreover, many other derivations by other workers like Smith 
(1931), Amy (1937) and Bruce (1926) have been shown to be derivable from Kubelka 
and Munk’s work. 
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For diffuse transmission (DT) on the other hand, light travelling in a medium is 
attenuated by absorption and scattering. The energy that is transmitted along the 
regular path is reduced more the longer it propagates in the medium or when the 
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concentration of the absorbing ingredient in the medium is higher. For a medium that 
does not cause significant multiple scattering, the radiant flux density of the transmitted 
light is related to the radiant flux density of the incident light by Beer-Lambert law, 
which holds true only when the effect of multiple scattering is negligible because the 
energy scattered forwards by one particle can be scattered backwards by a second 
particle. Although the interaction of light with materials was studied extensively, 
especially at the visual range (light propagation theory and optical dispersion (Lee 
2005), the complexity of the optical path inside a compacted material and the 
dependence of this path on physical properties of the compact (packing density, particle 
size, thickness, absorbing species concentration and distribution, etc.) hindered the 
development of a complete theory describing (DT) to date.  
As mentioned before, variations in the physical properties of samples can have 
significant effects on spectra. For tablets, mainly variation in bulk density (porosity and 
hardness); and in particle size range of compacted material would change the total 
surface area of the compacted particles and the ratio of voids to solids, hence spectral 
scaling will be evident for both effects. In DR mode, this will show as baseline shifts that 
can complicate content analysis or form the basis for hardness predictions (Short 2009 
and Blanco 2006), and is one of the reasons for using various pre-processing techniques 
(Shi and Anderson 2009). 
Another important aspect in the determination of content uniformity (CU) in 
pharmaceutical tablets is portion being sampled. The higher this portion is, the less 
likely the predictions will be affected by non-homogeneity in the tablet contents. In DT 
mode, experimental evidence have shown that >90% of the spectral information is from 
the central 7-mm of a typical pharmaceutical tablet, (Saeed et al, 2009) and the fact that 
radiation traverses the whole thickness of the sample means that this mode scans a 
considerable portion of the tablet volume.  
In DR mode however, the information depth (the depth of the sample contributing to the 
final detected radiation and for which the spectrum is representative) would determine 
the sampled portion of the tablet. Moreover, the extent of this depth would determine 
the applicability of this mode to coated or multi-layered tablets. 
9.1.3.2 Current evidence on DR information depth 
Few researchers have tried to DR estimate information depth for powder mixtures. 
Olinger and Griffiths (1992), (2002) used absorbance values for mixtures with known 
absorptivities and particle size values and reported an upper boundary of 1 mm at 1653 
nm. It was also reported that if scattering effect was to be considered, this range would 
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unlikely be more than 300 µm. Others have reported different values but without 
supporting experimental or theoretical evidence: 5 mm (MacDonald and Prebble 1993), 
1-2 cm (Ciurczak 1991), 1-4 mm (Olinger and Griffiths 1992), 0.5 mm (Stephen Victor 
Hammond 1997).  
The evidence is even smaller for compacted solids. Iyer et al. (2002) have tried to 
estimate the sampled mass in DR using single and double-layered tablets and second 
derivative spectra. He concluded that the effective sampling depth was between 1.9 and 
2.7 mm depending on the wavelength. Another study by Andersson et al. (1999) showed 
different values and suggested an information depth of 0.1 - 0.2 mm using incremental 
coating and tablets with 2 different components. The authors however maintained that 
these figures are only rough estimates because the results were obtained using 
extrapolation and may only be valid for specific materials and instruments. 
Because of such varying views on DR information depth, the exact value is still not clear 
to operators of the method. Additionally, since the majority of pharmaceutical tablets 
range in thickness between 1 – 4 mm, determining this depth is crucial to the selection 
of appropriate measurement modes for different coated, uncoated and multi-layered 
tablets and can provide better understanding of the performance differences between 
DR and DT modes. 
9.1.3.3 Study aims 
The study aims to determine the portion of the tablet contributing to DR spectral 
information (DR information depth). Because the evidence would be experimental and 
in many cases indirect, three different studies are made using tablets with increasing 
thickness, double-layered and incrementally coated tablets. Finally, an estimation of the 
pharmaceutical tablet depth at which 50% and 95% drop in the DR information is to be 
proposed. 
9.1.4 Experimental 
9.1.4.1 Materials 
Microcrystalline cellulose 102 (MCC SANAQ 102 G) (Pharmatrans SANAQ AG, Basel, 
Switzerland), Phenylbutazone (Sigma-Aldrich, Buchs, Switzerland), Caffeine anhydrous 
powder (BASF AG, Schaffhausen, Switzerland), Magnesium Stearate (Sigma-Aldrich, 
Buchs, Switzerland), FD+C Red 3 LA (Sigma-Aldrich, Buchs, Switzerland), Pharmacoat 
603 (HPMC) (Novartis Pharma AG, Basel, Switzerland), Aquacoat ECD 30 (FMC 
Biopolymer, Houston, TX), Triethylcitrate (Sigma-Aldrich, Buchs, Switzerland). 
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9.1.4.2 Tableting 
Variable thickness tablets were compacted on a Zwick Material Testing Machine (Zwick 
GmbH & Co., Ulm, Germany). Double layer tablets were compacted on a Presster™ tablet 
press simulator (Metropolitan Computing Corporation, East Hanover, New Jersey). 
Tablets for coating were compacted on an eccentric press (Korsch Schweiz GmbH, 
Trimbach, Switzerland). 
True density measurements were performed using a helium pycnometer (AccuPyc 1330, 
Micromeritics, Norcross, GA, USA) at room temperature. Air was extracted to generate a 
vacuum and then Helium was pumped-in 5 times until equilibrium was reached. Tablet 
thickness was measured using a digital calliper (Mitutoyo, Tokyo, Japan), and tablet 
mass was measured using an analytical scale AX204 (Mettler Toledo, Switzerland). 
Detailed method description is given in sections 14.3.1-14.3.3. 
9.1.4.3 Coating 
Tablets were coated inside Strea-1 laboratory fluid-bed (Aeromatic AG, Muttenz, 
Switzerland) and coat material was fed using a rotary pump. 
9.1.4.4 NIR measurements 
Tablets were scanned with NIRFlex N-500 (Büchi Labortechnik, Flawil, Switzerland), a 
Fourier-Transform spectrometer based on quartz polarization interferometer and a 
Tungsten halogen source. DR measurements used NIRFlex Solids cell with tablets add-
on and DT measurements used NIRFlex Solids Transmission cell with a sample size-
adjustable sample holder. Both cells use an extended range InGaAs detector 
(temperature controlled). More details are given in section 14.2.2. 
9.1.4.5 Data processing 
Data was fitted in a 3-way curve using Tablecurve 3D (Statcon, Germany). Spectral data 
processing and chemometrics were performed using NIRCal v5 (Büchi, Flawil, 
Switzerland). Exported spectra were averaged and correlated using standard Microsoft 
Excel functions and a VB macro to examine the entire wavenumber regions. 
9.1.4.6 Experiment 1: Variable-thickness tablets 
MCC powder was compacted into 0.5 – 10 mm thick tablets in a porosity range of 25 – 
33% using the Zwick. The mass of each tablet was calculated from the porosity equation 
(0.27) where porosity of the tablet (F) is related to the density of the compact (ρ) and 
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the true density of the powder mix (ρ0). Ρ was simply the tablet mass (m) over its 
volume (V). 
 
0 0
1 1
m
VF ρ
ρ ρ
= − = −  (0.27) 
Because the Zwick is a hydraulic press where the force of compaction rather than the 
gap is set, and because this force is dependent on both the final tablet thickness and 
mass for the same powder mix, the press was calibrated using different powder masses 
and different tablet thickness and the data was fitted on a 3-dimensional calibration 
curve (Figure 30) to calculate compaction forces for all tablets made (Table 5). DR 
spectra where then collected from all tablets, both the upper and lower surfaces. The 
collected DR spectra were processed with and without pre-treatments (normalisations, 
1st and 2nd derivatives, standard normal variate and multiplicative scatter corrections). 
However, non-pretreated spectra in this case showed the best grouping, because the 
sample density was tightly controlled. 
Table 5: Incremental thickness tablet details 
Tablet mass [mg] Thickness [mm] after 24h Porosity
41.90 0.50 25.68%
83.80 1.00 25.39%
125.50 1.52 26.24%
167.20 2.01 25.86%
208.90 2.50 25.63%
252.80 3.01 25.24%
293.30 3.52 25.85%
335.20 4.05 26.27%
380.00 4.56 25.72%
419.80 5.06 26.06%
461.40 5.55 25.91%
504.20 6.07 25.99%
545.90 6.58 26.09%
589.70 7.07 25.75%
630.30 7.57 25.84%
672.40 8.05 25.65%
714.00 8.57 25.83%
757.00 9.12 26.06%
799.90 9.54 25.35%
840.30 10.06 25.63%
 
Mean 25.80%
 
SD 2.79E-03
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Figure 30: Three-factorial fitting of tablet thickness, mass and compaction force of MCC 
102 on Zwick 
 
9.1.4.7 Experiment 2: double-layered tablets 
In these tablets, the lower layer contained phenylbutazone (PBZ), pigment and lubricant 
while the upper layer contained MCC and lubricant only (Table 6). The tablets where 
compacted in Presster™ using a flat face 10 mm punch. The powders where manually fed 
for each tablet. The lower layer was fed first and loosely compacted. The compaction 
was interrupted before ejection and the upper layer was fed on top and both where 
compacted and the double-layered tablet was ejected. Table 6 also lists the proportions 
of each layer, compaction forces used and compacted thickness. DR and DT spectra 
where then collected from both sides of the tablets and a principal component analysis 
(PCA) cluster models were constructed using different pretreatments, wavelength 
regions and number of PCs, and models with the best clustering (least amount of SE) 
were selected. 
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Table 6: Double-layered tableting 
Upper layer (PBZ) Lower layer (MCC) Final tablet
mass
Comp
-action 
gap
Thickness after 
compaction
mass
Comp
-action 
gap
Thickness after 
compaction
mass
Thick
ness
mg mm mm % tablet mg mm mm % tablet mg mm
0 0.0 0.00 0.0 400 3.2 4.27 100.0 394.7 4.27
50 0.6 0.50 11.7 350 3.2 3.77 88.3 391.0 4.27
100 1.8 0.95 23.5 300 3.2 3.10 76.5 396.6 4.05
150 2.8 1.58 38.7 250 3.2 2.50 61.3 394.1 4.08
200 3 2.09 49.2 200 3.2 2.16 50.8 388.5 4.25
250 3 2.7 65.1 150 3.2 1.45 34.9 391.1 4.15
300 3.4 3.21 75.5 100 3.2 1.04 24.5 393.2 4.25
350 3.4 3.8 88.4 50 3.2 0.50 11.6 392.9 4.30
400 3.2 4.45 100.0 0 0 0.00 0.0 389.4 4.45
 
9.1.4.8 Experiment 3: Coating experiment 
Placebo (99% MCC and 1% MgSt) and caffeine (30% caffeine, 69% MCC and 1% MgSt) 
tablets where compacted using a Korsch eccentric press and 7 mm concave punch with a 
5.5 mm curvature radius. Tableting involved strict and frequent in-process-control 
sampling. Both batches produced tablets with 100.57 mg (SD 1.03) mass and 3.16 mm 
(SD 0.022) thickness. 
Both placebo and caffeine tablets were coated (separately) with a typical film coat 
formulation (Aquacoat ECD – Table 7) inside a fluidized bed. The process was stopped 
every 50 g of coat sprayed and samples were collected for analysis. The process was 
stopped after 6 batches because the coating started to be non-homogeneous. Figure 31 
shows the weight and thickness gain along the process. It is noticeable that coating was 
continued much beyond normal film coating (10 – 100 µm) (Swarbrick and Boylan 
1988) in order to investigate the DR information depth. NIR DR and DT spectra were 
then collected for all coat levels. The spectral data were then exported to Excel for 
analysis. 
Table 7: Film coat formulation 
Component Proportion %
Aquacoat ECD-30 (30% w/w) 22.22
Pharmacoat 603 (19% w/w) 35.09
Triethylcitrate 1.33
FD+C Red 3 LA 7
Water (dist.) 34.36
 
Figure 31: Film-
9.1.5 Results and discussion
9.1.5.1 Incremental thickness tablets
Table 5 shows the gradual and uniform increase in tablets thickness
mm. It was not possible to manufacture a tablet with a thickness of less than 0.5 mm, 
and 10 mm was chosen because it was higher than any published data on DR depth. The 
tablets had a uniform porosity (mean of 25.8%), as shown from the 
graphically in Figure 32 (no correlation with thickness). Any changes in porosity with 
thickness would make interpretation of the spectra very difficult.
Figure 32: Plot of tablet thickness against porosity for incremental thickness tablets 
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Figure 33 shows a plot of several DR spectral maxima of the increasing thickness tablets, 
from both upper and lower surface scans. There was a gradual increase in reflectance 
with thickness, until 2-3 mm, followed by a gradual drop until 7 mm, and then another 
increase. This pattern was seen in all scans and cannot be relied upon for estimation of 
the depth with any certainty. One possibility was that the information depth was already 
missed with the thinnest tablet (0.5 mm). Both the upper and lower surfaces were 
scanned because tablets compacted in Zwick have different density distributions across 
its surfaces. However, the same pattern was observed. 
 
Figure 33: DR spectral changes with increasing tablet thickness, both for the upper and 
lower tablet surfaces and different spectral maxima. The blue bars indicate porosity of 
the same tablets (secondary axis) 
Since all the tablets were produced from the same raw material batch (MCC only) with 
excluded effect of porosity (Figure 34), the pattern could also be due to instrument-
related density distribution or tablet surface texture changes with different compaction 
force/tablet mass profiles. This meant that the experiment did not yield useful 
information and other approaches had to be tried. 
9.1.5.2 Double-layer tablets 
The selected Presster compaction scheme was able to produce double-layered tablets of 
uniform layers (Table 6 and Figure 35). Again, the thinnest layer was 0.5 mm and less 
than that cannot achieve homogenous and complete layer. Figure 36 shows SNV 
pretreated DR spectra of double-layered tablets, scanned with the PBZ layer 
downwards, as well as single layered MCC and PBZ tablets (white and pink respectively). 
There was a marked spectral difference betwe
several regions (marked red) which enabled a good interpretation of the results.
Figure 34: Plot of DR against tablet porosity of increasing thickness tablets, for upper 
and lower surface at di
Figure 35: Layer thickness of double
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Figure 36: Double-layer tablets DR spectra (PBZ down
spectra are non-distinguishable from PBZ, except the single layer MCC tablet.
If there was any DR radiation penetration beyond the thinnest PBZ layer (0.5 mm) into 
the MCC layer, the spectra of these tablets should have carrie
spectrum, which was not the case in 
compared with DT spectra of the same tablets in the same orientation (
this mode which penetrates both layers, there was a gradual change of spectral features 
from the PBZ-only tablets, and then the double layers with decreasing PBZ layer 
thickness, until the MCC-only tablet. Because this picture is not
double-layered tablets, the conclusion would be that DR information depth should be 
less than 0.5 mm. 
Tablet sampling span in diffuse reflection
wards, SNV pretreatment). All 
d some features of the MCC 
Figure 36. The picture becomes more clear when 
 shown in any of the 
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Figure 37). In 
Figure 37: Double-layer tablets DT spectra (PBZ downwards, db1 and ncl 
pretreatments). Spectra feature cha
Because the results above depended on visual inspection of the spectra, they had to be 
confirmed by cluster analysis chemometric models. 
scores of the DR spectra, referenced as MCC property (blue), except the PBZ
labelled as PBZ (green). This was to see if the model can identify any of the double
layered tablets as MCC when the MCC layer is upwards (and hence 
across PBZ). The score plot very clearly show
grouped with the PBZ-only tablet away from the MCC
spectral features are available to distinguish them. The model had a very l
(<0.4). 
Tablet sampling span in diffuse reflection
nge gradually from PBZ to MCC as PBZ layer 
thickness decreases 
Figure 38 shows
s that all the double-layered tablets were 
-only tablet because no MCC 
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 PC 1 versus PC 2 
-only tablet 
-
DR penetration 
ow Q-value 
Figure 38: Cluster analysis of double
tablets labelled as MCC (upper layer) was grouped with the MCC
had scores similar to the PBZ
This was not the case with DT cluster analysis of the same tablets (
the double-layered tablets were correctly identified and clustered with the MCC
tablet, with scores moving towa
a very high Q-value (>0.9) and other models consisting of one PC were also possible.
Tablet sampling span in diffuse reflection
-layer tablets in DR mode. None of the double
-only tablet, and instead 
-only tablet 
Figure 
rds the PBZ with increasing PBZ content. The model had 
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-layer 
39) where all 
-only 
 
Figure 39: Cluster analysis of double
tablets labelled as MCC (upper layer) were grouped with the MCC
scores gradually moving to the PBZ cluster as its layer gets bigger
9.1.5.3 Incremental tablet coating
The coating process for both tablet batches (MCC and caffeine tablets) produced 
incremental coatings, as shown from the thickness and mass
Another crucial fact was to have comparable coating thickness mean at each coating step 
for both batches (Figure 31), otherwise data analysis and interpretation would be very 
difficult. The maximum coat thickness possibly was 0.35 
coats were pitted and cracking and therefore useless.
Tablet sampling span in diffuse ref
-layer tablets in DT mode. All of the double
-only tablet, with 
 
-gain data (
– 0.37 mm, beyond that the 
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Table 8: Incremental coating details, showing mass and thickness increasing with 
coating (average of 10 tablets). Coat thickness from one side was calculated by dividing 
thickness gain by 2. 
Coat level 0 1 2 3 4 5 6
M
C
C
 t
ab
le
ts
 
mass [mg] 100.57 104.97 110.10 116.20 120.54 126.93 133.34
Mass SD 1.03 1.05 1.29 1.03 1.90 1.86 2.03
Mass gain [mg] 0.00 4.40 9.53 15.63 19.97 26.36 32.77
Thickness [mm] 3.169 3.258 3.393 3.504 3.612 3.756 3.879
Thickness SD 0.022 0.027 0.037 0.040 0.043 0.051 0.037
Coat thickness [mm] 0.000 0.045 0.112 0.168 0.222 0.294 0.355
ca
ff
ei
n
e 
ta
b
le
ts
 
mass [mg] 100.65 105.06 109.53 116.00 122.18 128.48 135.32
Mass SD 2.04 1.16 0.78 1.12 0.88 1.79 1.76
Mass gain [mg] 0.00 4.41 8.88 15.35 21.53 27.83 34.67
Thickness [mm] 3.141 3.222 3.355 3.487 3.623 3.725 3.880
Thickness SD 0.023 0.027 0.017 0.026 0.032 0.046 0.041
Coat thickness [mm] 0.000 0.041 0.107 0.173 0.241 0.292 0.370
 
Figure 40 (lower part) shows the DR spectra of both batches. The MCC tablets (blue) and 
caffeine tablets (green) spectra have different spectral features (example 6000 – 7000 
cm-1 shown in the zoomed pane) that are evident for uncoated tablets, and start to 
decrease gradually with incremental coatings of both batches until both MCC and 
caffeine spectra are indistinguishable, an indication that the spectrum carried 
information from the coat only. DT scans of these tablets show a different picture 
(Figure 31, upper part). Here, spectral features for both MCC and caffeine batches were 
preserved in all coating steps, because the radiation was always probing the tablet core, 
even at exaggerated film coat thickness. 
Figure 40: Pretreated spectra of 
(above) and DR (below) modes, with the area between 6000
Cluster analysis of these spectra was also performed, and PC plots are shown in 
41 (upper part DT and lower part DR spectra). In DR mode, 
classify all the MCC and caffeine spectra separately with any number of PCs, because 
there are spectra with indistinguishable features (hence coat information only). In DT, 
all the spectra from each batch (MCC and caffeine) were clearly separable with only one 
PC. 
Tablet sampling span in diffuse reflection
MCC and caffeine incrementally coated tablets in DT 
-7000 cm
it was not possibl
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-1 zoomed. 
Figure 
e to 
Figure 41: Cluster analysis of coated tablets in DT (above) and DR (below) modes, 
showing scores vs. PCs plots
In Figure 42, the cluster analysis results are very striking when “scores versus scores” 
plot is viewed. In DT, all spectra are grouped separately with o
spectra are only well separated in the uncoated and thin coated batches, and move 
closer together until inseparable at the 4
that the DR information depth and radiation penetration sho
maximum coat thickness reached (0.37 mm).
Tablet sampling span in diffuse reflection
. Calibration and validation spectra are identified by pluses 
and squares, respectively. 
ne PC, while in DR, the 
th and 5th coating levels. This clearly suggests 
uld be less than the 
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Figure 42: Cluster analysis of coated tablets in DT (above) and DR (below) modes, 
showing scores vs. scores plots
pluses and squares, respectively.
From the DR spectra analysed above, different spectral regions can from both MCC and 
caffeine batches can be plotted together against coat thickness (
showed how the spectral differences decreased gradually between the two batches. 
These differences can be expressed in terms of percentage from the maximum spectral 
difference in the uncoated tablets (100% difference = 100% information between MCC 
and caffeine DR spectra). This is shown in 
drop in spectra differentiation (= DR spectral information) with coat thickness and a 
very high correlation coefficient (r
Tablet sampling span in diffuse reflection
. Calibration and validation spectra are identified 
 
Figure 
Figure 44 which also show an exponential 
2>0.99). 
 
135  
 
by 
43). These plots 
Figure 43: DR values of both MCC and caffeine tablets against coat thickness,  at 6220 
cm-1 and db1 pretreatment (above); and 4420 cm
The drop reached 50% at 0.05 
Figure 45). The 90% signal drop (10% information content) can be seen between 0.2 
0.25 mm without extrapolation, while the 99% drop is a bit further at 0.3 
(extrapolated and higher SD). 
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Figure 44 and 
– 
– 0.4 mm 
0.4
0.4
Figure 44: Plot of DR spectral difference between MCC and caffeine tablets against coat 
thickness. The difference was taken as percentage of the maximum difference at coat 
level 0 (uncoated tablets). Two different spectral positions and pretreatments are 
As shown, this signal drop depth decreased with decreasing wavenumbers (increasing 
wavelength). Figure 46 show a 3.5 mm
percentage from the experimental exponential fit represented converted to red colour 
values, fading gradually with increasing penetration depth. This illustrate
small the DR sampling span is for typical pharmaceutical tablets
not the entire lower surface area is scanned, but only a central area (no determined yet) 
that depends on the instrument setup and the sampling slit.
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d clearly how 
-11.51x
-8.231x
Figure 45: DR Signal drop at various NIR wavelengths
and mf pretreatment. Only data with R
9.1.6 Conclusion 
The evidence collected to determine DR information depth was three
tablet thickness showed no constant relationship to spectra and indicated
depth was less than 0.5 mm. The double
through cluster analysis and finally, incremental coatings of tablets with different cores 
permitted the estimation of pattern and extent of the DR information drop
sample depth. 
The radiation in DR mode was found to be decaying exponentially after penetrating the 
tablet’s surface; hence no single depth can be defined as a margin for the sampled mass. 
Instead, the percentage of spectral information representin
be expressed. 50% of the spectral information represented 0.05 
the spectrum represented no more than 0.2 
in DR mode is really a surface
mode are only possible when the tablet surface contain accurate proportional 
representation of all the tablet contents, hence more potential for errors. 
The other aspect is its applicability to coated tablets. Most film
manufactured with coat thickness of 10 
probing the core and predicting content. In thicker coats, however, DR mode core 
quantification would not be that successful and DT mode in such cases is m
(e.g. thin layer coating – 0.2
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d tablets are 
ore suitable 
50% signal drop
90% signal drop
99% signal drop
hand, DR mode would be the ideal tool to study surface qualities, most importantly film
coat thickness, homogeneity and quality.
 
 
Figure 46: DR information depth for a typical pharmaceutical tablet, based on the 
exponential fitting in Figure 
estimate was based on area under curve 
Tablet sampling span in diffuse reflection
 
44 (lower plot). The 90% of information from 0.25 mm 
calculation.
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10. Research conclusions and prospective 
Throughout this research, different aspects of NIR spectroscopy for pharmaceutical 
tablets were assessed. These aspects are of prime practical importance to using the 
method in various applications, especially content determination. 
DT measurement mode was found able to perform well with quantification applications 
tablets, even for low-dose tablets. Such applications have the potential of completely 
replacing wet-chemistry assays and offer tremendous time, cost and even 
environmental savings. 
A crucial issue in such applications was seen to be method development and validation, 
which in some cases not a trivial matter, especially when the method was to be tested 
over extended production time-lines and potentially varying process conditions in 
response to varying starting materials. 
This leads to the second issue in method development, which is robustness, and a wait-
and-see approach to collect and include predictions outliers over time in hope of a 
robust model would not constitute a system that fits any PAT definition. Instead, all the 
parameters that have the potential of variability which would critically affect the 
method should be identified, studied and included in the model from the outset. 
Tableting press variability was seen to present potential problems for NIR methods. The 
radiation in DT mode traverses the entire thickness of the tablet, and hence is more 
liable for any variation that affects the internal structure, geometry, percentage and 
distribution of the voids within the tablet, hence porosity and tablet thickness variability 
was found to contribute significantly to prediction error or most importantly prediction 
failure and outliers. Pretreatments can minimise such effects but never completely 
remove them, and at a higher variability scale can introduce more errors. The best 
solution is a model with all possible variability sources included at their full possible 
scale (or even bigger scale). 
Another issue in DT mode is that the radiation interaction with compacted particulate 
solids remains little understood to date, and attempts to describe the spectral 
relationship to sample properties mathematically is as important as the development of 
high precision instruments. The experiments conducted studied the effects of tablets 
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12.2.2 NIRFlex N-500 
This is an FT NIR spectrometer from Büchi Labortechnik AG (Flawil, Switzerland). It is a 
quartz polarization interferometer consisting of two crystal wedges which splits 45° 
polarized light into two vectors, which traverse the crystal at different phase velocities. 
By moving one wedge relative to the other, the vectors undergo a systematically varied 
phase shift relative to each other. This changes the polarization of the combined beam. 
For monochromatic light, this results in a sinusoidal variation of the radiation after the 
second polarizer, while for polychromatic light an interferogram is formed. 
The spectrometer also has various gray filters and a wavelength standard, enabling 
wavelength accuracy, signal-to-noise ratio, and linearity to be checked in a series of tests 
(System Suitability Test - SST) to ensure validation of the spectrometer before any 
measurement session, including qualification and performance verification 
requirements of pharmacopoeial chapters “1119” (USP) and 2.2.40 (EP) on Near-
Infrared. The SST produces automatic validation reports and complies with 21 CFR Part 
11. 
 
Figure 58: NIRFlex N-500 specifications 
12.2.2.1 NIRFlex Solids Transmittance 
NIRFlex is a modular spectrometer enabling the use of different modules depending on 
the application. The “Solids Transmittance” module is optimized to perform 
transmission measurements of solid dosage forms, like tablets or capsules, using 
custom-made sample plates which are also designed and coated to prevent stray light.  
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Figure 59: Specifications of NIRFlex Solids Transmittance module 
12.2.3 Other apparatus 
12.2.3.1 UV spectrophotometer 
• Beckman - Du ® Series 500, instrument type UV-DU 530, series N° U 300 2050, 
(Beckman, Germany) 
12.2.3.2 Turbula mixer 
• Turbula, type T2A (Wily A Bachofen AG, Switzerland) 
12.2.3.3 Pycnometer 
• AccuPyc1330 (Micromeritics, Norcross, GA) 
• helium gas at room temperature 
12.2.3.4 Digital callipers 
12.2.3.5 Electron microscope 
• Philips XL30 ESEM (Philips, Eindhoven, Netherlands) 
12.2.3.6 Disintegration tester 
• DT2, Sotax, Switzerland 
12.2.3.7 Infrared balance 
• Mettler Toledo Type LP 16M (Mettler instruments, Switzerland) 
12.2.3.8 Scales 
• Delta Range®, instrument type AX204, (Mettler Toledo, Switzerland) 
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12.3 Methods 
12.3.1 Powder characterisation 
12.3.1.1 Residual moisture content 
USP30-NF25, 731: Loss on drying 
The residual moisture of a powder mixture is calculated from the moisture content of its 
components, equation (0.28), where wtot is the water content of the compound, ai is the 
fraction of the component in % (m/m) and wi is the residual moisture of the mixture in 
% (m/m). 
 1 1 2 2
1
...
100 100
n
i i n n
tot
i
a w a w a w a w
w
=
⋅ ⋅ + ⋅ + + ⋅
= =∑  (0.28) 
Moisture content was determined using the loss on drying method with an infrared 
balance Mettler Toledo Type LP 16M (Mettler instruments, Switzerland) and standard 
USP methods. Samples of 1.0-1.5 g were heated for 15 min at 105°C and the mass loss 
was reported in percent to sampled mass. 
12.3.1.2 Bulk and tapped density 
USP30-NF25: Bulk and tapped density (method I) 
A comparison of the bulk and tapped densities can be often used as an index of the 
ability of the powder to flow. The bulk density often is the bulk density of the powder “as 
poured” or as passively filled into a measuring vessel. The tapped density is a limiting 
density attained after tapping down, usually in a device that lifts and drops a volumetric 
measuring cylinder containing the powder a fixed distance. 
1. A quantity of material sufficient to complete the test was passed through a 1.00-
mm (No. 18) screen to break up agglomerates . 
2. Approximately 100 g (M) of powder was introduced in a dry 250-mL cylinder, 
without compacting. 
3. The powder was levelled carefully without compacting and read the apparent 
volume, V0 to the nearest graduated unit. 
4. Bulk density, in g per cm3, was calculated by the formula: (M) / (V0). 
5. The cylinder was mechanically tapped (STAV 2003, J. Engelsmann AG) 500 times 
initially and the tapped volume Va was measured. 
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6. Tapping was repeated an additional 750 times the tapped volume, Vb, was 
measured. 
7. When the difference between the two volumes was < 2%, Vb was taken as the final 
tapped volume, Vf , otherwise tapping was repeated in increments of 1250 taps 
until the difference between succeeding measurements was < 2%. 
8. The tapped density, in g per mL, was calculated by the formula: (M ) / (Vf). 
12.3.1.3 Compressibility and Hausner factor 
The Compressibility Index, equation (0.29), and Hausner factor (or ratio), equation 
(0.30), are measures of the degree to which a powder can be compressed. As such, they 
are measures of the relative importance of inter-particulate interactions. 
In a free-flowing powder, such interactions are generally less significant, and the bulk 
and tapped densities will be closer in value. 
For poorer flowing materials, there are frequently greater inter-particle interactions, 
and a greater difference between the bulk and tapped densities will be observed. These 
differences are reflected in the Compressibility Index and the Hausner factor. 
 
0
0
Compressibility index 100 f
V V
V
−
= ⋅  (0.29) 
 
0
Hausner Factor= f
V
V
 (0.30) 
12.3.1.4 Particle Size Measurement  
A laser scattering particle sizer (MasterSizer X Long Bed, Malvern Instruments, UK) was 
used to determine the particle size distribution, employing an MSX64 – Manual Dry 
Powder Feeder (Malvern Instruments, UK) to apply a dry analysis method. Data analysis 
of the results and the apparatus system were operated using MasterSizer X version 2.19 
software (Malvern Instruments, UK). 
12.3.1.5 True density 
The true density powders and powder mixtures were measured with a helium 
pycnometer (AccuPyc 1330, Micromeritics, Norcross, GA) at room temperature. Air was 
extracted to generate a vacuum and then Helium was pumped-in 5 times until 
equilibrium was reached.  
 
165 Appendix I 
12.3.1.6 Scanning Electron Microscopy (SEM) 
Images were taken using a Philips XL30 ESEM (Philips, Eindhoven, Netherlands) 
electron microscope. Powder samples were mounted on aluminium stubs and sputtered 
with Platinum coating of 20nm. 
12.3.2 Low-dose folic acid tablets 
12.3.2.1 Formulation 
• A directly compactable folic acid tablet formulation was devised using MCC 102 
as filler, Ac Di Sol as disintegrant and magnesium stearate as lubricant (Gohel 
2005). 
• Tablet weight was 200 mg. 
• The nominal dose of folic acid was 5 mg per tablet (2.5%) 
• NIR calibration batches had folic acid content varying from 0 to 5%. Other 
components were kept constant and the filler was adjusted to accommodate the 
change. 
• Of each concentration step (batch), 20 tablets where compacted to make a total of 
220 calibration and validation samples. 
• The formulations of the 11 folic acid batches in the API range of 0 to 5% are 
summarized in Table 9. 
Table 9: Formulation of folic acid tablets (calibration and validation batches) 
Folic acid % m/m MCC % m/m Ac-Di-Sol % m/m Mg-stearate % m/m
0.0 93.75 6.0 0.25
0.5 93.25 6.0 0.25
1.0 92.75 6.0 0.25
1.5 92.25 6.0 0.25
2.0 91.75 6.0 0.25
2.5 91.25 6.0 0.25
3.0 90.75 6.0 0.25
3.5 90.25 6.0 0.25
4.0 89.75 6.0 0.25
4.5 89.25 6.0 0.25
5.0 88.75 6.0 0.25
 
12.3.2.2 Powder preparation and mixing 
• Foe each batch, the powdered components were screened through a 90 µm mesh 
before weighing on Mettler Toledo scales - Delta Range ®, instrument type 
AX204, series N° 1121140335, Switzerland).  
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• Powder mixtures ware transferred to 100 mL amber glass bottles 
• Mixing was made using a Turbula blender (type T2A, Wily A Bachofen AG, 
Switzerland).  
• Folic acid was pre-mixed with MCC for 5 minutes. 
• The remaining excipients, except of magnesium stearate, were added and lot 
mixed for 5 minutes.  
• Magnesium stearate was finally added and the mixture was blended for another 2 
minutes. 
12.3.2.3 Powder compaction 
The tableting process was controlled using the Presster™ (MCC, NJ, USA) with software 
version 3.8.4. 
• Korsch rotary press PH336 was selected for simulation. 
• The default press speed (10800 TPH) and dwell time (118.3 msec) were used.  
• A flat face punch with a diameter of 10.0 mm was used for compaction. 
• Gap vs. thickness and gap vs. hardness plots for 200 mg tablet mixtures was 
performed (see Appendix I.1-2, Figure 60 and Figure 61) 
o The gap size was decreased gradually from 2.7 mm until satisfactory 
tablet crushing strength was reached. 
o Tablet thickness and crushing strength was measured with each 
adjustment step. 
• A crushing strength around 104 N, a thickness around 2.41 mm and an upper 
compaction around 3.9 kN were achieved with a gap size of 1.8 mm. 
Figure 60: Presster plot: 
Figure 
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61: Hardness vs. upper punch force 
y = 8.9461x2
R² = 0.9978
1.1 1.3 1.5 1.7
gap size [mm]
y = 0.0001x2 + 0.0025x + 2.7034
R² = 0.9981
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12.3.2.4 Tablet production 
• Powder mixture mass for each tablet (around 208 mg to accommodate for loss 
during compaction) was weighted manually for each tablet by using an analytical 
balance. 
• The powder mixture was filled carefully inside the press well. 
• “One tablet” was ordered from Presster software 
• 24 hours after the compaction of the tablet the thickness was measured by a 
digital calliper and the tablet mass was measured by an analytical balance. (see 
Appendix IV.3) 
• The tablets were put in tablet holders and were provided with batch and tablet 
number and stored protected from light inside a box.  
• Two batches of the 2.5% tablets were manufactured. One set was referenced by 
the UV analytical method before light exposure and the other set of ten 2.5% 
tablets after light exposure. 
• To exclude the effect of light exposure on predictions, ten 2.5% tablets were used 
as light exposure control and were exposed to light whenever any batch was 
handled to record the NIR spectra for the development of the calibration model. 
12.3.3 Tablet characterisation 
12.3.3.1 Resistance to crushing (hardness’) 
Ph. Eur. 5, method 2.9.8: Resistance to Crushing of Tablets 
Crushing strength is a measure of the load where the tablet breaks under diametrical 
compaction between two flat platens. 
Tablets crushing strength was measured after 24 hours using an automated tablet 
hardness tester Dr. Schleuniger® (Tablet Tester 8M, Pharmatron, Switzerland). 
12.3.3.2 Tensile strength 
Tensile strength is a fundamental measurement of the resistance to fracture. Crushing 
strength can be converted into tensile strength (σ  in [N/cm2]) using equation (0.31). 
 
2 cS
D T
σ
pi
⋅
=
⋅ ⋅
 (0.31) 
where 
Sc =  crushing strength in N 
D = tablet diameter in cm 
T =  tablet thickness in cm 
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However, this equation is only applicable to round flat-faced tablets when they fail in 
tension by splitting cleanly into halves under diametric compaction. 
12.3.3.3 Porosity 
The porosity of the tablets was calculated from equation (0.32). 
 
11 100M
V
ε
ρ
 
= − ⋅ × 
 
 (0.32) 
where 
ε  = porosity in % (v/v) 
M = tablet mass in g 
V = tablet volume in cm3 
ρ = true density of the powder mixture in g cm-3 
 
12.3.3.4 Disintegration time 
USP30 NF25, 701: Disintegration 
Disintegration time of three tablets was measured using a disintegration tester (DT2, 
Sotax, Switzerland) with a disk. The disintegration medium consisted of distilled water 
maintained at 37°C ±  0.5.  
12.3.3.5 Scanning Electron Microscopy (SEM) 
Refer to “Scanning Electron Microscopy (SEM)” page 165. 
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12.3.4 NIR quantitative model development 
12.3.4.1 NIR spectral collection 
• Tablets from all batches were scanned on NIRFlex N-500 spectrometer using the 
solids transmittance mode and adjustable plate using default instrument settings. 
• The spectra were labelled so as to identify each spectrum to its tablet. 
• Two quantitative properties were created (folic acid nominal and UV) and added 
to the spectral set. 
• Nominal content of each tablet was referenced for each spectrum in the nominal 
property field. 
12.3.4.2 UV assay standardisation  
• 0.1 M NaOH (molar mass = 40 g/mol) was used as a solvent for folic acid in the 
UV assay. 
• 4 grams of NaOH were dissolved in 1 L distilled water to produce NaOH 0.1 M 
solution. 
• For added accuracy, the UV calibration curve was constructed from tablet 
mixtures with standard folic acid concentration rather than from folic acid alone. 
• 10 mg of every 200 mg powder mixture with folic acid in an API range of 0 to 5% 
was dissolved in 10 ml NaOH 0.1M of a test tube.  
• A 1ml syringe with a filter attachment was used to take some of the solution out 
of the test tube after dissolution of folic acid into a 1 cm quartz glass cuvette of 1 
cm. 
• UV absorbance at 235 nm was measured and NaOH 0.1M stock solution as blank. 
• The powder mixtures of all 11 batches were used to create a linear calibration 
line with the UV spectrophotometer with a zero intercept. (see Appendix IV.4-5) 
• To get an estimation of the assay SD, 10 absorption measurements of the 1% 
powder mixture had been taken to calculate the average and the standard 
deviation of the content. 
12.3.4.3 UV Content determination (spectral referencing) 
• Each tablet was weighed, crushed and homogenised using a pestle and mortar. 
• 10 mg was sampled and dissolved, similar to the above method and UV 
absorbance taken and content per tablet calculated in mg using: 
100
10
tablet
tablet calib abs
massAPI Slope UV
mg
= × × ×  
• shows the referenced data for all tablets 
• API reference value (in mg per tablet) for each tablet was added in the “folic acid 
UV” property field of its respective NIR spectrum in the database. 
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12.3.4.4 NIR Calibration model development 
• A new project was created in NIRCal and tablet spectra imported from the 
database 
• One third of the spectra set to validation (except 0% and 5% batches), the rest set 
to calibration spectra 
• One property was selected for the model (first nominal folic acid and then UV 
reference) 
• Both manual (Figure 62) and automatic (Q value wizard) were tried to search for 
best model optimisation. 
• Models were evaluated using  
o Q-value: as close to 1 as possible 
o SEP: as low as possible 
o consistency: as close to 100 as possible 
o bias: as low as possible 
o regression coefficient and slope: as close to 0.999 as possible 
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Figure 62: Suggested calibration model flow-chart (NIRCal 5.2 user manual) 
12.3.4.5 External prediction 
• The selected optimal calibration models were used to predict the content of 2.5% 
folic acid tablets which were not used for developing the calibration model. 
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• The spectra of the 2.5% folic acid tablets were recorded and the API content of 
these tablets was predicted. 
• To evaluate the calibration model the predicted values were compared with the 
values obtained in the UV reference method. 
• An independent t-test for the significance of the difference between the means of 
two samples, was applied to assess a possible significant difference between the 
NIR and the UV reference method: 
o H0: there is no significant difference between the UV assay results and NIR 
predictions of folic acid content in tablets 
against 
o H1: there is a significant difference 
o Rejecting H0 indicates that the differences between UV and NIR are 
significant and not due to chance only. 
o H0 can be rejected with 95% confidence if P<0.05 
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12.3.5 Press effect on NIRS predictions 
12.3.5.1 Porosity and thickness outliers (i) 
• The same folic acid tablet formulation was used (Table 9, page 165) 
• For each batch (0%-5% API), the same method for making the fixed porosity 
tablets was repeated, except the following: 
o Presster gap size set for 1.0 mm 
o 2 tablets made 
o Gap increased by 0.1 mm 
o 2 more tablets and gap increments until gap size of 1.9 mm was reached 
and 20 tablets were made 
• Tablets were weighed, stored, thickness measured after 24h, and UV referenced 
(Appendix V.1). 
12.3.5.2 Porosity and thickness outlier external prediction (ii) 
• An 2.5% API external prediction batch (20 tablets) was also manufactured with 
the same gap range as above (Appendix V.2) 
12.3.5.3 Tableting speed (possible) outliers (iii) 
• 15 2.5% API folic acid tablets (Table 9, page 165) were manufactured in Presster: 
o 1.8 mm gap size 
o Tableting speed range from  15,000 – 135,000 TPH (85.2-9.5 ms dwell 
time) 
• Tablets were weighed, stored, thickness measured after 24h, and UV referenced 
12.3.5.4 Testing model robustness 
• 5 different NIR calibration models (F1-F5) developed using previous folic acid 
calibration spectra. 
• Batches from items (ii) and (iii) above where predicted using these models and 
predictions compared to their UV assay content. 
• A further model (FV) constructed by adding spectra of variable compaction force 
(item i above) and prediction batch (item ii above) was predicted and evaluated. 
12.3.5.5 Effect of tablet porosity and thickness change on spectra 
• 2 sets of placebo tablets (formulation Table 9, page 165)  manufactured on 
Presster: 
o Varying porosity and constant thickness, mass-adjusted tablets 
(Table 3, P1-3) 
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o Varying thickness and constant porosity, mass adjusted tablets 
(Table 3, T1-6) 
• Tablets were scanned on NIRFlex N-500 solids transmittance and 
maximum at 8880  cm-1  plotted against thickness and porosity 
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12.4 Results 
12.4.1 Characterisation 
12.4.1.1 Loss on drying 
Table 10: water content in excipients 
excipient water content in % [m/m]
Ac-Di-Sol® 7.3
MCC 4.2
Mg-stearate 3.9
 
• The theoretical residual moisture was 4.39% 
• Powder mixture loss on drying for all mixtures was 4.45 (±0.08) % 
12.4.1.2 Bulk and tapped density, Hausner factor 
• Bulk and tapped volumes are listed in Appendix I.6 
• Hausner Factor of 2.5 powder mix = 1.1951 
12.4.1.3 Particle Size Measurement  
• 90% of the MCC 102 particles were ≤ 111.12 µm 
• 90% of the Ac-Di-Sol® particles were ≤ 78.0 µm 
• 90% of the folic acid particles were ≤ 62.5 µm 
• 90% of the Magnesium Stearate particles were ≤ 25.4 µm 
12.4.1.4 True density 
• Average true density was 1.544 (±0.0046) g cm-3 for 5 runs 
Table 11: True density of 2.5% powder mixture 
run density [g cm-3]
1 1.540
2 1.551
3 1.546
4 1.541
5 1.543
 
 
12.4.1.5 Scanning Electron Microscopy (SEM) 
• The SEM images of excipients are shown in the methods section (pages 152-158) 
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• The SEM images of the 2.5% powder mixture is shown in SEM of 2.5% powder 
mixture (Figure 63) 
• The SEM images of a 2.5% API tablet surface is shown Figure 64 
  
 
  
Figure 63: SEM of 2.5% powder 
mixture 
Figure 64: SEM of 2.5% tablet 
surface 
12.4.1.6 Tablets physical parameters
Description 
• The tablets had a flat smooth surface, sharp edges and colour varying from white 
to faint yellow to yellow, increasing with the API con
• No signs of capping or lamination were observed on any of the tablets.
Figure 65: 1 tablet of each of the 11 batches of folic acid tablets, from 0% (far left) to 5% 
Thickness and crushing strength
• The diameter, the thickness and the crushing strength was measured for 2.5% 
(m/m) folic acid tablets. 
Table 12: Tablet thickness and crushing strength for 2.5% batch
tablet diameter [mm]
1
2
3
4
5
6
Average (SD)
 
Tensile strength: 
•  
2
c
S
D T cm cm cm
σ
pi pi
⋅
= = = =
⋅ ⋅ ⋅ ⋅
Porosity 
•    
11


⋅−=
pV
M
ε
Disintegration time 
• The tablets disintegrated within 34.5 (
 
tent (Figure 
(far right) API 
 
 
 
thickness [cm]
10.00 2.39
10.00 2.38
10.00 2.39
10.00 2.40
10.00 2.39
10.00 2.38
10.00 (0) 2.39 (0.007)
2
2 95.33 253.93 253.93 N cm
1 0.239
N N⋅
100
/544.1
1
187.0
2.01100 33 ×





⋅−=×


cmgcm
g
±2.3) seconds 
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65). 
 
 
crushing strength [N]
95
94
96
98
95
94
95.33 (1.52)
1−
 
%73.30=
 
12.4.2 First calibration models
12.4.2.1 SD of UV method 
• The average of the content was 2.2089 mg and the standard deviation of the 
content was 0.1133 mg. The recorded absorption values and the calcu
content of folic acid are shown below (
Table 13: UV standard deviation for a 10 mg 1% API powder mixture
12.4.2.2 Calibration models
• Calibration project is shown in 
property. Spectra showed no v
except scaling. Figure 
why there is no obvious peak shifts with the API change.
Figure 66: NIR spectra of a 100% filler (MCC) tablet (red), and 100% API (folic acid) 
• Leverage plot showed 2 potential outliers (
 
Table 13). 
 
UV A UV content [mg]
0.243 2.3729
0.211 2.0604
0.229 2.2362
0.213 2.0800
0.230 2.2460
0.223 2.1776
0.223 2.1776
0.237 2.3143
0.240 2.3436
0.213 2.0800
mean 2.2089
SD 0.1133
 
Figure 67, using nominal content as calibration 
isible peak changes with folic acid concentration, 
66 show the spectra of MCC and folic acid and gives an idea 
 
tablet (blue) 
Figure 67). 
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• Applying normalisation, first derivative and 1 PC selection improved the model 
(consistency) and leverage showed 1 outlier (Figure 68). 
• Figure 69 show the model (A1) with UV reference data used as calibration 
property, with still 2 prediction outliers. 
• Two more calibration models developed, A2 (Figure 70 and Figure 71) and A3 
(Figure 72 and Figure 73) employing different pretreatments, wavelength 
selection and wavelength regions. 
• First derivative reveal 2 small peak changes at 8500 and 8800 cm-1 (Figure 70). 
• NIRCal data (Table 16) show that A1 is the best model (lowest SEP, highest r2, 
best consistency). The software's Q-value agreed with this evaluation and was a 
good total evaluation tool. (Full calibration protocols in appendices I.7,8,9) 
 
 
Figure 67: A new NIRCal project with folic acid spectra (before optimization) 
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Figure 68: Applying ncl and db1 pretreatments and fact selection (1 PC) 
 
Figure 69: Calibration model (A1) applying db1 and nle pretreatments and 5 PCs
Figure 70: Calibration model (A2) applying ncl, db1 and SNV pret
Figure 71: Calibration model (A2) wavelength regression
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Figure 72: Calibration model (A3) applying nsd pretreatment, 8 PCs and tight 
wavelength selection 
 
Figure 73: Calibration model (A3) wavelength regression 
 
 
• NIR SEP (0.2731 mg) should be evaluated in terms of the UV own SE (SD=0.1133 
mg), 2.4 times larger. 
• SEP should also be evaluated in terms of the target content evaluated (5 mg folic 
acid per 2.5% tablet) and relative NIR SEP was 5.462%. 
• External prediction by the three models is shown in Figure 74.. Tablets 1,2,8,15 
and 19 show relatively big differences from UV method. 
• A two-tailed student t-test show that all three models are statistically different 
from the UV method, with A1 being the best model (Table 17). 
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• Light effect (Table 18) was small and the average drop in folic acid content was 
0.0733 mg over the whole process (tablet analytics, referencing and NIR 
scanning). This should be much less if the referencing step was omitted (after 
complete NIR method development). 
• If the referencing method was HPLC, this light effect is expected to be much 
higher due to longer analysis time and NIR prediction would have had more 
benefit. 
 
Table 14: External prediction set tablets (mass and UV content) 
tablet 
number
mass 
[mg]
UV A 1 UV A 2 UV A 3 UV A 4 UV A 5
UV A 
average
UV 
content 
[mg]
1 205.50 0.697 0.697 0.698 0.698 0.698 0.698 6.045
2 200.40 0.749 0.751 0.751 0.750 0.750 0.750 6.340
3 198.40 0.577 0.577 0.577 0.577 0.578 0.577 4.829
4 204.10 0.543 0.543 0.543 0.543 0.544 0.543 4.675
5 200.30 0.609 0.609 0.609 0.609 0.609 0.609 5.144
6 202.40 0.651 0.651 0.651 0.650 0.650 0.651 5.553
7 202.00 0.580 0.581 0.581 0.582 0.582 0.581 4.951
8 205.40 0.720 0.720 0.720 0.720 0.719 0.720 6.235
9 199.40 0.627 0.627 0.627 0.627 0.628 0.627 5.274
10 202.80 0.573 0.573 0.573 0.573 0.572 0.573 4.899
11 203.50 0.594 0.594 0.594 0.594 0.594 0.594 5.097
12 198.00 0.576 0.577 0.577 0.578 0.578 0.577 4.819
13 204.20 0.566 0.564 0.565 0.567 0.565 0.565 4.869
14 200.90 0.608 0.607 0.607 0.607 0.607 0.607 5.144
15 204.40 0.688 0.689 0.689 0.689 0.689 0.689 5.937
16 201.50 0.589 0.589 0.589 0.588 0.588 0.589 5.001
17 200.40 0.633 0.635 0.635 0.635 0.635 0.635 5.363
18 204.00 0.617 0.617 0.619 0.619 0.619 0.618 5.318
19 203.90 0.551 0.551 0.551 0.550 0.550 0.551 4.734
20 204.40 0.657 0.659 0.659 0.658 0.658 0.658 5.673
 
Table 15: UV content and NIR external prediction from 3 calibration models
tablet 
number
mass 
[mg]
UV 
[mg]
1 205.5 6.045
2 200.4 6.34
3 198.4 4.829
4 204.1 4.675
5 200.3 5.144
6 202.4 5.553
7 202.0 4.951
8 205.4 6.235
9 199.4 5.274
10 202.8 4.899
11 203.5 5.097
12 198.0 4.819
13 204.2 4.869
14 200.9 5.144
15 204.4 5.937
16 201.5 5.001
17 200.4 5.363
18 204.0 5.318
19 203.9 4.734
20 204.4 5.673
 
Figure 74: Folic acid content in external prediction set, UV assay vs. three NIR models. 
Bars indicate residuals of respective model, with A2 residuals (green) scaled down 20 
0
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NIR A1 
[mg]
NIR A2 
[mg]
NIR A3 
[mg]
Residuals
A1
4.953 4.562 4.678 0.000450
0 5.079 4.795 4.984 0.000492
5.000 4.773 5.091 0.000484
5.269 4.686 5.421 0.000548
5.009 4.626 5.241 0.000416
5.359 4.890 5.306 0.000538
5.236 4.794 5.450 0.000449
5.391 4.984 4.716 0.000444
4.589 4.367 4.700 0.000454
5.088 4.733 5.318 0.000433
5.013 4.694 4.748 0.000412
4.865 4.589 5.110 0.000442
5.153 4.718 4.999 0.000440
4.753 4.598 4.560 0.000433
4.885 4.561 4.676 0.000406
4.919 4.666 4.749 0.000439
4.880 4.529 4.428 0.000416
5.111 4.677 4.716 0.000488
5.079 4.732 4.506 0.000403
4.815 4.539 4.574 0.000501
times for clarity. 
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
tablet number
UV [mg]
NIR A1 [mg]
NIR A2 [mg]
NIR A3 [mg]
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A2 A3
0.019094 0.000569
0.018114 0.000624
0.017422 0.000666
0.020807 0.000776
0.016324 0.000592
0.019485 0.000986
0.018312 0.000498
0.017114 0.000754
0.017491 0.00057
0.016305 0.000516
0.016304 0.000601
0.017455 0.000625
0.017268 0.000449
0.016335 0.000634
0.016557 0.000631
0.016356 0.000463
0.016017 0.000406
0.019164 0.000615
0.016390 0.000446
0.018945 0.000616
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Table 16: Overview of the 3 NIR calibration models 
calibration model  A1 A2 A3
method PLS PLS PLS
pretreatments db1,nle ncl,db1, SNV nsd
wavelength selection [cm-1] 6000-10600 8500-10600
8876-9216, 
10488-10724
PCs 5 4 8
Q-value 0.8782 0.877 0.862
SEC  [mg] 0.2731 0.2958 0.3365
SEP  [mg] 0.2739 0.291 0.3385
consistency 99.72 101.67 99.4
V-set Bias [mg] 0.0727 0.0208 0.0277
V-set regression coefficient 0.9945 0.9936 0.9913
 
Table 17: Statistical evaluation of the 3 NIR models 
 UV NIR A1 NIR A2 NIR A3
Mean 5.289471 5.022145 4.675565 4.89848
Variance 0.263305 0.04077 0.019195 0.104224
Observations 20 20 20 20
Hypothesized Mean Difference 0 0 0
df 25 22 32
t Stat 2.16803 5.16544 2.884266
P(T<=t) one-tail 0.019939 1.77E-05 0.003482
t Critical one-tail 1.708141 1.717144 1.693889
P(T<=t) two-tail 0.039878 3.53E-05 0.006963
t Critical two-tail 2.059539 2.073873 2.036933
 
Table 18: Possible light effect on predictions during whole experiment 
Without light exposure With light exposure
tablet 
number
tablet mass 
[mg] 
thickness 
[mm]
UV content 
[mg]
tablet 
mass [mg] 
thickness 
[mm]
UV content 
[mg]
1 0.2005 2.41 5.0777 0.2003 2.39 4.8500
2 0.1995 2.37 4.9596 0.2004 2.39 5.0693
3 0.2008 2.39 5.0524 0.2008 2.40 4.7825
4 0.2009 2.40 5.0861 0.2005 2.40 5.0440
5 0.2004 2.40 5.1199 0.2009 2.41 4.8415
6 0.2006 2.39 5.0271 0.2008 2.39 5.1199
7 0.2004 2.38 4.9596 0.2008 2.39 5.0271
8 0.2009 2.39 5.0355 0.2008 2.39 5.0440
9 0.2002 2.38 4.8668 0.2004 2.38 4.7825
10 0.2009 2.39 4.9933 0.2009 2.39 4.8837
Average 
(SD)
0.2005 
(0.0004332)
2.39 
(0.01155)
5.0178 
(0.07487)
0.2007 
(0.0002319)
2.39 
(0.008233)
4.9445  
(0.1285)
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12.4.3 Tablet press effect 
• As the upper punch compaction force increased, the tablets became thinner and 
denser (less porous). They also became slightly darker in colour (Figure 76). 
• In terms of NIR, transmittance spectra showed upward scaling with increased 
compaction force. One factor is reduced scattering and more light reaching the 
detector. This can also be considered reduction in apparent absorption (Figure 
75). 
• Although pretreatments are considered as a tool to reduce baseline and scale 
effects on spectra, this was not the case for such a wide change in compaction 
differences, as shown in Figure 79. No single pretreatment was able to group the 
spectra because scaling was not only higher with higher frequency (in 
transmittance), but also absorption dependant. 
 
Figure 75: Raw spectra of placebo tablets with increasing compaction force. Gap size 
from 0.8 mm (biggest spectrum) to 1.7 (smallest spectrum) 
 
Figure 76: 2.5% folic acid tablet compacted with gap 0.8 mm (left) and 1.8 mm (right) 
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• Increasing tableting speed, in terms of dwell time (Table 19) had no observable 
effect on NIR spectra (Figure 77). 
• Prediction of this variable speed batch also showed no difference pattern from 
the UV-assayed content (Figure 78), indicating that tableting speed (for the 
current tablet formulation) had no effect on NIR predictions. This cannot be 
generalised however, and other diluents may show different behaviour. 
Table 19: Presster tableting to assess speed (dwell time) effect on predictions 
No. 
Gap / 
mm
Thickne
ss / mm
Upper
Force / 
kN
Powder
mass / 
mg
Speed / 
TPH
Dwell
time / 
ms
UV
NIR 
F2
NIR 
F3
1 1.8 2.40 3.5 202.6 15000 85.2 5.200 5.092 5.216
2 1.8 2.41 3.5 201.2 25000 51.1 5.175 5.135 5.157
3 1.8 2.43 3.6 202.1 35000 36.5 5.225 5.339 5.176
4 1.8 2.42 3.7 201.3 45000 28.4 5.075 5.154 5.174
5 1.8 2.44 3.7 201.7 55000 23.2 5.250 5.368 5.274
6 1.8 2.42 3.7 202.0 65000 19.7 5.075 5.287 5.198
7 1.8 2.43 3.6 202.0 75000 17.0 5.200 5.308 5.264
8 1.8 2.43 3.9 202.0 85000 15.0 5.250 5.454 5.237
9 1.8 2.43 3.7 202.9 95000 13.5 5.125 5.375 5.193
10 1.8 2.45 4.0 203.0 105000 12.2 5.250 5.435 5.324
11 1.8 2.45 3.8 202.3 115000 11.1 5.058 4.832 4.987
12 1.8 2.42 2.7 202.2 125000 10.2 5.065 5.004 5.054
13 1.8 2.42 3.6 201.2 135000 9.5 5.020 5.028 5.043
14 1.8 2.43 3.6 201.6 145000 8.8 5.033 4.969 5.062
15 1.8 2.46 3.7 202.3 155000 8.2 5.025 5.017 5.096
mean 2.43 3.6385 202.0 n/a n/a 5.135 5.186 5.164
SD 0.01183 0.3070 0.5317 n/a n/a
0.089
39
0.193
2
0.096
68
 
Figure 77: Raw spectra of 2.5
Figure 78: Prediction of variable compaction speed tablets by two NIR models, 
compared to the UV assay content
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Figure 79: Various pretreatments applied to transmittance spectra of variable 
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Table 20: Variable compaction force prediction set, UV content and NIR predictions 
# Mass 
Thick
ness
Poros
ity
UV F1 F2 F3 F4 F5 FV
mg mm % mg mg mg mg mg mg mg
1 204.5 1.99 0.15 5.17 19.96 1.58 -12.19 6.43 6.48 5.13
2 206.7 2.00 0.15 5.11 20.53 1.60 -12.80 6.57 6.61 5.10
3 200.2 2.00 0.17 5.01 16.45 3.14 -6.95 6.40 6.46 5.08
4 199.8 2.00 0.18 5.00 16.31 3.23 -6.43 6.46 6.52 5.04
5 204.0 2.07 0.19 5.14 13.18 4.21 -2.87 6.48 6.54 5.25
6 205.7 2.08 0.18 5.10 13.56 4.02 -3.31 6.48 6.53 5.15
7 200.8 2.10 0.21 5.02 10.76 5.19 0.80 6.37 6.42 5.16
8 200.0 2.11 0.22 5.00 9.86 5.05 1.37 6.24 6.29 5.09
9 202.2 2.20 0.24 5.14 8.31 6.04 3.85 6.11 6.14 5.17
10 205.7 2.20 0.23 5.06 8.34 5.70 3.53 6.17 6.20 5.25
11 196.0 2.22 0.27 5.09 5.91 5.35 5.11 5.70 5.74 4.56
12 203.7 2.28 0.26 4.90 6.05 5.28 5.15 5.69 5.71 4.66
13 199.2 2.31 0.29 4.98 5.62 5.42 5.55 5.47 5.49 4.69
14 199.0 2.30 0.29 4.98 5.93 5.30 5.61 5.52 5.54 4.74
15 194.5 2.37 0.32 4.97 5.20 4.73 5.36 5.10 5.10 4.68
16 200.9 2.39 0.31 4.86 5.27 4.95 5.41 5.00 5.02 4.85
17 198.7 2.45 0.33 4.97 5.55 5.36 5.85 5.05 5.04 4.47
18 202.2 2.47 0.32 5.02 5.32 4.33 5.29 4.87 4.87 4.70
19 198.9 2.53 0.35 5.06 5.99 5.95 6.95 5.37 5.31 4.12
20 194.7 2.55 0.37 4.87 5.67 5.69 6.11 4.91 4.88 3.87
 
 
• The five NIR models details constructed from fixed compaction folic acid tablets 
(F1-F5) are shown in Table 21. F4 and F5 had no statistically significant 
difference from the UV assay, as shown from Table 22. 
• Predicting the variable compaction tablets by F1-F5 models showed gradual drift 
with the change of tablets porosity (and thickness) from UV content and accuracy 
only in the porosity region of 33%, in which the calibration tablets are made 
(Figure 80 and Table 20).  
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Table 21: Overview of fixed compaction force calibration models (F0-F5) and model 
with additional variable compaction force spectra (FV) 
 F1 F2 F3 F4 F5 FV
Wavelengths 
Project Set
6000-
11520. (total 
1381/1381)
6000-
11520. (total 
1381/1381) 
6000-
11520. (total 
1381/1381)
6000-
11520. (total 
1381/1381) 
6000-
11520. (total 
1381/1381)
6000-
11520. (total 
1381/1381)
Wavelengths 
Calibration Set
6000-
11520. (total 
1381/1381)
7400-
11520. (total 
1031/1381) 
8500-
11520. (total 
756/1381)
6000-
11520. (total 
1381/1381) 
7400-
11520. (total 
1031/1381)
6000-
10600. (total 
1151/1381)
Data Pretreatment 
Sequence (short form)
mf mf SNV db1,SNV db1,SNV mf, ncl
Method PLS PLS PLS PLS PLS PLS
Max Iterations 3000 3000 3000 3000 3000 3000
Mean Centring yes yes yes yes yes yes
Number of Primary 
PCs
9 9 8 3 3 14
Secondary/Calibrati
on PCs
1-7. (total 
7/9)
1-7. (total 
7/9) 
1-6. (total 
6/8)
1-3. (total 
3/3) 
1-3. (total 
3/3)
1-12. 
(total 12/14)
V-Set BIAS 0.020901 -0.02879 0.017055 -0.00096 -0.00155
0.015475
3
C-Set SEE (SEC) 0.249761 0.323872 0.259507 0.286846 0.286303 0.312529
V-Set SEE (SEP) 0.258087 0.31796 0.254297 0.292198 0.290546 0.311205
Consistency 96.7739 101.859 102.049 98.1682 98.5396 100.426
 
  C-Set Regression 
Coefficient 0.997209 0.995125 0.996986 0.996318 0.996332 0.995599
V-Set Regression 
Coefficient 0.995108 0.994061 0.995263 0.993946 0.994011 0.992966
C-Set Regression 
Intercept 0.027482 0.049445 0.029669 0.036633 0.036495
0.042895
7
V-Set Regression 
Intercept 0.039841 -0.01142 0.056711 0.037676 0.041552
0.019216
4
C-Set Regression 
Slope 0.994425 0.990275 0.993981 0.99265 0.992678 0.991217
V-Set Regression 
Slope 0.98766 1.00851 0.985014 0.992555 0.991889 0.992981
 
  V-Set t-value 0.600605 0.799727 0.497373 0.024149 0.039284 0.540175
Confidence % 44.9384 57.3671 37.9055 1.91752 3.11883 40.9897
 
• Model FV consisted of 440 calibration/validation spectra, by adding the variable 
compaction calibration set (appendix V.1) to the previous set (appendix I.3). The 
model details are set in Table 21. 
• This model (FV) was able to predict the variable compaction tablets across the 
whole porosity range and is hence completely robust to press compaction 
variability (Figure 81 and Table 20). 
• Although FV model has slightly worse SEP (0.31 mg) than models F4 and F5 (0.29 
mg), it was still statistically equivalent to the UV method (Table 22). 
Table 22: Statistical evaluation of the fixed
 
Mean 4.832661
Variance 0.085586
Observations
Pooled Variance
Hypothesized
Mean
Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail
Mean 4.832661
Figure 81: Prediction of variable compaction force tablets using the new model FV
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• Figure 82 shows the spectral down
cm-1) with increasing tablet thickness and constant porosity. The drop was 
exponential and relates to decreasing NIR radiation reaching the detector in 
diffuse transmittance as the ta
the spectrum was very small but still preserved its shape and whether a 
calibration model is achievable at such tablet thickness remains to be 
investigated. 
• Increasing porosity in tablets with constant thick
similar effect, but this time less radiation is being detected due to more scattering 
(forward as well as backward) in higher porosity and less chances for photons to 
find their way to the tablet's other 
porosity range chosen represents the normal manufacturing range of commercial 
tablets. 
• The two parameters, tablet thickness and porosity are both exerting an 
exponential scaling effect, in the same direction, 
(Figure 75). 
Figure 82: Effect of tablet thickness on transmittance spectra, with fixed porosity 
(A) Plot of maximum (B) Raw spectra
0
0.001
0.002
0.003
0.004
0.005
0 1tr
a
n
sm
it
ta
n
ce
 (
n
o
n
-p
re
tr
e
a
te
d
 
sp
e
ct
ra
)
Tablet thickness [mm] (constant density)
Tr
a
n
s
m
itt
a
n
ce
11000
0.000
0.001
0.002
0.003
0.004 Calibration Spectra
B
-scaling at one wavenumber position (8880 
blets became thicker and thicker. Beyond is 5 mm 
ness (Figure 
surface. The drop was also exponential and the 
during compaction variability 
(apparent density) 
 
y = 0.0236e
R² = 0.9974
2 3 4 5 6 7
peak at 8880
Expon. (peak at 8880)
Original Spectra
All Spectra
1/cm
70008000900010000
 
194 Appendix I 
83) caused a 
 
 
-1.614x
6000
NI
RC
al
 
: 
 
un
n
am
ed
 
05
.
02
.
20
08
 
17
:0
4:
42
 
m
o.
s
 Figure 83: Effect of tablet porosity on transmittance spectra, with fixed tablet thickness
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13. Appendix II 
Expanded methods and results sections: Tablet 
sampling span in diffuse transmittance 
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13.1 Materials and instruments 
13.1.1 Micro-crystalline cellulose 
Please refer to section 12.1.2, page 153. 
13.1.2 Carboxymethylcellulose sodium 
Please refer to section 12.1.3 page 155. 
13.1.3 Magnesium stearate 
Please refer to section 12.1.4, page 157. 
13.1.4 White paper 
• A4 standard printer paper 
• 80 g m-2 
13.1.5 Laser printer 
• HP LaserJet 2200dn network printer 
• 1200×1200 dpi 
• HP LaserJet C4096 family printer cartridge 
13.1.6 Presster 
Please refer to sections 12.2.1, page 159. 
13.1.7 NIRFlex N-500 with Solids Transmittance cell 
Please refer to section 12.2.2, page 161. 
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13.2 Methods 
13.2.1 Tableting 
• Placebo tablet mixture was prepared from formulation in Table 9. 
• 200 mg tablets were compacted in Presster. 
• Korsch rotary press PH336 was selected for simulation, with of a speed 10800 
TPH and dwell time of 118.3 msec.  
• A flat face punch with a diameter of 10.0 mm was used for compaction. 
• Presster gap size set for 1.0 mm 
• 1 tablets made 
• Gap increased by 0.1 mm 
• 1 more tablets and gap increments until gap size of 1.4 mm was reached and 5 
tablets were made. 
13.2.2 Paper filters 
• 10 boxes were drawn in word, with 13 mm width and height. 
• Over each box, a circle of 10 mm diameter and black fill was drawn, centre-align 
to the box above. 
• Over the above circle, another white-filled circle, centre-aligned was drawn. The 
diameter of that circle was decreasing from 9 (filter F1) to 1 mm filter (F9). 
• Filter F10 had no white circle (complete block). 
• Filter F0 had no circles (no block). 
• Figure 16 shows the filters and their labelling and Appendix VI.1 shows an exact 
print-out of the filters. 
• After printing, each box was carefully cut and kept for scanning. 
• 3 sets of each filter were made to assess experimental error. 
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13.2.3 NIR Spectral collection 
• Each tablet was placed on the DT sample tray, and one type of paper filter placed 
on top of the tablet with forceps, so that the box corners align with the tablet tray 
position walls. 
• The tablet was scanned. 
• The filter was carefully removed and another placed on the same way and the 
tablet was scanned. 
• The process was repeated until all filters are used. 
• The second tablet was taken and the same steps undertaken until spectra of the 
five tablets, each covered by all filter types were obtained. 
13.2.4 Data processing and calculations 
• Transmittance at 8880 cm-1 for one tablet (one porosity) was plotted against 
filter types (average of 3 measurements for three filters of the same type). 
• This was also compared with the same for other tablets (different porosities). 
• Theoretical signal drop for filter Fx was calculated as a ratio between the block 
(black) area and tablet surface area: 
100%x blockx theor
tablet
ADrop
A
= ⋅  
o This represents the block ratio of each filter if the NIR radiation was 
equally distributed across the whole tablet surface. 
o This was scaled because complete block was not 100% according to the 
DT data (see discussion). 
• Actual (measured) signal drop for filter Fx was calculated as a ratio between 
transmittance at 8800 cm-1 from filter Fx and the transmittance at 8800 cm-1 
from filter F0: 
8880
8880
0
100%Fxx actual
F
DTDrop
DT
= ⋅  
• Theoretical signal drop for each ring was calculated by subtracting the 
Droptheor of each filter, from Droptheor  of the subsequent filter: 
1x theor x theor x theorRing Drop Drop+= −  
o This made the tablet surface consist of 10 rings, each 1 mm thick. 
o It represents the signal drop due to the block of one ring, if the NIR 
radiation was equally distributed across the whole tablet surface. 
• Actual (measured) signal drop for each ring was calculated by subtracting the 
actual drop Dropactual of each filter, from Dropactual of the subsequent filter: 
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1x actual x actual x actualRing Drop Drop+= −  
o It represents the measured signal drop due to the block of one ring. 
• Theoretical signal distribution for each ring was calculated by dividing the 
theoretical signal drop from each ring by the sum of theoretical signal drop due 
to all rings, multiplied by 100%: 
9
0
100%x theorx theor
i theor
i
RingContribution
Ring
=
= ⋅
∑
 
o This represents the share of each ring in the total signal drop in that filter, 
if the NIR radiation was equally distributed across the tablet surface. 
o In this case it will be simply related to the ring area. 
• Measured signal distribution for each ring was calculated by dividing the 
measured signal drop from each ring by the sum of measured signal drop due to 
all rings, multiplied by 100%: 
9
0
100%x actualx actual
i actual
i
RingContribution
Ring
=
= ⋅
∑
 
o This represents the measured share of each ring in the total signal drop in 
that filter in DT mode 
o Plotting this for all filters gives a picture of the distribution of the 
radiation emerging from the tablet surface in DT mode. 
13.3 Results 
With the application of paper filters F0 
spectra were scaled-down gradually with each increase in the block inner diameter 
(Figure 84). F1 and F2 block was small and difficult to judge whether due to positioning 
noise effect (most peripheral blocks) or real signal block. From F3 onwards, the block 
was strongly evident. 
In Figure 22, the DT filters block test was repeated for tablets with different porosities 
(15 - 25%) and 8880 cm-1 
block pattern, an indication that porosity change (in that range), was not affecting the 
signal distribution to a big degree. The plots do, however, have different scales, and it is 
due to due increase in radiation scatter at lower sample densities (higher porosity) 
press effect, chapter 8. 
Figure 84: DT spectra of MCC tablet covered with paper filters F0
down
 
Table 23 shows the calculated actual and theoretical signal drop, and drop due to each 1
mm ring of gradually decreasing diameters. The latter values were converted to 
proportions of the total block due to all rin
drop across tablet surface.  This was also graphically illustrated in 
shows that central areas carry represent more of the signal than their proportional area 
– F10 (from Figure 16) on the tablet, the DT 
maxima plotted. All the tablets showed similar sigmoidal 
-F10, showing spectral 
-scaling with increasing block. 
gs and would represent the distribution of the 
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– see 
 
-
Figure 24 which 
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(as expected). However, the representation of the tablet was continued up to 7 mm in 
diameter (90.6% of signal). 
Table 23: Measured and theoretical relative drops with each filter, and respective drop 
for block rings. 
Filte
r
Dropactual Droptheor
Ring 
#
Ringactu
al
Ringtheo
r
Contributionactu
al
Contributiontheo
r
F0 100.00% 100.00%
F1 96.89% 87.24% 1 3.11% 12.76% 3.30% 14.43%
F2 94.04% 75.34% 2 2.85% 11.89% 3.02% 13.45%
F3 96.95% 64.32% 3 2.90% 11.02% 3.08% 12.46%
F4 92.24% 54.17% 4 4.70% 10.15% 4.99% 11.48%
F5 83.92% 44.89% 5 8.32% 9.28% 8.82% 10.49%
F6 65.05% 36.48% 6 18.87% 8.41% 20.01% 9.51%
F7 53.39% 28.94% 7 11.67% 7.54% 12.37% 8.52%
F8 32.04% 22.28% 8 21.35% 6.67% 22.64% 7.54%
F9 19.32% 16.48% 9 12.71% 5.79% 13.48% 6.55%
F10 11.51% 11.56% 10 7.81% 4.92% 8.29% 5.57%
 
Sum 100.00% 100.00%
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14. Appendix III 
Expanded methods section: Tablet sampling span in 
diffuse reflection 
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14.1 Materials 
14.1.1 Micro-crystalline cellulose 
Please refer to section 12.1.2, page 153. 
14.1.2 Phenylbutazone 
• source 
o Sigma-Aldrich, Buchs, Switzerland 
• functional category 
o API 
o Cyclo-oxygenase inhibitor; pyrazolone analgesic 
• empirical formula: C19H20N2O2 
• molecular mass: 308.37 g mol-1 
• structural formula (Figure 85) 
 
Figure 85: Molecular structure of phenylbutazone 
• Appearance 
o White or almost white, crystalline powder. 
• Solubility 
o Practically insoluble in water, sparingly soluble in alcohol. It dissolves in 
alkaline solutions. 
• Storage 
o Store in an air-tight container 
• Particle size 
o 90% of the particles < 38.2 μm 
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14.1.3 Caffeine (anhydrous) 
• source 
o BASF AG, Schaffhausen, Switzerland 
• functional category 
o  API 
o Central nervous system stimulant  
• empirical formula: C8H10N4O2 
• molecular mass: 194.19 g mol-1 
• structural formula (Figure 86) 
 
Figure 86: Molecular structure of caffeine 
• Appearance 
o White or almost white, crystalline powder or silky, white or almost white, 
crystals. 
• Solubility 
o Sparingly soluble in water, freely soluble in boiling water, slightly soluble 
in ethanol (96 per cent). 
o Dissolves in concentrated solutions of alkali benzoates or salicylates. 
o Readily sublimes. 
• Storage 
o Store in an air-tight container 
• Particle size 
o 90% of the particles < 37 μm 
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14.1.4 Magnesium stearate 
Please refer to section 12.1.4, page 157. 
14.1.5 FD+C Red 3 LA 
• E number 
o E127 
• Common name 
o Erythrosine 
• source 
o Sandoz Pharma, Switzerland 
• functional category 
o  Colouring agent 
• empirical formula: C20H6I4Na2O5 
• molecular mass: 879.86 g mol-1 
• structural formula (Figure 87) 
 
Figure 87: Molecular structure of erythrosine 
• Appearance 
o Cherry red powder. 
• Solubility 
o Soluble in water and alcohol and acidic solutions. 
o Insoluble in alkaline solutions. 
• Storage 
o Store in an air-tight container 
 
207 Appendix III 
14.1.6 Hydroxypropylmethylcellulose 
• source 
o Pharmacoat 603, Novartis Pharma AG, Basel, Switzerland 
• functional category 
o sustained release; stabilizing agent; suspending agent; tablet binder; 
viscosity-increasing agent.  
• non-proprietary name 
o Hypromellosum (Ph. Eur.) 
• empirical formula: C6H7O2(OH)x(OCH3)y(OC3H7)z 
• molecular mass: 10 000–1 500 000 g mol-1 
• structural formula (Figure 88) 
 
Figure 88: Molecular structure of HPMC 
• pharmaceutical applications 
o In oral products, HPMC is primarily used as a tablet binder, in film-coating, 
and as a matrix for use in extended-release tablet formulations. 
Concentrations of 2–20% w/w are used for film-forming solutions to film-
coat tablets. Lower-viscosity grades are used in aqueous film-coating 
solutions, while higher-viscosity grades are used with organic solvents. 
• appearance and characteristics 
o odourless and tasteless, white or creamy white fibrous or granular 
powder. 
• stability and storage conditions 
o should be stored in a well-closed container in a cool, dry place. 
• incompatibilities 
o Since it is non-ionic, hypromellose will not complex with metallic salts or 
ionic organics to form insoluble precipitates. 
• safety 
o generally regarded as a nontoxic and non-irritant material. 
• Solubility 
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o soluble in cold water, forming a viscous colloidal solution; practically 
insoluble in chloroform, ethanol (95%), and ether. 
14.1.7 Ethylcellulose 
• source 
o Aquacoat ECD 30, FMC Biopolymer, Houston, TX 
• functional category 
o Coating agent; viscosity-increasing agent.  
• non-proprietary name 
o Ethylcellulosum (Ph. Eur.) 
• empirical formula: C12H23O6(C12H22O5)nC12H23O5 
• structural formula (Figure 88) 
 
Figure 89: Molecular structure of ethylcellulose 
• pharmaceutical applications 
o The main use of ethylcellulose in oral formulations is as a hydrophobic 
coating agent for tablets and granules and modify the release of a drug, to 
mask an unpleasant taste, or to improve the stability of a formulation. 
Higher-viscosity ethylcellulose grades tend to produce stronger and more 
durable films. Ethylcellulose films may be modified to alter their solubility, 
by the addition of hypromellose or a plasticizer. An aqueous polymer 
dispersion of ethylcellulose such as Aquacoat ECD may also be used to 
produce ethylcellulose films without the need for organic solvents. 
• Glass transition temperature: 129–133°C 
• appearance and characteristics 
o tasteless, free-flowing, white powder. 
• incompatibilities 
o Incompatible with paraffin wax and microcrystalline wax. 
• safety 
o safe, used in food products, not metabolised enterally. 
• Solubility 
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o practically insoluble in glycerine, propylene glycol, and water. Solubility 
depends on the percentage of ethoxyl groups. 
14.1.8 Triethyl citrate 
• source 
o Triethyl citrate, FCC FEMA 3083, Sigma-Aldrich, Buchs, Switzerland. 
• functional category 
o Plasticizer 
• non-proprietary name 
o Triethylis citras (Ph. Eur.) 
• empirical formula: C12H20O7 276.29 
• molecular mass: 276.29 g mol-1 
• structural formula (Figure 90) 
 
Figure 90: Molecular structure of triethyl citrate 
• pharmaceutical applications 
o Used to plasticize polymers in formulated pharmaceutical coatings. 
• appearance and characteristics 
o a clear, odourless, practically colourless, oily liquid. 
• incompatibilities 
o Incompatible with strong alkalis and oxidizing materials. 
• safety 
o Generally regarded as a nontoxic and non-irritant material. 
• Solubility 
o soluble 1 in 15 of water. Miscible with ethanol (95%), acetone, and 
propan-2-ol. 
• Viscosity (dynamic) 
o 35.2 mPa s (35.2 cP) at 25°C 
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14.2 Instruments, apparatus and software 
14.2.1 Zwick Material Tester 
This is a hydraulic press (Type 1478TM, Wick Roell, Germany) designed to mimic the 
compaction cycle of any prescribed shape by using hydraulic control mechanisms that 
are driving a punch in and out of the die. 
Under computer control, the hydraulic actuator maintain load, position, and strain 
associated with the punch. The simulation can be achieved by controlling the force (load 
control) or punch displacement at any given moment of time, while the machine plots 
the compaction and punch displacement profiles. 
14.2.2 NIRFlex N-500 with solids measurement cell 
Please refer to section 12.2.2, page 161. The solids measurements cell scans samples in 
diffuse reflection mode (Figure 91). The tablets where mounted on a tablet sample plate 
with adjustable holding mechanism. 
 
Figure 91: Specifications of the Solids measurement cell 
14.2.3 Strea-1™ Fluid-bed 
This is a fluid-bed coater/dryer/granulator from Aeromatic-Fielder (Bubendorf, 
Switzerland), with a 16.5 l container and 2 m3 min-1 air flow. Spraying is possible from 
top or bottom and product temperature, air volume, filter resistance are continuously 
instrumented. 
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14.2.4 Eccentric tablet press 
This is an electric, single station eccentric tableting machine from Korsch (Germany) 
with adjustable tableting speed, lower punch filling position and upper punch gap 
position. 
14.2.5 Presster™ tablet press simulator 
Please refer to section 12.2.1, page 159. 
14.2.6 Other instruments 
For scales, Turbula mixer, micrometer, please refer to section 12.2.3, page 162. 
14.2.7 Software 
14.2.7.1 NIR Cal 
This is a chemometrics software from Büchi, used for spectral pretreatments and 
calibration model development. 
14.2.7.2 Table Curve 3D 
This is a n-factorial fitting software from Statcon (Wizenhausen, Germany). 
14.2.7.3 Excel 2007 with VBA 
This is a spreadsheet software, used with the built-in Visual Basic for Applications 
module to write and run macros. 
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14.3 Methods 
14.3.1 Incremental thickness tablets 
This experiment was used to test the effect of increasing tablet thickness (with fixed 
tablet composition and density) on DR spectra, and hence the possibility of reaching a 
thickness with minimum spectral variability that may present a candidate for 
determining DR information depth. 
• Zwick hydraulic press was used with a 10 mm die and flat punches. 
• A 3D curve fitting was calculated using TableCurve3D between tablet mass, 
thickness and compaction force was calculated: 
o Powder masses of 30, 100, 200, 300 and 430 mg were fed in the die. 
o For each powder mass, 500 – 5000 N compaction forces were tried in 4 
steps 
o With each trial, the tablet mass was measured. 
o The mass, thickness and force data were imported in TableCruve3D and 
the best and simplest fitting was selected (Figure 30). 
o The fitting equation was used to determine the compaction force for 
experimental samples. 
• 20 MCC tablets with thickness of 0.5 – 10 mm (in 0.5 mm steps) and a porosity of 
25% were compacted in the Zwick using compaction force determined from the 
fitting equation (Appendix VII.3). 
• Tablet thickness and porosity were determined after 24h, and a plot of tablet 
thickness against porosity was used to determine whether or not porosity and 
thickness variabilities were co-related. 
• Tablets were scanned in DR mode and spectra imported in NIRCal. 
• Spectral data table was obtained by clicking “G” and imported in Excel. 
• Various spectral positions, with and without pretreatments, were examined for 
correlation with tablet thickness. 
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14.3.2 Double-layer tablets 
Tablets consisting of 2 layers (PBZ-phenylbutazone and MCC) of varying layer 
thicknesses were used to possibility of detecting DR spectral features of one layer 
through the other. The DR information depth would be less than the lower layer 
thickness if the upper layer is undistinguishable. 
 
Figure 92: Overview of double layer tablets 
• The formulations of upper and lower layers are shown in table. 
• Samples were tableted in Presster with a 10-mm flat punch and Korsch PH 336 
press simulation. 
• The PBZ layer was fed first and pre-compacted. 
• The station was moved back to home position and the upper punch was cleaned. 
• The MCC layer powder was fed and both layers were compacted and tablet 
ejected. 
• Tablets were weighed, thickness measured and DR were spectra collected for 
both sides by flipping the tablets. 
• Spectra were imported in NIRCal and layer features inspected in comparison to 
tablets 1 and 10 using different pretreatments. 
• Each spectrum was assigned 2 qualitative properties, PBZ and MCC. Tablets 
scanned with PBZ layer down were checked as PBZ and those with MCC layer 
down as MCC. Tablet 1 was MCC and 10 PBZ (Figure 92). Same applied to spectra 
of flipped tablets. 
• Cluster analysis models were started in NIRCal, one for each qualitative property. 
PC scores were used to analyse the ability to cluster tablets: 
o For PBZ property, clustering tablets scanned with the PBZ layer down 
with MCC-only tablet.
o For MCC property, clustering tablets scanned with the MCC layer down 
with PBZ-only tablet.
Table 24: Double-layered tablets for
Phenylbutazone
MCC layer
PBZ layer
 
14.3.3 Incremental tablet coating
This experiment was used to examine DR information depth by scanning tablets coated 
with increasingly thicker coats. Thi
its minimum. A second batch of tablets of different core and same coating conditions 
was used to confirm this estimation of information depth.
Figure 93: Overview of increment
• A simple directly compactable tablet formulation was used to make to batches of 
tablets, MCC placebo and 30% caffeine tablets (
• Tablets were compacted on en eccentric Korsch press with a concave pun
mm diameter, 5.5 dome height).
• The tableting mixture was fed into the hopper and the press was manually 
adjusted to produce tablet having:
o Mass 100 ±1.5% mg
o Thickness 3.1 
o Hardness 90-110 N
• The press was then run and tableting continued with 
• The same procedure was used for the second batch.
 
 
mulation 
Pigment MCC 102 MgSt
- - 99%
98% 1% -
 
s depth is reached after spectral variability reaches 
 
al coating experiment
Table 25). 
 
 
 
– 3.2 mm 
 
IPC every 50 samples.
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Total
1% 100%
1% 100%
 
 
ch (7 
 
 
215 Appendix III 
Table 25: MCC and caffeine tablet formulation 
MCC tablets Caffeine tablets
MCC 102 99 % 69 %
Caffeine - 30 %
MgSt 1 % 1 %
Total 100 % 100 %
 
• An Aquacoat film coat formulation was derived from Aquacoat ECD product 
manual (FMC Biopolymer, PA, USA) to coat the tablets (Table 26): 
o 19% Pharmacoat 603 solution was prepared. 
o (A) Triethylcitrate and Aquacoat were added to a beaker and mixed for 30 
minute with a magnetic stirrer. 
o (B) The dye powder was sieved over the Pharmacoat solution and mixed 
for 5 minutes. 
o (A) and (B) were mixed together with stirred with paddle throughout the 
coating process 
Table 26: Aquacoat film coat formulation 
Component Percentage [%] 
Aquacoat ECD 30 (30% m/m) 22.22 
Pharmacoat 603 (19% m/m) 35.09 
Triethylcitrate 1.33 
Fd+C Red 3 LA 7.00 
Water (dist.) 34.36 
Total 100.00 
 
Table 27: Aeromatic process parameter for Aquacoat film coating 
Parameter Value
Inlet temperature 60 .0 °C 
Outlet temperature 35 .0 °C 
Product temperature 47.5 °C 
Atomising pressure 0.8 Bar 
Spray rate 52.4 mg s-1 
 
• The tablets were incrementally coated inside the Aeromatic fluid bed: 
o 250 g of tablets were fed in the product chamber and preheated to the 
product temperature (Table 27). 
o The coat suspension was fed using a pump at the specified rate. 
o Coating was interrupted after 50 g of coat suspension was used. 
o Tablets were dried for 1 minute and 10 tablets were sampled for analysis 
and then coating was continued for another 50 g of coat suspension. 
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o 5 coating steps were possible (+1 uncoated) before tablets showed 
cracked, and pitted surfaces and coating was terminated. 
o The same coating process was repeated for the caffeine tablets using the 
same film coat formulation. 
• Mass and thickness of tablets from all coating steps and for both tablet batches 
were determined. 
• DR and DT spectra were collected from all tablets. 
• 2 qualitative properties (MCC and Caffeine) were created and assigned for the 
respective tablets’ DR and DT spectra. 
• The decay curve in different spectral regions was estimated: 
o The spectra were imported in NIRCal and spectral data were exported to 
excel using different pre-treatments (each spectrum in a column). 
o An Excel macro (Appendix VII.2) was used to search for spectral regions 
with difference between MCC and caffeine DR spectra of the same coating 
level highly correlating with the coat thickness; using r2 of an exponential 
fit (other fittings did not produce any correlation). 
o When the DR difference was converted to percentage, (100% being the 
maximum difference of the uncoated tablets), the fit represented the DR 
signal decay with increasing coat thickness. 
• The spectra were also investigated using cluster analysis to assess the possibility 
of predicting a tablet correctly (MCC or Caffeine) with increasing coat thickness: 
o DR spectra were imported in a qualitative CLU model in NIRCal. 
o One third of the spectra were assigned as validation. 
o Best qualitative model was searched for using manual and automatic 
model optimizations, using Q value as a performance indicator. 
o Clustering was visualized using the Scores vs. Scores plot. 
o The same was repeated for the DT spectra and the results were compared 
with DR. 
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15. Appendix IV 
Appendix IV.1: Presster compaction profile for folic acid tablets 
tablet 
number 
tablet 
mass 
[mg] 
thick
ness 
[mm] 
crushin
g strength 
[N] 
CO step motor 
position (gap size) 
[mm] 
upper 
compaction [kN] 
1 203.2 3.31 27 2.7 1.4 
2 198.1 2.90 40 2.3 1.9 
3 201.3 2.92 47 2.3 2.1 
4 200.1 2.67 75 2.0 2.8 
5 201.6 2.44 104 1.8 4.0 
6 200.3 2.44 104 1.8 3.9 
7 201.8 2.48 109 1.8 3.9 
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Appendix IV.2: Complete data from Presster compaction profile for folic acid tablets 
b
atch 
# 
bat
ch tablet 
# 
press brand press 
model 
desired 
press speed [TPH] 
desired dwell 
time [ms] 
achieved 
dwell time [ms] 
0 0 KORSCH PH336 10'800 118.3 31.1 
0 0 KORSCH PH336 10'800 118.3 31.1 
0 0 KORSCH PH336 10'800 118.3 31.6 
0 0 KORSCH PH336 10'800 118.3 31.1 
0 0 KORSCH PH336 10'800 118.3 31.1 
0 0 KORSCH PH336 10'800 118.3 31.1 
0 0 KORSCH PH336 10'800 118.3 31.1 
b
atch 
# 
bat
ch tablet 
# 
effective 
dwell time [ms] 
upper pre-
compression 
peak [kN] 
lower pre-
compression peak 
[kN] 
upper 
compression peak 
[kN] 
lower 
compression peak 
[kN] 
0 0 5.1 0.1 0.1 1.4 0.6 
0 0 15.2 0.2 0.1 1.9 1.2 
0 0 5.1 0.1 0.1 2.1 1.2 
0 0 17.7 0.1 0.1 2.8 2.1 
0 0 10.1 0.1 0.1 4.0 3.0 
0 0 10.1 0.1 0.1 3.9 2.9 
0 0 12.6 0.1 0.1 3.9 3.0 
b
atch 
# 
bat
ch tablet 
# 
maximum 
upper punch 
displacement 
[mm] 
maximum 
lower punch 
displacement 
[mm] 
peak ejection 
[N] 
peak take-off 
[N] 
peak radial 
die wall pressure 
[MPa] 
0 0 4.300 6.670 119.4 16.0500 20.5100 
0 0 4.290 6.280 156.3 16.0500 24.3600 
0 0 4.300 6.290 139.9 16.0500 21.4300 
0 0 4.290 6.030 144.0 16.0500 24.0400 
0 0 4.300 5.850 139.9 16.0500 24.1000 
0 0 4.300 5.840 115.4 16.0500 23.7400 
0 0 4.290 5.850 107.2 16.0500 27.2100 
b
atch 
# 
bat
ch tablet 
# 
punch ID tool type effective 
contact time [ms] 
effective rise 
time [ms] 
effective fall 
time [ms] 
0 0 Flat Face 
10.0 mm 
EU B 75.8 53.0 17.7 
0 0 Flat Face 
10.0 mm 
EU B 73.2 35.4 22.7 
0 0 Flat Face 
10.0 mm 
EU B 101.0 45.5 50.5 
0 0 Flat Face 
10.0 mm 
EU B 75.8 37.9 20.2 
0 0 Flat Face 
10.0 mm 
EU B 83.3 48.0 25.3 
0 0 Flat Face 
10.0 mm 
EU B 85.9 53.0 22.7 
0 0 Flat Face 
10.0 mm 
EU B 80.8 40.4 27.8 
b
atch 
# 
bat
ch tablet 
# 
minimum 
punch gap [mm] 
corrected 
gap [mm] 
CO step 
motor position 
[mm] 
dosing step 
motor position [mm] 
PCO step 
motor position 
[mm] 
0 0 2.82  2.7 17.4 14.3 
0 0 2.47  2.3 17.4 14.3 
0 0 2.46  2.3 17.4 14.3 
0 0 2.23  2.0 17.4 14.3 
0 0 2.05  1.8 17.4 14.3 
0 0 2.05  1.8 17.4 14.3 
0 0 2.06  1.8 17.4 14.3 
b
atch 
# 
bat
ch tablet 
# 
EJ step 
motor position 
[deg] 
number of 
stations 
achieved 
RPM 
sampling rate 
[Hz] 
achieved 
linear speed [m/s] 
0 0 10.9 36.0 19.0 396.0 0.408 
0 0 10.9 36.0 19.0 396.0 0.408 
0 0 10.9 36.0 18.7 396.0 0.402 
0 0 10.9 36.0 19.0 396.0 0.408 
0 0 10.9 36.0 19.0 396.0 0.408 
0 0 10.9 36.0 19.0 396.0 0.408 
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0 0 10.9 36.0 19.0 396.0 0.408 
b
atch 
# 
bat
ch tablet 
# 
desired RPM desired 
linear speed 
[m/s] 
punch head 
flat [mm] 
achieved press 
speed [TPH] 
depth of fill 
[mm] 
0 0 5.0 0.107 12.7 41'037 11.3 
0 0 5.0 0.107 12.7 41'037 10.8 
0 0 5.0 0.107 12.7 40'489 11.1 
0 0 5.0 0.107 12.7 41'037 10.6 
0 0 5.0 0.107 12.7 41'037 10.5 
0 0 5.0 0.107 12.7 41'037 10.5 
0 0 5.0 0.107 12.7 41'037 10.5 
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Appendix IV.3: Calibration/validation folic acid tablets physical parameters 
# Batc
h 
tablet  tablet [mg]  thickness [mm] Porosity [%] 
1 0.0% 1 200.5 2.40 31.10845 
2 0.0% 2 200.3 2.39 30.88921 
3 0.0% 3 200.4 2.40 31.14281 
4 0.0% 4 200.2 2.38 30.63347 
5 0.0% 5 200.3 2.38 30.59883 
6 0.0% 6 200.6 2.39 30.78570 
7 0.0% 7 200.1 2.38 30.66812 
8 0.0% 8 200.2 2.38 30.63347 
9 0.0% 9 200.2 2.38 30.63347 
10 0.0% 10 200.2 2.39 30.92371 
11 0.0% 11 200.6 2.39 30.78570 
12 0.0% 12 200.5 2.40 31.10845 
13 0.0% 13 200.4 2.39 30.85470 
14 0.0% 14 200.5 2.39 30.82020 
15 0.0% 15 200.6 2.40 31.07409 
16 0.0% 16 200.5 2.40 31.10845 
17 0.0% 17 200.5 2.39 30.82020 
18 0.0% 18 200.3 2.38 30.59883 
19 0.0% 19 200.1 2.37 30.37558 
20 0.0% 20 200.5 2.39 30.82020 
21 0.5% 1 200.0 2.38 30.70277 
22 0.5% 2 200.2 2.38 30.63347 
23 0.5% 3 200.3 2.39 30.88921 
24 0.5% 4 200.4 2.40 31.14281 
25 0.5% 5 200.4 2.39 30.85470 
26 0.5% 6 200.6 2.39 30.78570 
27 0.5% 7 200.2 2.38 30.63347 
28 0.5% 8 200.9 2.40 30.97101 
29 0.5% 9 200.6 2.39 30.78570 
30 0.5% 10 200.5 2.38 30.52953 
31 0.5% 11 200.0 2.38 30.70277 
32 0.5% 12 200.4 2.39 30.85470 
33 0.5% 13 200.9 2.40 30.97101 
34 0.5% 14 200.2 2.39 30.92371 
35 0.5% 15 200.3 2.39 30.88921 
36 0.5% 16 200.8 2.38 30.42558 
37 0.5% 17 200.4 2.40 31.14281 
38 0.5% 18 201.1 2.40 30.90229 
39 0.5% 19 200.5 2.39 30.82020 
40 0.5% 20 200.7 2.40 31.03973 
41 1.0% 1 200.6 2.39 30.78570 
42 1.0% 2 200.0 2.38 30.70277 
43 1.0% 3 200.6 2.40 31.07409 
44 1.0% 4 201.0 2.41 31.22322 
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45 1.0% 5 200.8 2.40 31.00537 
46 1.0% 6 200.9 2.41 31.25744 
47 1.0% 7 200.1 2.39 30.95822 
48 1.0% 8 200.2 2.39 30.92371 
49 1.0% 9 201.1 2.41 31.18900 
50 1.0% 10 200.6 2.39 30.78570 
51 1.0% 11 200.5 2.39 30.82020 
52 1.0% 12 200.9 2.38 30.39093 
53 1.0% 13 200.6 2.39 30.78570 
54 1.0% 14 200.6 2.40 31.07409 
55 1.0% 15 200.6 2.39 30.78570 
56 1.0% 16 200.2 2.38 30.63347 
57 1.0% 17 200.6 2.40 31.07409 
58 1.0% 18 200.6 2.39 30.78570 
59 1.0% 19 200.5 2.39 30.82020 
60 1.0% 20 200.8 2.39 30.71669 
61 1.5% 1 200.7 2.41 31.32587 
62 1.5% 2 200.2 2.39 30.92371 
63 1.5% 3 200.5 2.38 30.52953 
64 1.5% 4 200.6 2.40 31.07409 
65 1.5% 5 201.0 2.40 30.93665 
66 1.5% 6 199.9 2.37 30.44517 
67 1.5% 7 200.0 2.40 31.28025 
68 1.5% 8 200.6 2.38 30.49488 
69 1.5% 9 200.4 2.40 31.14281 
70 1.5% 10 200.8 2.40 31.00537 
71 1.5% 11 200.8 2.40 31.00537 
72 1.5% 12 200.7 2.38 30.46023 
73 1.5% 13 200.0 2.37 30.41038 
74 1.5% 14 200.5 2.38 30.52953 
75 1.5% 15 200.6 2.39 30.78570 
76 1.5% 16 200.9 2.40 30.97101 
77 1.5% 17 200.2 2.38 30.63347 
78 1.5% 18 200.3 2.37 30.30599 
79 1.5% 19 200.8 2.38 30.42558 
80 1.5% 20 200.6 2.39 30.78570 
81 2.0% 1 200.2 2.38 30.63347 
82 2.0% 2 200.5 2.38 30.52953 
83 2.0% 3 200.1 2.39 30.95822 
84 2.0% 4 200.3 2.37 30.30599 
85 2.0% 5 200.4 2.40 31.14281 
86 2.0% 6 200.6 2.40 31.07409 
87 2.0% 7 200.1 2.39 30.95822 
88 2.0% 8 200.1 2.39 30.95822 
89 2.0% 9 200.4 2.39 30.85470 
90 2.0% 10 200.8 2.39 30.71669 
91 2.0% 11 200.3 2.39 30.88921 
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92 2.0% 12 200.1 2.38 30.66812 
93 2.0% 13 200.8 2.38 30.42558 
94 2.0% 14 200.3 2.39 30.88921 
95 2.0% 15 200.3 2.39 30.88921 
96 2.0% 16 200.5 2.39 30.82020 
97 2.0% 17 200.3 2.38 30.59883 
98 2.0% 18 200.3 2.38 30.59883 
99 2.0% 19 200.3 2.38 30.59883 
100 2.0% 20 200.4 2.39 30.85470 
101 2.5% 1 200.9 2.39 30.68219 
102 2.5% 2 201.1 2.40 30.90229 
103 2.5% 3 201.1 2.41 31.18900 
104 2.5% 4 201.0 2.38 30.35629 
105 2.5% 5 200.9 2.37 30.09723 
106 2.5% 6 200.2 2.36 30.04562 
107 2.5% 7 201.0 2.40 30.93665 
108 2.5% 8 200.4 2.40 31.14281 
109 2.5% 9 200.9 2.39 30.68219 
110 2.5% 10 200.4 2.41 31.42852 
111 2.5% 11 200.3 2.41 31.46274 
112 2.5% 12 200.7 2.41 31.32587 
113 2.5% 13 201.0 2.40 30.93665 
114 2.5% 14 200.6 2.38 30.49488 
115 2.5% 15 200.5 2.40 31.10845 
116 2.5% 16 200.8 2.39 30.71669 
117 2.5% 17 201.0 2.40 30.93665 
118 2.5% 18 200.9 2.40 30.97101 
119 2.5% 19 200.6 2.40 31.07409 
120 2.5% 20 200.5 2.39 30.82020 
121 3.0% 1 199.8 2.37 30.47997 
122 3.0% 2 200.5 2.39 30.82020 
123 3.0% 3 200.1 2.40 31.24589 
124 3.0% 4 200.1 2.40 31.24589 
125 3.0% 5 200.0 2.37 30.41038 
126 3.0% 6 200.6 2.39 30.78570 
127 3.0% 7 200.7 2.40 31.03973 
128 3.0% 8 200.0 2.37 30.41038 
129 3.0% 9 201.0 2.38 30.35629 
130 3.0% 10 200.9 2.41 31.25744 
131 3.0% 11 200.3 2.38 30.59883 
132 3.0% 12 200.8 2.40 31.00537 
133 3.0% 13 200.7 2.39 30.75119 
134 3.0% 14 200.1 2.37 30.37558 
135 3.0% 15 200.6 2.39 30.78570 
136 3.0% 16 200.9 2.41 31.25744 
137 3.0% 17 200.6 2.39 30.78570 
138 3.0% 18 200.4 2.38 30.56418 
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139 3.0% 19 200.6 2.40 31.07409 
140 3.0% 20 200.5 2.40 31.10845 
141 3.5% 1 200.4 2.39 30.85470 
142 3.5% 2 200.3 2.39 30.88921 
143 3.5% 3 200.3 2.39 30.88921 
144 3.5% 4 200.8 2.40 31.00537 
145 3.5% 5 200.4 2.40 31.14281 
146 3.5% 6 200.4 2.39 30.85470 
147 3.5% 7 200.8 2.39 30.71669 
148 3.5% 8 200.6 2.39 30.78570 
149 3.5% 9 200.7 2.39 30.75119 
150 3.5% 10 200.7 2.38 30.46023 
151 3.5% 11 200.1 2.38 30.66812 
152 3.5% 12 200.6 2.40 31.07409 
153 3.5% 13 200.2 2.38 30.63347 
154 3.5% 14 200.3 2.38 30.59883 
155 3.5% 15 200.6 2.40 31.07409 
156 3.5% 16 200.6 2.39 30.78570 
157 3.5% 17 199.9 2.37 30.44517 
158 3.5% 18 200.6 2.40 31.07409 
159 3.5% 19 200.9 2.37 30.09723 
160 3.5% 20 200.7 2.38 30.46023 
161 4.0% 1 200.2 2.38 30.63347 
162 4.0% 2 199.8 2.37 30.47997 
163 4.0% 3 200.5 2.39 30.82020 
164 4.0% 4 200.6 2.40 31.07409 
165 4.0% 5 200.5 2.39 30.82020 
166 4.0% 6 201.0 2.41 31.22322 
167 4.0% 7 200.6 2.39 30.78570 
168 4.0% 8 199.8 2.37 30.47997 
169 4.0% 9 200.2 2.38 30.63347 
170 4.0% 10 200.6 2.39 30.78570 
171 4.0% 11 200.4 2.38 30.56418 
172 4.0% 12 200.2 2.38 30.63347 
173 4.0% 13 200.3 2.39 30.88921 
174 4.0% 14 200.1 2.38 30.66812 
175 4.0% 15 200.0 2.37 30.41038 
176 4.0% 16 200.3 2.38 30.59883 
177 4.0% 17 200.1 2.38 30.66812 
178 4.0% 18 200.7 2.39 30.75119 
179 4.0% 19 200.2 2.38 30.63347 
180 4.0% 20 200.5 2.40 31.10845 
181 4.5% 1 200.0 2.37 30.41038 
182 4.5% 2 200.4 2.38 30.56418 
183 4.5% 3 200.1 2.38 30.66812 
184 4.5% 4 200.4 2.38 30.56418 
185 4.5% 5 200.0 2.37 30.41038 
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186 4.5% 6 200.9 2.41 31.25744 
187 4.5% 7 200.4 2.39 30.85470 
188 4.5% 8 200.3 2.38 30.59883 
189 4.5% 9 200.2 2.38 30.63347 
190 4.5% 10 201.0 2.41 31.22322 
191 4.5% 11 200.1 2.38 30.66812 
192 4.5% 12 200.5 2.39 30.82020 
193 4.5% 13 200.8 2.40 31.00537 
194 4.5% 14 200.8 2.40 31.00537 
195 4.5% 15 200.6 2.39 30.78570 
196 4.5% 16 200.8 2.39 30.71669 
197 4.5% 17 200.4 2.38 30.56418 
198 4.5% 18 200.3 2.38 30.59883 
199 4.5% 19 200.5 2.39 30.82020 
200 4.5% 20 200.4 2.38 30.56418 
201 5.0% 1 200.0 2.38 30.70277 
202 5.0% 2 200.8 2.39 30.71669 
203 5.0% 3 200.3 2.38 30.59883 
204 5.0% 4 200.3 2.38 30.59883 
205 5.0% 5 200.5 2.39 30.82020 
206 5.0% 6 201.0 2.41 31.22322 
207 5.0% 7 200.4 2.38 30.56418 
208 5.0% 8 200.4 2.38 30.56418 
209 5.0% 9 200.6 2.38 30.49488 
210 5.0% 10 199.8 2.39 31.06173 
211 5.0% 11 200.2 2.38 30.63347 
212 5.0% 12 200.6 2.39 30.78570 
213 5.0% 13 199.7 2.37 30.51476 
214 5.0% 14 199.8 2.37 30.47997 
215 5.0% 15 200.2 2.38 30.63347 
216 5.0% 16 200.2 2.38 30.63347 
217 5.0% 17 200.5 2.39 30.82020 
218 5.0% 18 200.2 2.38 30.63347 
219 5.0% 19 200.5 2.39 30.82020 
220 5.0% 20 199.9 2.37 30.44517 
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Appendix IV.5: UV assay calibration line for folic acid tablets
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UV calibration line for folic acid tablets
n 
nominal content [mg] conc. [g/100ml]
0 0.0000
1 0.0005
2 0.0010
3 0.0015
4 0.0020
5 0.0025
6 0.0030
7 0.0035
8 0.0040
9 0.0045
10 0.0050
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 UV A 
 0.002 
 0.119 
 0.234 
 0.343 
 0.456 
 0.581 
 0.724 
 0.839 
 0.947 
 1.071 
 1.186 
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Appendix IV.1: UV referencing for calibration / validation folic acid tablets 
# tab
let  
tablet 
mass[mg]  
UV Abs nominal 
[mg] 
referenced content 
[mg] 
1 1 200.5 0.00300 0.00000 0.02537 
2 2 200.3 0.00200 0.00000 0.01689 
3 3 200.4 0.00400 0.00000 0.03381 
4 4 200.2 0.00500 0.00000 0.04222 
5 5 200.3 0.00500 0.00000 0.04224 
6 6 200.6 0.00100 0.00000 0.00846 
7 7 200.1 0.00200 0.00000 0.01688 
8 8 200.2 0.00600 0.00000 0.05066 
9 9 200.2 0.00300 0.00000 0.02533 
10 10 200.2 0.00400 0.00000 0.03377 
11 11 200.6 0.00300 0.00000 0.02538 
12 12 200.5 0.00200 0.00000 0.01691 
13 13 200.4 0.00200 0.00000 0.01690 
14 14 200.5 0.00100 0.00000 0.00846 
15 15 200.6 0.00300 0.00000 0.02538 
16 16 200.5 0.00100 0.00000 0.00846 
17 17 200.5 0.00200 0.00000 0.01691 
18 18 200.3 0.00100 0.00000 0.00845 
19 19 200.1 0.00300 0.00000 0.02532 
20 20 200.5 0.00100 0.00000 0.00846 
21 1 200.0 0.14400 1.00000 1.21460 
22 2 200.2 0.15400 1.00000 1.30024 
23 3 200.3 0.13400 1.00000 1.13195 
24 4 200.4 0.13100 1.00000 1.10716 
25 5 200.4 0.14600 1.00000 1.23393 
26 6 200.6 0.14700 1.00000 1.24362 
27 7 200.2 0.14600 1.00000 1.23270 
28 8 200.9 0.11200 1.00000 0.94894 
29 9 200.6 0.14000 1.00000 1.18440 
30 10 200.5 0.14100 1.00000 1.19227 
31 11 200.0 0.14100 1.00000 1.18929 
32 12 200.4 0.12900 1.00000 1.09025 
33 13 200.9 0.11600 1.00000 0.98283 
34 14 200.2 0.11900 1.00000 1.00473 
35 15 200.3 0.12200 1.00000 1.03058 
36 16 200.8 0.14200 1.00000 1.20252 
37 17 200.4 0.11200 1.00000 0.94658 
38 18 201.1 0.13400 1.00000 1.13647 
39 19 200.5 0.14100 1.00000 1.19227 
40 20 200.7 0.12100 1.00000 1.02417 
41 1 200.6 0.23500 2.00000 1.98810 
42 2 200.0 0.22500 2.00000 1.89781 
43 3 200.6 0.25400 2.00000 2.14884 
44 4 201.0 0.24300 2.00000 2.05988 
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# tab
let  
tablet 
mass[mg]  
UV Abs nominal 
[mg] 
referenced content 
[mg] 
45 5 200.8 0.22000 2.00000 1.86306 
46 6 200.9 0.22600 2.00000 1.91482 
47 7 200.1 0.22400 2.00000 1.89032 
48 8 200.2 0.25200 2.00000 2.12767 
49 9 201.1 0.25500 2.00000 2.16268 
50 10 200.6 0.22200 2.00000 1.87812 
51 11 200.5 0.23400 2.00000 1.97865 
52 12 200.9 0.22700 2.00000 1.92329 
53 13 200.6 0.21000 2.00000 1.77660 
54 14 200.6 0.21400 2.00000 1.81044 
55 15 200.6 0.25100 2.00000 2.12346 
56 16 200.2 0.24100 2.00000 2.03480 
57 17 200.6 0.24000 2.00000 2.03040 
58 18 200.6 0.20800 2.00000 1.75968 
59 19 200.5 0.22300 2.00000 1.88564 
60 20 200.8 0.25300 2.00000 2.14252 
61 1 200.7 0.31900 3.00000 2.70009 
62 2 200.2 0.35600 3.00000 3.00576 
63 3 200.5 0.31500 3.00000 2.66357 
64 4 200.6 0.33300 3.00000 2.81718 
65 5 201.0 0.34400 3.00000 2.91604 
66 6 199.9 0.31200 3.00000 2.63031 
67 7 200.0 0.33600 3.00000 2.83406 
68 8 200.6 0.34100 3.00000 2.88486 
69 9 200.4 0.36400 3.00000 3.07637 
70 10 200.8 0.33900 3.00000 2.87080 
71 11 200.8 0.32600 3.00000 2.76071 
72 12 200.7 0.36700 3.00000 3.10637 
73 13 200.0 0.37400 3.00000 3.15458 
74 14 200.5 0.35100 3.00000 2.96798 
75 15 200.6 0.32900 3.00000 2.78334 
76 16 200.9 0.33700 3.00000 2.85529 
77 17 200.2 0.35500 3.00000 2.99731 
78 18 200.3 0.33200 3.00000 2.80452 
79 19 200.8 0.31900 3.00000 2.70143 
80 20 200.6 0.34300 3.00000 2.90178 
81 1 200.2 0.40400 4.00000 3.41103 
82 2 200.5 0.46400 4.00000 3.92349 
83 3 200.1 0.43400 4.00000 3.66249 
84 4 200.3 0.46200 4.00000 3.90268 
85 5 200.4 0.46400 4.00000 3.92153 
86 6 200.6 0.45000 4.00000 3.80700 
87 7 200.1 0.44500 4.00000 3.75532 
88 8 200.1 0.41500 4.00000 3.50215 
89 9 200.4 0.44800 4.00000 3.78630 
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# tab
let  
tablet 
mass[mg]  
UV Abs nominal 
[mg] 
referenced content 
[mg] 
90 10 200.8 0.46600 4.00000 3.94629 
91 11 200.3 0.45300 4.00000 3.82665 
92 12 200.1 0.47400 4.00000 4.00005 
93 13 200.8 0.47700 4.00000 4.03945 
94 14 200.3 0.42600 4.00000 3.59857 
95 15 200.3 0.50300 4.00000 4.24902 
96 16 200.5 0.49100 4.00000 4.15179 
97 17 200.3 0.44400 4.00000 3.75062 
98 18 200.3 0.43600 4.00000 3.68305 
99 19 200.3 0.48000 4.00000 4.05473 
100 20 200.4 0.46900 4.00000 3.96379 
101 1 200.9 0.55500 5.00000 4.70232 
102 2 201.1 0.58000 5.00000 4.91903 
103 3 201.1 0.59800 5.00000 5.07169 
104 4 201.0 0.59400 5.00000 5.03526 
105 5 200.9 0.58500 5.00000 4.95650 
106 6 200.2 0.54200 5.00000 4.57618 
107 7 201.0 0.57500 5.00000 4.87420 
108 8 200.4 0.54100 5.00000 4.57230 
109 9 200.9 0.61500 5.00000 5.21068 
110 10 200.4 0.62700 5.00000 5.29913 
111 11 200.3 0.61700 5.00000 5.21202 
112 12 200.7 0.56700 5.00000 4.79921 
113 13 201.0 0.58600 5.00000 4.96745 
114 14 200.6 0.58000 5.00000 4.90680 
115 15 200.5 0.63200 5.00000 5.34406 
116 16 200.8 0.63100 5.00000 5.34358 
117 17 201.0 0.57300 5.00000 4.85725 
118 18 200.9 0.57900 5.00000 4.90567 
119 19 200.6 0.58700 5.00000 4.96602 
120 20 200.5 0.59400 5.00000 5.02274 
121 1 199.8 0.76000 6.00000 6.40396 
122 2 200.5 0.66000 6.00000 5.58082 
123 3 200.1 0.76200 6.00000 6.43046 
124 4 200.1 0.64900 6.00000 5.47686 
125 5 200.0 0.68100 6.00000 5.74403 
126 6 200.6 0.70500 6.00000 5.96430 
127 7 200.7 0.69700 6.00000 5.89956 
128 8 200.0 0.67500 6.00000 5.69342 
129 9 201.0 0.68300 6.00000 5.78970 
130 10 200.9 0.74800 6.00000 6.33755 
131 11 200.3 0.75600 6.00000 6.38620 
132 12 200.8 0.72100 6.00000 6.10574 
133 13 200.7 0.68500 6.00000 5.79799 
134 14 200.1 0.72700 6.00000 6.13509 
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# tab
let  
tablet 
mass[mg]  
UV Abs nominal 
[mg] 
referenced content 
[mg] 
135 15 200.6 0.68700 6.00000 5.81202 
136 16 200.9 0.72300 6.00000 6.12573 
137 17 200.6 0.72500 6.00000 6.13350 
138 18 200.4 0.73900 6.00000 6.24571 
139 19 200.6 0.74200 6.00000 6.27732 
140 20 200.5 0.73800 6.00000 6.24037 
141 1 200.4 0.80600 7.00000 6.81196 
142 2 200.3 0.81200 7.00000 6.85925 
143 3 200.3 0.79400 7.00000 6.70720 
144 4 200.8 0.86300 7.00000 7.30826 
145 5 200.4 0.79900 7.00000 6.75280 
146 6 200.4 0.82200 7.00000 6.94719 
147 7 200.8 0.83800 7.00000 7.09655 
148 8 200.6 0.86200 7.00000 7.29252 
149 9 200.7 0.85500 7.00000 7.23691 
150 10 200.7 0.87300 7.00000 7.38927 
151 11 200.1 0.80300 7.00000 6.77645 
152 12 200.6 0.79300 7.00000 6.70878 
153 13 200.2 0.81200 7.00000 6.85583 
154 14 200.3 0.87700 7.00000 7.40833 
155 15 200.6 0.80500 7.00000 6.81030 
156 16 200.6 0.81800 7.00000 6.92028 
157 17 199.9 0.83900 7.00000 7.07317 
158 18 200.6 0.82700 7.00000 6.99642 
159 19 200.9 0.84300 7.00000 7.14245 
160 20 200.7 0.81600 7.00000 6.90680 
161 1 200.2 0.94400 8.00000 7.97032 
162 2 199.8 0.95700 8.00000 8.06394 
163 3 200.5 0.93500 8.00000 7.90616 
164 4 200.6 0.90600 8.00000 7.66476 
165 5 200.5 0.96000 8.00000 8.11756 
166 6 201.0 0.91600 8.00000 7.76482 
167 7 200.6 0.91300 8.00000 7.72398 
168 8 199.8 0.92500 8.00000 7.79430 
169 9 200.2 0.94600 8.00000 7.98721 
170 10 200.6 0.92200 8.00000 7.80012 
171 11 200.4 0.98900 8.00000 8.35860 
172 12 200.2 0.98400 8.00000 8.30804 
173 13 200.3 0.92500 8.00000 7.81380 
174 14 200.1 0.93100 8.00000 7.85663 
175 15 200.0 0.92700 8.00000 7.81897 
176 16 200.3 0.92100 8.00000 7.78001 
177 17 200.1 0.92600 8.00000 7.81444 
178 18 200.7 0.94600 8.00000 8.00715 
179 19 200.2 0.98500 8.00000 8.31649 
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# tab
let  
tablet 
mass[mg]  
UV Abs nominal 
[mg] 
referenced content 
[mg] 
180 20 200.5 0.92100 8.00000 7.78778 
181 1 200.0 1.07400 9.00000 9.05887 
182 2 200.4 1.03100 9.00000 8.71357 
183 3 200.1 1.05900 9.00000 8.93681 
184 4 200.4 1.05500 9.00000 8.91641 
185 5 200.0 1.07000 9.00000 9.02513 
186 6 200.9 1.07300 9.00000 9.09116 
187 7 200.4 1.07100 9.00000 9.05163 
188 8 200.3 1.01300 9.00000 8.55717 
189 9 200.2 1.02100 9.00000 8.62044 
190 10 201.0 1.07600 9.00000 9.12112 
191 11 200.1 1.08400 9.00000 9.14779 
192 12 200.5 1.04000 9.00000 8.79402 
193 13 200.8 1.05300 9.00000 8.91727 
194 14 200.8 1.08700 9.00000 9.20519 
195 15 200.6 1.05700 9.00000 8.94222 
196 16 200.8 1.08600 9.00000 9.19672 
197 17 200.4 1.08200 9.00000 9.14460 
198 18 200.3 1.07700 9.00000 9.09780 
199 19 200.5 1.06300 9.00000 8.98850 
200 20 200.4 1.06800 9.00000 9.02628 
201 1 200.0 1.15300 10.00000 9.72521 
202 2 200.8 1.18100 10.00000 10.00123 
203 3 200.3 1.15300 10.00000 9.73980 
204 4 200.3 1.17900 10.00000 9.95943 
205 5 200.5 1.12200 10.00000 9.48739 
206 6 201.0 1.20000 10.00000 10.17225 
207 7 200.4 1.16900 10.00000 9.87988 
208 8 200.4 1.18700 10.00000 10.03201 
209 9 200.6 1.16900 10.00000 9.88974 
210 10 199.8 1.17400 10.00000 9.89244 
211 11 200.2 1.18600 10.00000 10.01356 
212 12 200.6 1.18400 10.00000 10.01664 
213 13 199.7 1.18900 10.00000 10.01382 
214 14 199.8 1.13300 10.00000 9.54696 
215 15 200.2 1.19700 10.00000 10.10643 
216 16 200.2 1.15200 10.00000 9.72649 
217 17 200.5 1.17800 10.00000 9.96092 
218 18 200.2 1.17600 10.00000 9.92913 
219 19 200.5 1.16300 10.00000 9.83408 
220 20 199.9 1.15700 10.00000 9.75407 
Average 200.46    
SD 0.031    
Max 201.10    
Min 199.70    
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Appendix IV.6: Bulk and tapped volume data 
 MCC Ac-Di-Sol Mg-stearate 
mass [g] 43.75 73.17 22.91 
        
bulk volume [ml] 112 132 96 
        
tapped volume [ml]    
after 10 taps 110 126 94 
after 500 taps 96 112 83 
after 1250 taps 94 111 76 
 after 2500 taps     74 
 
232 Appendix IV 
 
 
233 Appendix IV 
Appendix IV.7: Calibration protocol of NIR model A1 
Software NIRCal V5.2 (Build 1000) 
Project File Name folic acid 
Project Comment  
Project GUID {68EA7997-6ACB-4021-9791-F8D94B542C86}P    
Calibration Name A1 
Calibration Comment  
Calibration GUID {073F90A1-75C3-42B7-AB76-F87557A16636} 
Calibration Version 0 
_____________________________
____ 
 
  
Properties in Project Folic acid, Folic acid nominal. (total 2/2) 
Properties in Calibration Set Folic acid. (total 1/2) 
_____________________________
____ 
 
  
Spectra in Project 220 
Spectra in Calibration Set 161 
Spectra in Validation Set 59 
  
Spectra in Calibration Set 1-2, 4-5, 7-8, 10-11, 13-14, 16-17, 19-20, 22-23, 
 25-26, 28-29, 31-32, 34-35, 37-38, 40-41, 43-44, 46-
47, 
 49-50, 52-53, 55, 58-62, 64-65, 67-68, 70-71, 73-74, 
76-77, 
 79-83, 85-86, 88-89, 91-93, 95, 99-106, 109, 112-113, 
 115-116, 118-119, 121-122, 124-125, 127-128, 130-
131, 
 133-134, 136-137, 139-140, 142-143, 145-146, 148-
149, 
 151-152, 154-155, 157-158, 160-164, 166-167, 169-
170, 
 172-173, 175-216, 218, 220. 
  
Spectra in Validation Set 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 
48, 
 51, 54, 56-57, 63, 66, 69, 72, 75, 78, 84, 87, 90, 94, 
96-98, 
 107-108, 110-111, 114, 117, 120, 123, 126, 129, 132, 
135, 
 138, 141, 144, 147, 150, 153, 156, 159, 165, 168, 
171, ) 
 174, 217, 219. 
  
Validation Method Validation Set 
  
C-Set Spectra  
Instrument type / serial NIRFlex N500 / 600000281 
y-Unit / Measurements / Scans Transmittance / 1 / 64 
  
V-Set Spectra  
Instrument type / serial NIRFlex N500 / 600000281 
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y-Unit / Measurements / Scans Transmittance / 1 / 64 
  
Spectra Resolution 4 1/cm 
Spectra y-Unit Transmittance 
Wavelengths Project Set 6000-11520. (total 1381/1381) 
Wavelengths Calibration Set 6000-10600. (total 1151/1381) 
  
Number of Data Pretreatments 2 
Data Pretreatment Sequence  db1,nle 
Data Pretreatment Sequence  1. First Derivative BCAP 
 2. Normalization to Unit Length*, 
  6000-10600. 
Method PLS 
Max Iterations 3000 
Mean Centring yes 
Number of Primary PCs 5 
Secondary/Calibration PCs 1-5. (total 5/5) 
  
Blow Up Parameter  
Residual Blow Up 2 
Score Blow Up 1.05 
  
Max C-Set Spectra Residual 0.000556 
Max Allowed Residual for 
Calibration 
0.001113 
_____________________________  
  
Q-Value V5 0.878166 
Validation Method Validation Set 
  
C-Set Residual too big 0 
V-Set Residual too big 0 
  
Num Properties 1 
Rel. Consistency 0.000604 
Weighted BIAS 0.007186 
Validity 0.005527 
Comparability 0.002164 
Precision 0.027079 
Weighted Accuracy 0.088387 
_____________________________  
  
Property Statistics Folic acid [mg] 
  
C-Set BIAS 0 
V-Set BIAS 0.072673 
C-Set SEE (SEC) 0.273086 
V-Set SEE (SEP) 0.273855 
Consistency 99.7192 
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C-Set Regression Coefficient 0.996637 
V-Set Regression Coefficient 0.994473 
C-Set Regression Intercept 0.033263 
V-Set Regression Intercept 0.063931 
C-Set Regression Slope 0.993286 
V-Set Regression Slope 0.972477 
C-Set Orig. min 0.008435 
V-Set Orig. min 1.02903 
C-Set Orig. max 10.1216 
V-Set Orig. max 9.16008 
C-Set Orig. mean 4.954 
V-Set Orig. mean 4.96332 
C-Set Orig. sdev 3.3327 
V-Set Orig. sdev 2.57637 
  
C-Set Pred. min -0.13916 
V-Set Pred. min 0.893304 
C-Set Pred. max 10.3353 
V-Set Pred. max 9.07157 
C-Set Pred. mean 4.954 
V-Set Pred. mean 4.89065 
C-Set Pred. sdev 3.32149 
V-Set Pred. sdev 2.51938 
  
C-Set RSS 11.9321 
V-Set RSS 4.6614 
  
C-Set Durbin-Watson 1.86243 
C-Set Durbin-Watson in range 1.5 
to 2.5 
Yes 
V-Set Durbin-Watson 1.28254 
V-Set Durbin-Watson in range 1.5 
to 2.5 
No 
  
C-Set Resid. min -1.32909 
V-Set Resid. min -0.44622 
C-Set Resid. max 0.643026 
V-Set Resid. max 1.06942 
  
V-Set t-value 2.03836 
V-Set t-Test(n-1,2-tail) Confidence 
[%] 
95.3918 
  
C-Set n 161 
V-Set n 59 
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Appendix IV.8: Calibration protocol of NIR model A2 
Software NIRCal V5.2 (Build 3000) 
Project File Name folic acid  
Project Comment  
Project GUID {9A382F82-8E6E-42E7-9C70-AFD3F9B17884} 
Calibration Name A2 
Calibration Comment  
Calibration GUID {DF1DCEDF-3DFA-410F-B9D0-EC5B7E510DCD} 
Calibration Version 0 
_____________________________
____ 
 
  
Properties in Project Folic acid, Folic acid nominal. (total 2/2) 
Properties in Calibration Set Folic acid. (total 1/2) 
_____________________________
____ 
 
  
Spectra in Project 220 
Spectra in Calibration Set 161 
Spectra in Validation Set 59 
  
Spectra in Calibration Set 1-2, 4-5, 7-8, 10-11, 13-14, 16-17, 19-20, 22-23, 25-26, 28-29,  
 31-32, 34-35, 
 37-38, 40-41, 43-44, 46-47, 49-50, 52-53, 55-56, 58-59, 61-62, 
  64-65, 67-68, 
 70-71, 73-74, 76-77, 79-80, 82-83, 85, 88-89, 91-95, 97-98,  
 100-101, 103-104, 
 106-107, 109-110, 112-113, 115-116, 118-119, 121-122,  
 124-125, 127-128, 130-131, 
 133-134, 136-137, 139-140, 142-143, 145-146, 148-149,  
 151-152, 154-155, 157-158, 
 160-161, 163-164, 166-167, 169-170, 172-173, 175-218, 220.  
  
Spectra in Validation Set 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54,  
 57, 60, 63, 
 66, 69, 72, 75, 78, 81, 84, 86-87, 90, 96, 99, 102, 105, 108, 111,  
 114, 117, 
 120, 123, 126, 129, 132, 135, 138, 141, 144, 147, 150, 153, 156, 159, 
162, 165, 168, 171, 174, 219 
  
Validation Method Validation Set 
  
C-Set Spectra  
Instrument type / serial NIRFlex N500 / 600000281 
y-Unit / Measurements / Scans Transmittance / 1 / 64 
Spectra Resolution 4 1/cm 
Spectra y-Unit Transmittance 
_____________________________
____ 
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Wavelengths Project Set 6000-11520. (total 1381/1381) 
Wavelengths Calibration Set 8500-10600. (total 526/1381) 
  
Number of Data Pretreatments 3 
Data Pretreatment Sequence  ncl,db1,SNV 
Data Pretreatment Sequence  1. Normalization by Closure*, 6000-11520.  
 2. First Derivative BCAP 
 3. SNV Standard Normal Variate*, 8500-10600.  
  
Method PLS 
Max Iterations 3000 
Mean Centring yes 
Number of Primary PCs 4 
Secondary/Calibration PCs 1-4. (total 4/4) 
Blow Up Parameter  
Residual Blow Up 2 
Score Blow Up 1.05 
  
Max C-Set Spectra Residual 0.019124 
Max Allowed Residual for 
Calibration 
0.038248 
_____________________________
____ 
 
  
Q-Value V5 0.876954 
Validation Method Validation Set 
  
C-Set Residual too big 0 
V-Set Residual too big 0 
  
Num Properties 1 
Rel. Consistency 0.003751 
Weighted BIAS 0.00206 
Validity 0.00645 
Comparability 0.002509 
Precision 0.028773 
Weighted Accuracy 0.090958 
_____________________________  
  
Property Statistics Folic acid [mg] 
  
C-Set BIAS 0 
V-Set BIAS 0.02083 
C-Set SEE (SEC) 0.295844 
V-Set SEE (SEP) 0.290983 
Consistency 101.67 
  
C-Set Regression Coefficient 0.996059 
V-Set Regression Coefficient 0.99355 
C-Set Regression Intercept 0.039039 
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V-Set Regression Intercept 0.035007 
C-Set Regression Slope 0.992134 
V-Set Regression Slope 0.988696 
C-Set Pred. min -0.08475 
V-Set Pred. min 0.880036 
C-Set Pred. max 10.6774 
V-Set Pred. max 9.42144 
C-Set Pred. mean 4.96275 
V-Set Pred. mean 4.91862 
C-Set Pred. sdev 3.32248 
V-Set Pred. sdev 2.55331 
  
C-Set RSS 14.0038 
V-Set RSS 4.93652 
  
C-Set Durbin-Watson 1.97961 
C-Set Durbin-Watson in range 1.5 
to 2.5 
Yes 
V-Set Durbin-Watson 1.63596 
V-Set Durbin-Watson in range 1.5 
to 2.5 
Yes 
  
C-Set Resid. min -1.69417 
V-Set Resid. min -0.86411 
C-Set Resid. max 0.786573 
V-Set Resid. max 1.02183 
  
V-Set t-value 0.549857 
V-Set t-Test(n-1,2-tail) Confidence 
[%] 
41.5471 
  
C-Set n 161 
V-Set n 59 
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Appendix IV.9: Calibration protocol of NIR model A3 
Software NIRCal V5.2 (Build 3000) 
Project File Name folic acid 
Project Comment 
Project GUID {9A382F82-8E6E-42E7-9C70-AFD3F9B17884} 
Calibration Name A3 
Calibration Comment 
Calibration GUID {DF1DCEDF-3DFA-410F-B9D0-EC5B7E510DCD} 
Calibration Version 1 
_____________________________________ 
  
Properties in Project Folic acid, Folic acid nominal. (total 2/2) 
Properties in Calibration Set Folic acid. (total 1/2) 
_____________________________________ 
  
Spectra in Project 220 
Spectra in Calibration Set 160 
Spectra in Validation Set 59 
  
Spectra in Calibration Set 1-2, 4-5, 7-8, 10-11, 13-14, 16-17, 19-20, 22-23, 25-26, 28-29,  
 31-32, 34-35, 
 37-38, 40-41, 43-44, 46-47, 49-50, 52-53, 55-56, 58-59, 61-62,  
 64-65, 67-68, 
 70-71, 73-74, 76-77, 79-80, 82-83, 85, 88-89, 91-92, 94-95, 97-98, 100-101, 
 103-104, 106-107, 109-110, 112-113, 115-116, 118-119, 121-122, 124-125, 
127-128, 
 130-131, 133-134, 136-137, 139-140, 142-143, 145-146, 148-149, 151-152, 
154-155, 
 157-158, 160-161, 163-164, 166-167, 169-170, 172-173, 175-218, 220.  
  
Spectra in Validation Set 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48, 51, 54, 57, 60, 63, 
 66, 69, 72, 75, 78, 81, 84, 86-87, 90, 96, 99, 102, 105, 108, 111,  
 114, 117, 
 120, 123, 126, 129, 132, 135, 138, 141, 144, 147, 150, 153, 156,  
 159, 162, 165, 
 168, 171, 174, 219.  
Validation Method Validation Set 
  
C-Set Spectra 
Instrument type / serial NIRFlex N500 / 600000281 
y-Unit / Measurements / Scans Transmittance / 1 / 64 
  
V-Set Spectra 
Instrument type / serial NIRFlex N500 / 600000281 
y-Unit / Measurements / Scans Transmittance / 1 / 64 
Spectra Resolution 4 1/cm 
Spectra y-Unit Transmittance 
_____________________________________ 
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Wavelengths Project Set 6000-11520. (total 1381/1381) 
Wavelengths Calibration Set 8876-9216, 10488-10724. (total 146/1381) 
  
Number of Data Pretreatments 1 
Data Pretreatment Sequence  nsd 
Data Pretreatment Sequence  1. Normalization by Sdev*, 6000-11520. 
  
Method PLS 
Max Iterations 3000 
Mean Centring yes 
Number of Primary PCs 8 
Secondary/Calibration PCs 1-8. (total 8/8) 
  
Blow Up Parameter 
Residual Blow Up 2 
Score Blow Up 1.05 
  
Max C-Set Spectra Residual 0.000995 
Max Allowed Residual for 
Calibration 
0.00199 
_____________________________________ 
  
Q-Value V5 0.861954 
Validation Method Validation Set 
  
C-Set Residual too big 0 
V-Set Residual too big 0 
  
Num Properties 1 
Rel. Consistency 0.001525 
Weighted BIAS 0.002738 
Validity 0.008658 
Comparability 0.003589 
Precision 0.033474 
Weighted Accuracy 0.105905 
_____________________________________ 
  
Property Statistics            Folic acid [mg] 
  
C-Set BIAS 0 
V-Set BIAS 0.027694 
C-Set SEE (SEC) 0.336494 
V-Set SEE (SEP) 0.338533 
Consistency 99.3978 
  
C-Set Regression Coefficient 0.994931 
V-Set Regression Coefficient 0.991342 
C-Set Regression Intercept 0.050189 
V-Set Regression Intercept -0.00555 
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C-Set Regression Slope 0.989887 
V-Set Regression Slope 0.995517 
C-Set Orig. min 0.008435 
V-Set Orig. min 1.02903 
C-Set Orig. max 10.1216 
V-Set Orig. max 9.16008 
C-Set Orig. mean 4.96287 
V-Set Orig. mean 4.93945 
C-Set Orig. sdev 3.34609 
V-Set Orig. sdev 2.56585 
  
C-Set Pred. min -0.07869 
V-Set Pred. min 0.80691 
C-Set Pred. max 11.5259 
V-Set Pred. max 9.73067 
C-Set Pred. mean 4.96287 
V-Set Pred. mean 4.91175 
C-Set Pred. sdev 3.32913 
V-Set Pred. sdev 2.57666 
  
C-Set RSS 18.0033 
V-Set RSS 6.69232 
  
C-Set Durbin-Watson 1.50282 
C-Set Durbin-Watson in range 
1.5 to 2.5 
Yes 
V-Set Durbin-Watson 1.69863 
V-Set Durbin-Watson in range 
1.5 to 2.5 
Yes 
  
C-Set Resid. min -1.42957 
V-Set Resid. min -1.11547 
C-Set Resid. max 0.798551 
V-Set Resid. max 0.904472 
  
V-Set t-value 0.628364 
V-Set t-Test(n-1,2-tail) 
Confidence [%] 
46.7768 
  
C-Set n 160 
V-Set n 59 
 
  
 
242 Appendix V 
16. Appendix V 
Appendix V.1: Porosity and thickness outlier folic acid tablets 
Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
0.0% 1 1.00 12.87 199.30 1.98 0.1555 16.97 0.0000 
0.0% 2 1.00 13.44 204.90 2.02 0.1590 16.53 0.0000 
0.0% 3 1.10 10.49 196.40 2.02 0.1586 19.78 0.0000 
0.0% 4 1.10 10.07 200.00 2.05 0.1608 19.46 0.0000 
0.0% 5 1.20 9.52 200.20 2.11 0.1659 21.83 0.0000 
0.0% 6 1.20 8.40 198.50 2.10 0.1648 21.99 0.0000 
0.0% 7 1.30 7.94 199.10 2.17 0.1701 24.20 0.0000 
0.0% 8 1.30 7.96 202.50 2.19 0.1722 23.86 0.0000 
0.0% 9 1.40 7.47 198.20 2.22 0.1745 26.42 0.0000 
0.0% 10 1.40 7.58 205.00 2.28 0.1787 25.72 0.0000 
0.0% 11 1.50 6.65 196.70 2.27 0.1785 28.61 0.0000 
0.0% 12 1.50 6.02 197.30 2.28 0.1788 28.54 0.0000 
0.0% 13 1.60 4.00 203.00 2.39 0.1873 29.82 0.0000 
0.0% 14 1.60 4.13 201.50 2.37 0.1864 29.98 0.0000 
0.0% 15 1.70 4.31 198.00 2.41 0.1891 32.19 0.0000 
0.0% 16 1.70 5.21 198.10 2.41 0.1892 32.18 0.0000 
0.0% 17 1.80 3.23 200.80 2.49 0.1958 33.58 0.0000 
0.0% 18 1.80 3.33 195.20 2.45 0.1923 34.25 0.0000 
0.0% 19 1.90 3.91 203.70 2.58 0.2025 34.86 0.0000 
0.0% 20 1.90 3.72 200.90 2.56 0.2008 35.20 0.0000 
0.5% 1 1.00 12.03 202.50 2.01 0.1575 16.71 1.0125 
0.5% 2 1.00 12.24 196.90 1.96 0.1540 17.17 0.9845 
0.5% 3 1.10 11.35 204.50 2.08 0.1637 19.07 1.0225 
0.5% 4 1.10 10.86 204.60 2.08 0.1637 19.06 1.0230 
0.5% 5 1.20 10.20 203.00 2.13 0.1676 21.57 1.0150 
0.5% 6 1.20 10.19 201.50 2.12 0.1667 21.71 1.0075 
0.5% 7 1.30 8.98 200.20 2.17 0.1708 24.09 1.0010 
0.5% 8 1.30 7.57 203.80 2.20 0.1731 23.73 1.0190 
0.5% 9 1.40 6.74 200.50 2.24 0.1759 26.18 1.0025 
0.5% 10 1.40 6.77 197.70 2.22 0.1742 26.48 0.9885 
0.5% 11 1.50 5.04 193.80 2.25 0.1766 28.94 0.9690 
0.5% 12 1.50 6.54 198.70 2.29 0.1797 28.39 0.9935 
0.5% 13 1.60 4.93 191.70 2.29 0.1802 31.11 0.9585 
0.5% 14 1.60 4.55 193.60 2.31 0.1814 30.89 0.9680 
0.5% 15 1.70 4.58 195.50 2.39 0.1875 32.49 0.9775 
0.5% 16 1.70 3.77 192.50 2.36 0.1857 32.85 0.9625 
0.5% 17 1.80 4.59 194.80 2.45 0.1920 34.30 0.9740 
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Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
0.5% 18 1.80 4.63 193.40 2.43 0.1912 34.47 0.9670 
0.5% 19 1.90 3.11 197.00 2.53 0.1983 35.67 0.9850 
0.5% 20 1.90 4.20 196.10 2.52 0.1978 35.78 0.9805 
1.0% 1 1.00 11.76 202.40 2.00 0.1574 16.72 2.0240 
1.0% 2 1.00 13.04 202.30 2.00 0.1573 16.73 2.0230 
1.0% 3 1.10 11.51 201.60 2.06 0.1618 19.32 2.0160 
1.0% 4 1.10 11.16 202.00 2.06 0.1621 19.28 2.0200 
1.0% 5 1.20 10.18 200.40 2.11 0.1660 21.81 2.0040 
1.0% 6 1.20 9.33 199.60 2.11 0.1655 21.89 1.9960 
1.0% 7 1.30 8.54 198.90 2.16 0.1700 24.22 1.9890 
1.0% 8 1.30 8.67 194.40 2.13 0.1672 24.68 1.9440 
1.0% 9 1.40 6.38 197.50 2.22 0.1740 26.50 1.9750 
1.0% 10 1.40 7.05 197.30 2.21 0.1739 26.52 1.9730 
1.0% 11 1.50 5.34 204.30 2.33 0.1832 27.78 2.0430 
1.0% 12 1.50 6.17 203.00 2.32 0.1824 27.92 2.0300 
1.0% 13 1.60 3.93 197.40 2.34 0.1838 30.45 1.9740 
1.0% 14 1.60 4.64 198.30 2.35 0.1844 30.34 1.9830 
1.0% 15 1.70 4.86 196.60 2.40 0.1882 32.36 1.9660 
1.0% 16 1.70 5.16 198.70 2.41 0.1896 32.11 1.9870 
1.0% 17 1.80 4.32 189.90 2.41 0.1890 34.91 1.8990 
1.0% 18 1.80 2.96 190.80 2.41 0.1895 34.79 1.9080 
1.0% 19 1.90 4.26 193.90 2.50 0.1964 36.05 1.9390 
1.0% 20 1.90 2.57 191.80 2.48 0.1951 36.32 1.9180 
1.5% 1 1.00 11.88 213.60 2.09 0.1644 15.87 3.2040 
1.5% 2 1.00 12.98 210.70 2.07 0.1626 16.09 3.1605 
1.5% 3 1.10 11.79 206.30 2.10 0.1648 18.92 3.0945 
1.5% 4 1.10 11.43 208.90 2.12 0.1664 18.70 3.1335 
1.5% 5 1.20 8.75 209.40 2.19 0.1717 20.99 3.1410 
1.5% 6 1.20 10.15 207.90 2.17 0.1707 21.13 3.1185 
1.5% 7 1.30 7.17 206.40 2.22 0.1747 23.48 3.0960 
1.5% 8 1.30 7.68 205.90 2.22 0.1744 23.53 3.0885 
1.5% 9 1.40 6.70 203.00 2.26 0.1775 25.92 3.0450 
1.5% 10 1.40 6.08 203.30 2.26 0.1777 25.89 3.0495 
1.5% 11 1.50 5.58 201.60 2.31 0.1815 28.07 3.0240 
1.5% 12 1.50 6.46 203.90 2.33 0.1830 27.83 3.0585 
1.5% 13 1.60 5.19 200.00 2.36 0.1854 30.15 3.0000 
1.5% 14 1.60 5.42 201.70 2.37 0.1865 29.96 3.0255 
1.5% 15 1.70 3.63 197.90 2.41 0.1891 32.20 2.9685 
1.5% 16 1.70 4.93 195.60 2.39 0.1876 32.47 2.9340 
1.5% 17 1.80 2.99 199.30 2.48 0.1949 33.76 2.9895 
1.5% 18 1.80 4.32 203.70 2.52 0.1976 33.24 3.0555 
1.5% 19 1.90 2.84 189.00 2.46 0.1933 36.68 2.8350 
1.5% 20 1.90 3.93 192.70 2.49 0.1956 36.20 2.8905 
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Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
2.0% 1 1.00 12.12 207.40 2.04 0.1606 16.33 4.1480 
2.0% 2 1.00 12.05 206.70 2.04 0.1601 16.39 4.1340 
2.0% 3 1.10 11.93 203.80 2.08 0.1632 19.13 4.0760 
2.0% 4 1.10 11.69 203.70 2.08 0.1632 19.14 4.0740 
2.0% 5 1.20 8.88 204.20 2.14 0.1684 21.46 4.0840 
2.0% 6 1.20 9.50 204.40 2.15 0.1685 21.44 4.0880 
2.0% 7 1.30 7.19 203.70 2.20 0.1730 23.74 4.0740 
2.0% 8 1.30 7.37 204.00 2.21 0.1732 23.71 4.0800 
2.0% 9 1.40 5.94 204.00 2.27 0.1781 25.82 4.0800 
2.0% 10 1.40 5.83 202.40 2.26 0.1771 25.98 4.0480 
2.0% 11 1.50 5.81 198.40 2.29 0.1795 28.42 3.9680 
2.0% 12 1.50 4.81 197.10 2.28 0.1787 28.57 3.9420 
2.0% 13 1.60 4.45 198.90 2.35 0.1848 30.28 3.9780 
2.0% 14 1.60 4.60 197.40 2.34 0.1838 30.45 3.9480 
2.0% 15 1.70 3.58 207.30 2.48 0.1950 31.13 4.1460 
2.0% 16 1.70 5.14 206.60 2.48 0.1945 31.21 4.1320 
2.0% 17 1.80 4.63 201.80 2.50 0.1964 33.46 4.0360 
2.0% 18 1.80 4.23 198.50 2.47 0.1944 33.85 3.9700 
2.0% 19 1.90 2.87 195.20 2.51 0.1972 35.89 3.9040 
2.0% 20 1.90 4.02 191.80 2.48 0.1951 36.32 3.8360 
2.5% 1 1.00 12.48 202.00 2.00 0.1572 16.75 6.0338 
2.5% 2 1.00 12.74 200.20 1.99 0.1560 16.90 5.6306 
2.5% 3 1.10 10.15 198.20 2.03 0.1597 19.62 5.6361 
2.5% 4 1.10 11.78 196.10 2.02 0.1584 19.81 5.3084 
2.5% 5 1.20 9.35 198.00 2.09 0.1645 22.04 5.3442 
2.5% 6 1.20 9.70 200.60 2.12 0.1661 21.79 4.8061 
2.5% 7 1.30 8.95 195.90 2.14 0.1681 24.52 4.9318 
2.5% 8 1.30 7.65 201.10 2.18 0.1714 24.00 4.9550 
2.5% 9 1.40 7.54 195.90 2.20 0.1730 26.67 5.1005 
2.5% 10 1.40 6.83 197.60 2.22 0.1741 26.49 5.2911 
2.5% 11 1.50 6.51 200.50 2.30 0.1808 28.19 4.5771 
2.5% 12 1.50 4.85 199.70 2.30 0.1803 28.28 4.5889 
2.5% 13 1.60 4.47 203.20 2.39 0.1875 29.79 4.6009 
2.5% 14 1.60 5.48 198.00 2.35 0.1842 30.38 5.0326 
2.5% 15 1.70 4.36 201.50 2.44 0.1913 31.79 4.7504 
2.5% 16 1.70 3.38 203.30 2.45 0.1924 31.58 5.0950 
2.5% 17 1.80 4.02 197.70 2.47 0.1939 33.95 4.8643 
2.5% 18 1.80 3.23 197.20 2.46 0.1935 34.01 4.9474 
2.5% 19 1.90 2.59 204.20 2.58 0.2029 34.81 4.9098 
2.5% 20 1.90 4.35 201.20 2.56 0.2010 35.16 4.8904 
3.0% 1 1.00 13.19 201.70 2.00 0.1570 16.78 4.7589 
3.0% 2 1.00 12.78 202.50 2.01 0.1575 16.71 5.5332 
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Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
3.0% 3 1.10 10.05 203.90 2.08 0.1633 19.12 5.7137 
3.0% 4 1.10 10.58 204.90 2.09 0.1639 19.03 5.9321 
3.0% 5 1.20 10.26 208.50 2.18 0.1711 21.07 6.3522 
3.0% 6 1.20 9.61 202.50 2.13 0.1673 21.62 5.7970 
3.0% 7 1.30 8.09 205.40 2.22 0.1741 23.58 5.9251 
3.0% 8 1.30 7.99 202.00 2.19 0.1719 23.91 5.5902 
3.0% 9 1.40 6.67 203.60 2.26 0.1779 25.86 6.0681 
3.0% 10 1.40 7.19 197.70 2.22 0.1742 26.48 5.8722 
3.0% 11 1.50 5.71 202.60 2.32 0.1822 27.96 7.3678 
3.0% 12 1.50 5.13 203.40 2.33 0.1827 27.88 6.7621 
3.0% 13 1.60 5.16 202.30 2.38 0.1869 29.89 5.9944 
3.0% 14 1.60 4.84 200.90 2.37 0.1860 30.05 6.0639 
3.0% 15 1.70 4.01 198.40 2.41 0.1894 32.14 5.5717 
3.0% 16 1.70 5.00 200.90 2.43 0.1909 31.85 5.8893 
3.0% 17 1.80 3.42 201.50 2.50 0.1962 33.50 6.0658 
3.0% 18 1.80 3.87 196.20 2.46 0.1929 34.13 5.9427 
3.0% 19 1.90 2.49 198.00 2.53 0.1990 35.55 6.0381 
3.0% 20 1.90 3.52 194.30 2.50 0.1966 36.00 5.7991 
3.5% 1 1.00 12.76 204.40 2.02 0.1587 16.56 7.1540 
3.5% 2 1.00 13.47 203.30 2.01 0.1580 16.65 7.1155 
3.5% 3 1.10 11.46 208.40 2.11 0.1661 18.74 7.2940 
3.5% 4 1.10 11.55 206.30 2.10 0.1648 18.92 7.2205 
3.5% 5 1.20 8.54 207.60 2.17 0.1705 21.15 7.2660 
3.5% 6 1.20 9.55 202.10 2.13 0.1671 21.65 7.0735 
3.5% 7 1.30 7.07 206.50 2.23 0.1748 23.47 7.2275 
3.5% 8 1.30 7.93 200.70 2.18 0.1711 24.04 7.0245 
3.5% 9 1.40 7.77 209.90 2.32 0.1818 25.23 7.3465 
3.5% 10 1.40 7.13 197.50 2.22 0.1740 26.50 6.9125 
3.5% 11 1.50 6.19 200.50 2.30 0.1808 28.19 7.0175 
3.5% 12 1.50 6.07 202.20 2.32 0.1819 28.01 7.0770 
3.5% 13 1.60 4.30 202.70 2.38 0.1871 29.85 7.0945 
3.5% 14 1.60 4.80 201.50 2.37 0.1864 29.98 7.0525 
3.5% 15 1.70 4.15 200.60 2.43 0.1907 31.89 7.0210 
3.5% 16 1.70 3.68 203.00 2.45 0.1923 31.61 7.1050 
3.5% 17 1.80 4.50 206.80 2.54 0.1996 32.89 7.2380 
3.5% 18 1.80 2.79 198.50 2.47 0.1944 33.85 6.9475 
3.5% 19 1.90 2.60 194.40 2.50 0.1967 35.99 6.8040 
3.5% 20 1.90 2.77 194.30 2.50 0.1966 36.00 6.8005 
4.0% 1 1.00 12.27 194.40 1.94 0.1524 17.37 7.7760 
4.0% 2 1.00 12.20 197.40 1.96 0.1543 17.12 7.8960 
4.0% 3 1.10 11.85 206.40 2.10 0.1648 18.91 8.2560 
4.0% 4 1.10 11.11 197.50 2.03 0.1593 19.68 7.9000 
4.0% 5 1.20 10.19 204.60 2.15 0.1686 21.42 8.1840 
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Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
4.0% 6 1.20 10.24 196.60 2.08 0.1636 22.18 7.8640 
4.0% 7 1.30 7.89 200.20 2.17 0.1708 24.09 8.0080 
4.0% 8 1.30 8.23 201.50 2.19 0.1716 23.96 8.0600 
4.0% 9 1.40 7.02 202.20 2.25 0.1770 26.00 8.0880 
4.0% 10 1.40 7.53 205.60 2.28 0.1791 25.66 8.2240 
4.0% 11 1.50 6.35 202.00 2.31 0.1818 28.03 8.0800 
4.0% 12 1.50 5.25 203.50 2.33 0.1827 27.87 8.1400 
4.0% 13 1.60 4.78 201.10 2.37 0.1861 30.03 8.0440 
4.0% 14 1.60 5.18 197.70 2.34 0.1840 30.41 7.9080 
4.0% 15 1.70 3.92 198.10 2.41 0.1892 32.18 7.9240 
4.0% 16 1.70 3.83 201.20 2.43 0.1911 31.82 8.0480 
4.0% 17 1.80 3.20 195.80 2.45 0.1927 34.18 7.8320 
4.0% 18 1.80 4.36 194.20 2.44 0.1917 34.37 7.7680 
4.0% 19 1.90 2.98 197.30 2.53 0.1985 35.63 7.8920 
4.0% 20 1.90 2.44 196.90 2.52 0.1983 35.68 7.8760 
4.5% 1 1.00 13.16 200.10 1.99 0.1560 16.91 9.0045 
4.5% 2 1.00 12.76 202.30 2.00 0.1573 16.73 9.1035 
4.5% 3 1.10 9.95 201.40 2.06 0.1617 19.33 9.0630 
4.5% 4 1.10 10.47 203.00 2.07 0.1627 19.20 9.1350 
4.5% 5 1.20 10.19 203.80 2.14 0.1681 21.50 9.1710 
4.5% 6 1.20 8.94 202.20 2.13 0.1671 21.64 9.0990 
4.5% 7 1.30 8.26 203.10 2.20 0.1726 23.80 9.1395 
4.5% 8 1.30 8.66 197.70 2.15 0.1692 24.34 8.8965 
4.5% 9 1.40 7.17 201.00 2.24 0.1762 26.13 9.0450 
4.5% 10 1.40 7.11 199.80 2.23 0.1755 26.25 8.9910 
4.5% 11 1.50 6.40 200.20 2.30 0.1806 28.22 9.0090 
4.5% 12 1.50 5.19 203.80 2.33 0.1829 27.84 9.1710 
4.5% 13 1.60 5.30 199.50 2.36 0.1851 30.21 8.9775 
4.5% 14 1.60 4.21 202.50 2.38 0.1870 29.87 9.1125 
4.5% 15 1.70 4.11 201.90 2.44 0.1916 31.74 9.0855 
4.5% 16 1.70 3.43 199.60 2.42 0.1901 32.00 8.9820 
4.5% 17 1.80 4.35 200.60 2.49 0.1957 33.60 9.0270 
4.5% 18 1.80 4.50 201.60 2.50 0.1963 33.49 9.0720 
4.5% 19 1.90 2.49 193.80 2.50 0.1963 36.07 8.7210 
4.5% 20 1.90 2.78 198.30 2.54 0.1992 35.51 8.9235 
5.0% 1 1.00 12.46 201.60 2.00 0.1569 16.79 10.0800 
5.0% 2 1.00 13.11 201.90 2.00 0.1571 16.76 10.0950 
5.0% 3 1.10 10.59 204.80 2.09 0.1638 19.04 10.2400 
5.0% 4 1.10 10.22 200.90 2.05 0.1614 19.38 10.0450 
5.0% 5 1.20 8.97 200.30 2.11 0.1659 21.82 10.0150 
5.0% 6 1.20 10.23 202.30 2.13 0.1672 21.63 10.1150 
5.0% 7 1.30 7.02 198.70 2.16 0.1699 24.24 9.9350 
5.0% 8 1.30 8.72 201.10 2.18 0.1714 24.00 10.0550 
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Batch No. Gap 
size 
[mm] 
Uppe
r force 
[kN] 
Mass 
[mg] 
Thick
ness [mm] 
Volum
e [cm3] 
Poro
sity [%] 
UV 
Content 
5.0% 9 1.40 6.67 201.70 2.25 0.1767 26.06 10.0850 
5.0% 10 1.40 6.50 200.00 2.24 0.1756 26.23 10.0000 
5.0% 11 1.50 5.65 200.30 2.30 0.1807 28.21 10.0150 
5.0% 12 1.50 6.52 202.00 2.31 0.1818 28.03 10.1000 
5.0% 13 1.60 5.22 199.40 2.36 0.1851 30.22 9.9700 
5.0% 14 1.60 5.48 194.60 2.32 0.1821 30.77 9.7300 
5.0% 15 1.70 3.93 195.00 2.38 0.1872 32.55 9.7500 
5.0% 16 1.70 3.62 194.30 2.38 0.1868 32.63 9.7150 
5.0% 17 1.80 3.37 199.70 2.48 0.1951 33.71 9.9850 
5.0% 18 1.80 3.85 198.00 2.47 0.1940 33.91 9.9000 
5.0% 19 1.90 3.92 207.20 2.61 0.2047 34.46 10.3600 
5.0% 20 1.90 2.82 206.90 2.60 0.2046 34.49 10.3450 
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Appendix V.2: Variable porosity and thickness folic acid tablets external prediction 
batch 
# mass [mg] thickness [mm] porosity UV content 
[mg] 
1 204.5 1.99 18.67% 5.1125 
2 206.7 2.00 19.42% 5.1675 
3 200.2 2.00 20.18% 5.0050 
4 199.8 2.00 21.43% 4.9950 
5 204.0 2.07 22.69% 5.1000 
6 205.7 2.08 23.33% 5.1425 
7 200.8 2.10 23.98% 5.0200 
8 200.0 2.11 25.51% 5.0000 
9 202.2 2.20 27.04% 5.0550 
10 205.7 2.20 27.88% 5.1425 
11 196.0 2.22 28.71% 4.9000 
12 203.7 2.28 29.96% 5.0925 
13 199.2 2.31 31.21% 4.9800 
14 199.0 2.30 32.16% 4.9750 
15 194.5 2.37 33.10% 4.8625 
16 200.9 2.39 34.27% 5.0225 
17 198.7 2.45 35.43% 4.9675 
18 202.2 2.47 36.23% 5.0550 
19 198.9 2.53 37.03% 4.9725 
20 194.7 2.55 37.50% 4.8675 
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Appendix VI.1: Printed paper filters (exact experimental size) 
 
 
 
Appendix VI.2: Tableting data of DT sampling span tablets 
# Gap size 
[mm] 
Upper force 
[kN] 
Weight 
[mg] 
Thickness 
[mm] 
Volume 
[cm3] 
Porosity 
[%] 
1 1.00 12.40 199.77 1.95 0.1532 15.52 
2 1.10 11.82 202.65 2.01 0.1579 16.86 
3 1.20 9.24 204.73 2.11 0.1657 19.99 
4 1.30 8.79 202.64 2.16 0.1696 22.64 
5 1.40 6.11 204.55 2.26 0.1775 25.36 
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Appendix VI.3: DT data at 8880 cm-1 for 5 tablets and all filters. A, B and C represent 3 
measurements for the same filter type, (Fx). 
 Transmittance (non-pretreated) 
 15.52% 16.86% 19.99% 22.64% 25.36% 
F0      
A 0.000594 0.000465 0.00039 0.000289 0.000251 
B 0.0005987 0.0004728 0.000397 0.000296 0.000255 
C 0.0005893 0.0004572 0.000383 0.000282 0.000247 
F1      
A 0.000605 0.000429 0.000369 0.000287 0.000242 
B 0.0006097 0.0004368 0.000376 0.000294 0.000246 
C 0.0006003 0.0004212 0.000362 0.00028 0.000238 
F2      
A 0.000582 0.000432 0.000364 0.000275 0.000228 
B 0.0005867 0.0004398 0.000371 0.000282 0.000232 
C 0.0005773 0.0004242 0.000357 0.000268 0.000224 
F3      
A 0.00057 0.000449 0.000374 0.000291 0.00024 
B 0.0005747 0.0004568 0.000381 0.000298 0.000244 
C 0.0005653 0.0004412 0.000367 0.000284 0.000236 
F4      
A 0.000528 0.000425 0.00037 0.000274 0.000229 
B 0.0005327 0.0004328 0.000377 0.000281 0.000233 
C 0.0005233 0.0004172 0.000363 0.000267 0.000225 
F5      
A 0.000498 0.000387 0.000337 0.000236 0.000212 
B 0.0005027 0.0003948 0.000344 0.000243 0.000216 
C 0.0004933 0.0003792 0.00033 0.000229 0.000208 
F6      
A 0.000385 0.000311 0.000263 0.000178 0.000162 
B 0.0003897 0.0003188 0.00027 0.000185 0.000166 
C 0.0003803 0.0003032 0.000256 0.000171 0.000158 
F7      
A 0.000326 0.000261 0.00017 0.00016 0.000143 
B 0.0003307 0.0002688 0.000177 0.000167 0.000147 
C 0.0003213 0.0002532 0.000163 0.000153 0.000139 
F8      
A 0.000199 0.000166 0.000104 0.000088 0.000085 
B 0.0002037 0.0001738 0.000111 9.47E-05 8.93E-05 
C 0.0001943 0.0001582 9.73E-05 8.13E-05 8.07E-05 
F9      
A 0.000116 0.000083 0.000077 0.00006 0.000047 
B 0.0001207 0.0000908 8.37E-05 6.67E-05 5.13E-05 
C 0.0001113 0.0000752 7.03E-05 5.33E-05 4.27E-05 
F10      
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A 0.00007 0.00005 0.000044 0.000034 0.00003 
B 0.0000747 0.0000578 5.07E-05 4.07E-05 3.43E-05 
C 0.0000653 0.0000422 3.73E-05 2.73E-05 2.57E-05 
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Appendix VII.1: Incremental thickness tableting data (Zwick) 
Nominal thickness [mm] 
Powder mass 
[mg] Calculated force [N] 
Achieved force 
[N] 
0.5 42.12 4018 4058 
1.0 84.23 3788 3791 
1.5 126.35 3659 3641 
2.0 168.47 3571 3550 
2.5 210.58 3504 3494 
3.0 252.70 3450 3456 
3.5 294.82 3405 3413 
4.0 336.94 3366 3373 
4.5 379.05 3332 3370 
5.0 421.17 3303 3372 
5.5 463.29 3276 3370 
6.0 505.40 3252 3385 
6.5 547.52 3230 3369 
7.0 589.64 3209 3383 
7.5 631.75 3190 3370 
8.0 673.87 3173 3404 
8.5 715.59 3157 3417 
9.0 758.11 3141 3424 
9.5 800.22 3127 3439 
10.0 842.34 3113 3460 
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Appendix VII.2: Excel macro VBA code 
 
Sub Macro2() 
' 
' Macro2 Macro 
' 
' Keyboard Shortcut: Ctrl+w 
' 
     
    For i = 1 To 1501 
     
    ActiveCell.Offset(0, -2).Range("A1:B1").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("graph").Select 
    Range("B2").Select 
    Selection.PasteSpecial Paste:=xlPasteValues, Operation:=xlNone, SkipBlanks _ 
        :=False, Transpose:=False 
    Application.Calculate 
    Sheets("conclusion").Select 
    Range("L29:Q29").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Sheets("macro2").Select 
    ActiveCell.Offset(0, 2).Range("A1").Select 
    Selection.PasteSpecial Paste:=xlPasteValues, Operation:=xlNone, SkipBlanks _ 
        :=False, Transpose:=False 
    ActiveCell.Offset(1, 0).Range("A1").Select 
     
    Next 
End Sub 
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